Paclitaxel

Name	Value
Weight	853.918 g/mol
Zinc ID	ZINC96006020
Smiles	CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C
Molecular formula	C47H51NO14
Mode of inhibition	STAT; Natural product
CAS	33069-62-4

Clinical Trials

Study title	Status	Conditions	Link
Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response	Suspended	Breast Neoplasm Female	NCT03096418
Nab-paclitaxel in Combination With Gemcitabine for Pediatric Relapsed and Refractory Solid Tumors	Recruiting	Cancer	NCT03507491
Study to Evaluate CORT125134 in Combination With Nab-paclitaxel in Patients With Solid Tumors	Active, not recruiting	Solid Tumors	NCT02762981
Paclitaxel Injection (Albumin-bound) for Neoadjuvant Treatment of Breast Cancer	Not yet recruiting	Breast Cancer Stage	NCT03959397
Paclitaxel-binding Albumin and Cisplatin as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer	Recruiting	Bladder Cancer	NCT04060459
Clinical Study of Albumin-paclitaxel Combined With Apatinib and Camrelizumab in Advanced Gastric Cancer	Not yet recruiting	Advanced Gastric Cancer	NCT04286711
Treatment of Triple-negative Breast Cancer With Albumin-bound Paclitaxel as Neoadjuvant Therapy: a Prospective RCT	Not yet recruiting	Breast Cancer	NCT04137653
Nab-paclitaxel and Gemcitabine in Metastatic Pancreatic Cancer	Recruiting	Metastatic Pancreatic Cancer	NCT03929094
Clinical Trial of Combined Fostamatinib and Paclitaxel in Ovarian Cancer	Recruiting	Ovarian Cancer	NCT03246074
A Phase I Trial of the Combination of AZD2014 and Weekly Paclitaxel.	Completed	Advanced Cancer	NCT02193633
A Study to Evaluate Camrelizumab in Combination With Nb-Paclitaxel in Patients With Advanced or Metastatic NSCLC	Recruiting	Non-Small Cell Lung Cancer	NCT04167774
Phase IB Trial of LDE225 and Paclitaxel in Recurrent Ovarian Cancer	Completed	Recurrent Ovarian Cancer	NCT02195973
FRAIL-IMMUNE (GORTEC 2018-03) - Combination of Durvalumab With Carboplatin/Paclitaxel	Recruiting	Squamous Cell Carcinoma of the Head and Neck	NCT03723967
Study of Gemcitabine, Nab-paclitaxel, and Ficlatuzumab (AV-299) in Patients With Advanced Pancreatic Cancer	Active, not recruiting	Pancreatic Cancer	NCT03316599
Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Capecitabine in the Treatment of Advanced Triple-negative Breast Cancer	Recruiting	Triple Negative Breast Cancer\|Nab-paclitaxel	NCT04159142
Study of Concurrent Paclitaxel and Radiation: Correlation of Tumor Profiles With Pathologic Response	Active, not recruiting	Breast Cancer	NCT02280252
Lenvatinib and Weekly Paclitaxel for Patients With Recurrent Endometrial or Ovarian Cancer	Active, not recruiting	Fallopian Tube Carcinoma\|Recurrent Ovarian Cancer\|Primary Peritoneal Carcinoma\|Recurrent Endometrial Cancer	NCT02788708
A Study of Vantictumab (OMP-18R5) in Combination With Paclitaxel in Locally Recurrent or Metastatic Breast Cancer	Completed	Metastatic Breast Cancer	NCT01973309
Pembrolizumab and Paclitaxel in Refractory Small Cell Lung Cancer	Completed	Small Cell Lung Cancer	NCT02551432
Endoscopic Abraxane Injection Into Pancreatic Cysts	Terminated	Pancreatic Cysts	NCT01698710
AMG 386 Drug-Drug Interaction Study With Paclitaxel	Completed	Advanced Solid Tumors	NCT01992341
A Phase Ib/2 Clinical Study of Fruquintinib Combined With Paclitaxel in the Treatment of Advanced Gastric Cancer	Completed	Gastric Cancer	NCT02415023
Single Arm on the Tolerability of Weekly Nab-paclitaxel	Active, not recruiting	Non Small Cell Lung Cancer (NSCLC)	NCT01702844
Assessment Of Stromal Response To Nab-Paclitaxel In Combination With Gemcitabine In Pancreatic Cancer	Completed	Pancreatic Cancer	NCT01442974
Dose Escalation and Pharmacokinetic Study of Paclitaxel Liposome Injection in Treating Patients With Advanced Solid Tumor After Failure From Conventional Treatments	Unknown status	Solid Tumors	NCT01994031
Nab-paclitaxel as Second-line Therapy in Locally Advanced or Metastatic Squamous Lung Cancer	Unknown status	Squamous Cell Carcinoma of Lung	NCT01969955
Safety, Tolerability and Efficacy Profile of Rivoceranib With Paclitaxel in Advanced GC or GEJ Cancer.	Recruiting	Gastric Cancer\|Gastroesophageal Junction Adenocarcinoma	NCT03707028
Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Epirubicin in the Neoadjuvant Therapy for Breast Cancer	Recruiting	Breast Cancer\|Triple-negative Breast Cancer\|Nab-paclitaxel	NCT04138719
A Clinical Study in Cancer Patients to Investigate the Potential Impact of Custirsen, on the Blood Levels of the Chemotherapeutic Drug, Paclitaxel, When Given Together as Part of a Treatment Regimen	Completed	Cancer	NCT01497470
A Study of CRLX101(NLG207) in Combination With Weekly Paclitaxel in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer	Terminated	Ovarian Cancer	NCT02389985
Phase I/II Study of LDE225 With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer	Completed	Pancreatic Cancer	NCT02358161
Pembrolizumab With Nab-Paclitaxel in Non-Small Cell Lung Cancer	Active, not recruiting	Lung Cancer	NCT02733250
Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Squamous Cell Carcinoma of Esophagus	Withdrawn	Squamous Cell Carcinoma of Esophagus	NCT02033538
A Phase II Study of Interaction of Lovastatin and Paclitaxel For Patients With Refractory or Relapsed Ovarian Cancer	Terminated	Ovarian Cancer	NCT00585052
Nanoparticle-based Paclitaxel vs Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Early Breast Cancer (GeparSepto)	Unknown status	Tubular Breast Cancer Stage II\|Mucinous Breast Cancer Stage II\|Breast Cancer Female NOS\|Invasive Ductal Breast Cancer\|Tubular Breast Cancer Stage III\|HER-2 Positive Breast Cancer\|Inflammatory Breast Cancer Stage IV\|Inflammatory Breast Cancer	NCT01583426
Exploratory Study on the Paclitaxel + S-1 + Oxaliplatin (PSOX) for Locally Advanced or Advanced Gastric Cancer	Recruiting	Gastric Cancer	NCT03263741
Circulating Tumor Cells as Tools for Therapy Response in Nab-paclitaxel Treated Metastatic Pancreatic Cancer Patients	Unknown status	Metastatic Pancreatic Cancer	NCT02707159
The Efficacy and Safety of Nab-paclitaxel in Pretreated Patients With Extensive Disease of Small Cell Lung Cancer	Unknown status	Small Cell Lung Cancer	NCT02262897
A Study on Predictive Value of ERCC1 in Esophageal Cancer Patients Treated With Paclitaxel and Cisplatin	Unknown status	Esophageal Cancer	NCT01444547
A Study of CPI-613 With Gemcitabine and Nab-paclitaxel for Patients With Advanced or Metastatic Pancreatic Cancer	Unknown status	Pancreatic Cancer\|Metastatic Pancreatic Cancer	NCT03435289
Efficacy and Safety of Nab-Paclitaxel Plus S-1 in the First-line Treatment of Advanced Pancreatic Cancer	Unknown status	Advanced Pancreatic Cancer	NCT03415802
Nab-Paclitaxel With Gemcitabine for Relapsed Small Cell Cancer	Recruiting	Small Cell Lung Cancer (SCLC)	NCT02769832
Nab-paclitaxel Combined With Gemcitabine as Adjuvant Therapy for Pancreatic Cancer After Curative Resection	Completed	Stage IA Pancreatic Adenocarcinoma\|Stage IB Pancreatic Adenocarcinoma\|Stage IIA Pancreatic Adenocarcinoma\|Stage IIB Pancreatic Adenocarcinoma	NCT02023021
A Study in Hormone Receptor-positive Metastatic Breast Carcinoma Patients to Test a New Schedule of Efti (IMP321, Eftilagimod Alpha) as Adjunctive to a Weekly Treatment Regimen of Paclitaxel	Not yet recruiting	Metastatic Breast Cancer	NCT04252768
Combination Nilotinib and Paclitaxel in Adults With Relapsed Solid Tumors	Recruiting	Solid Tumors	NCT02379416
Gemcitabine + Oxaliplatin +Nab-paclitaxel in Subjects With Advanced Biliary Tract Cancer	Recruiting	Cholangiocarcinoma	NCT03943043
Paclitaxel-Avelumab for Angiosarcoma	Recruiting	Angiosarcoma Metastatic	NCT03512834
Treatment With Nab-paclitaxel in Cutaneous SCC	Terminated	Cutaneous Squamous Cell Carcinoma	NCT02076243
Study of Cirmtuzumab and Paclitaxel for Metastatic or Locally Advanced, Unresectable Breast Cancer	Recruiting	Breast Neoplasms	NCT02776917
Phase I Low Dose WART in Combination With Weekly Paclitaxel for Platinum Resistant Ovarian Cancer	Unknown status	Ovarian Cancer	NCT02545010
The Efficacy and Safety of Nab-paclitaxel Plus S-1 in First-line Treatment of Advanced Biliary Tract Adenocarcinoma	Recruiting	Biliary Tract Cancer	NCT03830606
A Trial of Paclitaxel (Albumin-binding) for Castration-resistant Prostate Cancer	Not yet recruiting	Castration-resistant Prostate Cancer	NCT04148885
A Phase III Study of Fruquintinib in Combination With Paclitaxel in Second Line Gastric Cancer(FRUTIGA)	Recruiting	Advanced Gastric Cancer	NCT03223376
F16IL2 Plus Paclitaxel in Metastatic Merkel Cell Carcinoma	Terminated	Merkel Cell Carcinoma	NCT02054884
NAPAGE: NAb-PAclitaxel and GEmcitabine in Advanced Soft Tissue Sarcoma	Recruiting	Soft Tissue Sarcoma	NCT03524898
A Study of KX2-391 With Paclitaxel in Patients With Solid Tumors	Unknown status	Unspecified Adult Solid Tumor, Protocol Specific\|Gastric Cancer\|Breast Cancer	NCT01764087
A Study of MM-121 in Combination With Paclitaxel in Patients With Advanced Gynecologic and Breast Cancers	Completed	Locally Advanced/Metastatic or Recurrent Ovarian Cancer, Fallopian Tube Cancer,\|Primary Peritoneal Cancer or Endometrial Cancer\|Locally Advanced/Metastatic Her2 Non Overexpressing Breast Cancer	NCT01209195
Paclitaxel (Albumin-bound) Combined With Oxaliplatin and S-1 Conversion Therapy for Gastric Adenocarcinoma	Not yet recruiting	Gastric Adenocarcinoma	NCT04047953
Trial of Neoadjuvant Chemotherapy With S1 Plus Paclitaxel-albumin on Pancreatic Cancer	Recruiting	Pancreatic Cancer\|Neoadjuvant Chemotherapy	NCT03585062
Neoadjuvant Chemotherapy With Nab-paclitaxel in Women With HER2-negative High-risk Breast Cancer	Active, not recruiting	Breast Cancer	NCT01822314
Carboplatin-Paclitaxel Adjuvant Chemotherapy in the Treatment of Locally Advanced Cervical Cancer	Not yet recruiting	Locally Advanced Cancer\|Cervical Cancer	NCT04016142
LDE225 and Paclitaxel in Solid Tumors	Completed	Solid Tumor\|Ovarian Cancer	NCT01954355
Paclitaxel Plus Pembrolizumab vs. Paclitaxel Weekly in ER+ Luminal B Metastatic Breast Cancer	Not yet recruiting	Breast Cancer	NCT03841747
Oral Paclitaxel Efficacy Safety and PK in Recurrent and Metastatic Breast Cancer	Recruiting	Recurrent or Metastatic Breast Cancer	NCT03326102
Abraxane in Treatment of Metastatic Breast Cancer	Completed	Metastatic Breast Cancer	NCT02555696
Pembrolizumab + Paclitaxel in Hormone Receptor-positive (HR+)/Human Epidermal Growth Factor Receptor 2-negative (HER2-) Non-luminal (by PAM50) Advanced Breast Cancer After Cyclin-dependent Kinase 4/6 (CDK4/6) Inhibitors Progression	Not yet recruiting	Metastatic Breast Cancer	NCT04251169
Paclitaxel and BKM120 Before Surgery in Treating Patients With Stage II or III Estrogen Receptor-Positive and HER2-Negative Breast Cancer	Withdrawn	Breast Neoplasms	NCT01953445
Nab-paclitaxel Plus Gemcitabine as First-line Therapy for Cisplatin-ineligible or Cisplatin-incurable Advanced Urothelial Carcinoma	Active, not recruiting	Urothelial Carcinoma\|Bladder Cancer\|Transitional Cell Carcinoma	NCT02887248
Paclitaxel Detection in NSCLC Treated With TC Regimen	Terminated	Non-small Cell Lung Cancer	NCT02737709
PU-H71 With Nab-paclitaxel (Abraxane) in Metastatic Breast Cancer	Active, not recruiting	Metastatic Breast Cancer	NCT03166085
Nab-Paclitaxel as Salvage Treatment in Locally Advanced or Metastatic Gastric Cancer	Completed	Stomach and Gastro-Esophageal Junction (GEJ) Cancer	NCT02251951
Phase I & II Trial of Intravesicular Abraxane for Treatment-refractory Bladder Cancer	Unknown status	Bladder Cancer	NCT00583349
Study With Pazopanib and Weekly Paclitaxel in Penile Carcinoma (PAZOPEN-SOGUG)	Terminated	Penile Squamous Cell Carcinoma Stage IV	NCT02279576
Ph2 Nab-paclitaxel With Gemcitabine to Determine Efficacy in Advanced Non-squamous NSCLC.	Withdrawn	Non-small Cell Lung Cancer	NCT02405910
The Addition of Nab-paclitaxel (Abraxane) to First Line Treatment of Metastasized Oesophagogastric Carcinoma (ACTION)	Completed	Esophageal Cancer\|Toxicity	NCT02273713
Retrospective Analysis of 2nd-line Nab-Paclitaxel + Gemcitabine After 1st-line FOLFIRINOX in Pancreatic Cancer	Completed	Pancreatic Cancer\|Metastatic Pancreatic Cancer	NCT04133155
Trial of Nab-paclitaxel in Patients With Desmoid Tumors and Multiply Relapsed/Refractory Desmoplastic Small Round Cell Tumors and Ewing Sarcoma	Recruiting	Tumor, Desmoplastic Small Round Cell, Adult\|Tumor, Desmoplastic Small Round Cell, Childhood\|Sarcoma, Ewing\|Sarcoma\|Desmoid	NCT03275818
Nab-paclitaxel and Gemcitabine, in Elderly Patients Untreated Metastatic Pancreatic Adenocarcinoma	Completed	Pancreatic Carcinoma Metastatic	NCT02391662
A Study to Evaluate the Potential Benefit of the Addition of BYL719 to Paclitaxel in the Treatment of Breast Cancer and Head-and-neck Cancer	Completed	Neoplasms, Breast Neoplasms, Head and Neck Neoplasms	NCT02051751
Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the Elderly	Completed	Non-Small Cell Lung Cancer\|Carcinoma\|Squamous Cell Carcinoma\|Adenocarcinoma\|Carcinoma, Large Cell\|Lung Neoplasm	NCT02151149
Regional Cryotherapy in Preventing Paclitaxel Induced Peripheral Neuropathy in Breast Cancer Patients	Recruiting	Breast Cancer	NCT03429972
Phase I/II Trial of the Combination of Lenalidomide (Revlimid) and Nab-paclitaxel (Abraxane) in the Treatment of Relapsed/Refractory Multiple Myeloma	Terminated	Relapsed or Refractory Multiple Myeloma	NCT02075021
Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Lung Cancer	Unknown status	Non Small Cell Lung Cancer	NCT02016209
Prevention of Paclitaxel Neuropathy With Cryotherapy	Unknown status	Breast Cancer	NCT02230319
Nab-paclitaxel Versus Topotecan As Second-Line Treatment for Patients With Extensive Stage Small Cell Lung Cancer	Recruiting	Extensive Stage Small Cell Lung Cancer	NCT04213937
Efficacy and Safety of Paclitaxel Liposome and S-1 as First-line Therapy in \ Advanced Pancreatic Cancer Patients	Not yet recruiting	Advanced Pancreatic Cancer	NCT04217096
Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study)	Active, not recruiting	Pancreatic Neoplasms\|Digestive System Neoplasms\|Neoplasms by Site\|Neoplasms\|Endocrine Gland Neoplasms\|Pancreatic Diseases\|Digestive System Diseases\|Endocrine System Diseases\|Gemcitabine\|Antimetabolites, Antineoplastic	NCT01964430
Nab-Paclitaxel Combined With Gemcitabine Adjuvant Chemotherapy After Radical Resection of Intrahepatic Cholangiocarcinoma	Not yet recruiting	Cholangiocarcinoma, Intrahepatic	NCT04077983
Reirradiation With Concurrent Paclitaxel for Breast Cancer	Withdrawn	Breast Cancer	NCT02058667
Neoadjuvant Treatment With Nab-paclitaxel for Patients With Stage II and III Luminal Breast Cancer	Unknown status	Breast Cancer	NCT01565499
Paclitaxel and TAK-228 in Urothelial Carcinoma	Recruiting	Metastatic Urothelial Cancer	NCT03745911
A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma	Active, not recruiting	Carcinoma, Pancreatic Ductal	NCT02993731
Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors	Completed	Neuroblastoma\|Rhabdomyosarcoma\|Ewing's Sarcoma\|Ewing's Tumor\|Sarcoma, Ewing's\|Sarcomas, Epitheliod\|Sarcoma, Soft Tissue\|Sarcoma, Spindle Cell\|Melanoma\|Malignant Melanoma\|Clinical Oncology\|Oncology, Medical\|Pediatrics, Osteosarcoma\|Osteogenic Sarcoma\|Osteosarcoma Tumor\|Sarcoma, Osteogenic\|Tumors\|Cancer\|Neoplasia\|Neoplasm\|Histiocytoma\|Fibrosarcoma\|Dermatofibrosarcoma	NCT01962103
Pazopanib and Paclitaxel as First-Line Treatment for Subjects With Unresectable Stage III and Stage IV Melanoma	Completed	Stage III Melanoma\|Stage IV Melanoma\|Unresectable Melanoma	NCT01107665
Treatment of Patients With Atherosclerotic Disease With Paclitaxel-associated to LDL Like Nanoparticles	Recruiting	Coronary Artery Disease\|Atherosclerosis\|Inflammation	NCT04148833
Endoscopic Ultrasound (EUS) Guided Ethanol With Paclitaxel Ablation for Pancreatic Mucinous Cystic Neoplasm	Terminated	Mucinous Cystic Tumor With Moderate Dysplasia\|Mucinous Cystadenoma of Pancreas\|Mucinous Cystadenocarcinoma of Pancreas\|Benign Neoplasm of Pancreas	NCT01525706
ALRN-6924 and Paclitaxel in Treating Patients With Advanced, Metastatic, or Unresectable Solid Tumors	Recruiting	Advanced Malignant Solid Neoplasm\|Anatomic Stage III Breast Cancer AJCC v8\|Anatomic Stage IIIA Breast Cancer AJCC v8\|Anatomic Stage IIIB Breast Cancer AJCC v8\|Anatomic Stage IIIC Breast Cancer AJCC v8\|Estrogen Receptor Positive\|HER2/Neu Negative\|Metastatic Malignant Solid Neoplasm\|Prognostic Stage III Breast Cancer AJCC v8\|Prognostic Stage IIIA Breast Cancer AJCC v8\|Prognostic Stage IIIB Breast Cancer AJCC v8\|Prognostic Stage IIIC Breast Cancer AJCC v8\|Recurrent Breast Carcinoma\|TP53 wt Allele\|Unresectable Malignant Solid Neoplasm	NCT03725436
Study of Weekly LOC-paclitaxel Injection for Melanoma	Terminated	Melanoma	NCT01039844
Phase II Safety and Tolerability Trial With Nab-Paclitaxel Plus Carboplatin Followed by Nab-Paclitaxel for First Line Treatment of NSCLC Subjects With ECOG PS 2	Completed	Carcinoma, Non-Small-Cell Lung	NCT02289456
Weight-based Dosing for Dense Weekly Paclitaxel and Carboplatin in Overweight Patients w/ BSA > 2.0	Active, not recruiting	Gynecologic Malignancies	NCT02756013
Hepatic Arterial Infusion of Nab-Paclitaxel in Patients With Metastatic Melanoma in the Liver	Completed	Melanoma\|Liver Metastasis	NCT00833807
Intraperitoneal Paclitaxel Plus Systemic mFOLFOX6	Recruiting	Gastric Cancer Stage IV\|Peritoneal Carcinomatosis\|Intraperitoneal Paclitaxel\|mFOLFOX6	NCT03618758
Phase II Neoadjuvant Chemotheraphy (Gemcitabine and Nab-Paclitaxel vs. mFOLFIRINOX) and Sterotatic Body Radiation Therapy for Borderline Resectable Pancreatic Cancer	Terminated	Borderline Resectable Pancreatic Cancer	NCT02241551
Paclitaxel Administered by HAI to Patients With Advanced Cancer and Dominant Liver Involvement	Completed	Advanced Cancer	NCT00508326
Preoperative Chemotherapy With Paclitaxel, Gemcitabine, and Lapatinib (TykerbÂ®) (PGT)	Completed	Breast Cancer	NCT01133912
Safety and Efficacy Study of Nab-paclitaxel Plus Gemcitabine in Chinese Patients With Metastatic Pancreatic Cancer	Completed	Pancreatic Neoplasms	NCT02017015
Nab-paclitaxel and Alpelisib for the Treatment of Anthracycline Refractory Triple Negative Breast Cancer With PIK3CA or PTEN Alterations	Recruiting	Anatomic Stage I Breast Cancer AJCC v8\|Anatomic Stage IA Breast Cancer AJCC v8\|Anatomic Stage IB Breast Cancer AJCC v8\|Anatomic Stage II Breast Cancer AJCC v8\|Anatomic Stage IIA Breast Cancer AJCC v8\|Anatomic Stage IIB Breast Cancer AJCC v8\|Anatomic Stage III Breast Cancer AJCC v8\|Anatomic Stage IIIA Breast Cancer AJCC v8\|Anatomic Stage IIIB Breast Cancer AJCC v8\|Anatomic Stage IIIC Breast Cancer AJCC v8\|Prognostic Stage I Breast Cancer AJCC v8\|Prognostic Stage IA Breast Cancer AJCC v8\|Prognostic Stage IB Breast Cancer AJCC v8\|Prognostic Stage II Breast Cancer AJCC v8\|Prognostic Stage IIA Breast Cancer AJCC v8\|Prognostic Stage IIB Breast Cancer AJCC v8\|Prognostic Stage III Breast Cancer AJCC v8\|Prognostic Stage IIIA Breast Cancer AJCC v8\|Prognostic Stage IIIB Breast Cancer AJCC v8\|Prognostic Stage IIIC Breast Cancer AJCC v8\|Refractory Breast Carcinoma\|Triple-Negative Breast Carcinoma	NCT04216472
Combination Therapy of F16IL2 and Paclitaxel in Solid Tumour Patients	Unknown status	Solid Tumour,\|Breast Cancer,\|Metastatic Melanoma,\|Non-small Cell Lung Cancer (NSCLC),	NCT01134250
Nab-paclitaxel Plus S-1 in Patients With Advanced Pancreatic Cancer	Unknown status	Advanced Pancreatic Cancer	NCT02124317
Nilotinib in Preventing Paclitaxel-Induced Peripheral Neuropathy in Patients With Stage I-III Breast Cancer	Not yet recruiting	Anatomic Stage I Breast Cancer AJCC v8\|Anatomic Stage IA Breast Cancer AJCC v8\|Anatomic Stage IB Breast Cancer AJCC v8\|Anatomic Stage II Breast Cancer AJCC v8\|Anatomic Stage IIA Breast Cancer AJCC v8\|Anatomic Stage IIB Breast Cancer AJCC v8\|Anatomic Stage III Breast Cancer AJCC v8\|Anatomic Stage IIIA Breast Cancer AJCC v8\|Anatomic Stage IIIB Breast Cancer AJCC v8\|Anatomic Stage IIIC Breast Cancer AJCC v8\|Prognostic Stage I Breast Cancer AJCC v8\|Prognostic Stage IA Breast Cancer AJCC v8\|Prognostic Stage IB Breast Cancer AJCC v8\|Prognostic Stage II Breast Cancer AJCC v8\|Prognostic Stage IIA Breast Cancer AJCC v8\|Prognostic Stage IIB Breast Cancer AJCC v8\|Prognostic Stage III Breast Cancer AJCC v8\|Prognostic Stage IIIA Breast Cancer AJCC v8\|Prognostic Stage IIIB Breast Cancer AJCC v8\|Prognostic Stage IIIC Breast Cancer AJCC v8	NCT04205903
DAPHNe: Paclitaxel/Trastuzumab/Pertuzumab in HER2-Positive BC	Active, not recruiting	Breast Cancer	NCT03716180
A Study of Demcizumab Plus Paclitaxel in Subjects With Platinum Resistant Ovarian	Terminated	Primary Peritoneal Carcinoma	NCT01952249
NAB-PACLITAXEL Plus FOLFOX as Perioperative Chemotherapy in Patients With Operable Oesogastric Adenocarcinoma	Recruiting	Cancer of Stomach	NCT02486601
Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel/Carboplatin vs. Paclitaxel /Carboplatin in Stage â…ˇ B and IIIA Squamous Cell Carcinoma of the Lung	Unknown status	Non-small Cell Lung Cancer	NCT01872403
A Safety Study of Oraxol (HM30181 + Oral Paclitaxel) in Cancer Patients	Recruiting	Solid Tumor	NCT04180384
PIPAC With Nab-paclitaxel and Cisplatin in Peritoneal Carcinomatosis	Not yet recruiting	Peritoneal Carcinomatosis	NCT04000906
Determination of Dose of Antiangiogenic Multitargeted DOVITINIB (TKI258) Plus Paclitaxel in Patients With Solid Tumors	Terminated	Solid Tumors	NCT01548924
A Study of Vantictumab (OMP-18R5) in Combination With Nab-Paclitaxel and Gemcitabine in Previously Untreated Stage IV Pancreatic Cancer	Completed	Pancreatic Cancer\|Stage IV Pancreatic Cancer	NCT02005315
Dose Escalation Study of OMP-54F28 in Combination With Paclitaxel and Carboplatin in Patients With Recurrent Platinum-Sensitive Ovarian Cancer	Completed	Ovarian Cancer	NCT02092363
Dasatinib In Combination With Weekly Paclitaxel For Patients With Metastatic Breast Carcinoma CA 180 194	Completed	Breast Cancer	NCT00820170
Primary Chemotherapy With Anthracycline Followed by Nab-paclitaxel and Trastuzumab	Completed	Breast Cancer\|HER-2 Positive Breast Cancer\|Effects of Chemotherapy	NCT01432223
Gemcitabine & Nab-Paclitaxel in Pancreatic Adenocarcinoma With Positive Peritoneal Cytology	Recruiting	Pancreatic Adenocarcinoma	NCT03703089
Dose-Escalation Study Of Palbociclib + Nab-Paclitaxel In mPDAC	Completed	Metastatic Pancreatic Ductal Adenocarcinoma	NCT02501902
Safety, Feasibility and Effect of TTFields (200 kHz) Concomitant With Weekly Paclitaxel in Recurrent Ovarian Carcinoma (INNOVATE)	Unknown status	Ovarian Carcinoma	NCT02244502
Phase II Study of Albumin Bound Paclitaxel With 5-FU and CF as Second Line in Taxanes Naive Advanced Gastric Cancer	Unknown status	Gastric Caner	NCT02229045
VQI DELTA Paclitaxel Device Safety Analysis	Completed	Peripheral Vascular Disease	NCT04110288
Phase Ib/II Study of LY2780301 in Combination With Weekly PACLITAXEL in HER2-metastatic Breast Cancer	Terminated	Breast Cancer	NCT01980277
A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers	Completed	Epithelial Ovarian Cancer\|Fallopian Tube Cancer\|Peritoneal Cancer	NCT01447706
IST Neoadjuvant Abraxane in Newly Diagnosed Breast Cancer	Active, not recruiting	Breast Cancer	NCT01830244
Nab-paclitaxel Plus S-1(AS) Versus Nab-paclitaxel Plus Gemcitabine(AG) in Patients With Advanced Pancreatic Cancer	Recruiting	Pancreatic Cancer	NCT03636308
Study of Nab-Paclitaxel and Ramucirumab as Second-line Treatment for Patients With Metastatic Gastroesophageal Cancer	Active, not recruiting	Gastroesophageal Cancer	NCT02317991
Phase I/II AZD8931/Paclitaxel in Treatment of Advanced Solid Tumours (Phase I) and Advanced Breast Cancer (Phase II)	Completed	Neoplasms\|Breast Neoplasms\|Breast Cancer	NCT00900627
Cisplatin vs Paclitaxel for Triple Neg	Active, not recruiting	Triple Negative Breast Cancer	NCT01982448
TAK-228 and TAK-117 Followed by Cisplatin and Nab Paclitaxel for Metastatic Triple Negative Breast Cancer	Recruiting	Triple Negative Breast Cancer	NCT03193853
A Phase 1b/2 Study of OMP-59R5 in Combination With Nab-Paclitaxel and Gemcitabine in Subjects With Previously Untreated Stage IV Pancreatic Cancer	Completed	Stage IV Pancreatic Cancer	NCT01647828
Schedules of Nab-Paclitaxel in Metastatic Breast Cancer	Active, not recruiting	Metastatic Breastcancer	NCT01746225
Induction Paclitaxel Followed by Concurrent Paclitaxel and Radiation Therapy for Cutaneous Angiosarcoma	Recruiting	Cutaneous Angiosarcoma	NCT03921008
Study of the Combination of Panitumumab With Paclitaxel as First-line Treatment of Subjects With Head and Neck Cancer	Completed	Head and Neck Cancer	NCT01264328
Nab-paclitaxel Plus Gemcitabine in Chinese Patients With Advanced Pancreatic Cancer	Unknown status	Advanced Pancreatic Cancer	NCT02135822
Clinical Study of Albumin-bound Paclitaxel Plus Nedaplatin in Cervical Cancer	Unknown status	Uterine Cervical Cancer	NCT01667211
Trial to Evaluate Paclitaxel Plus RAD001 in Urothelial Carcinoma	Terminated	Bladder Cancer	NCT00933374
Paclitaxel for the Treatment of Gastric or Gastroesophageal Cancer	Recruiting	Carcinomatosis\|Clinical Stage IV Gastric Cancer AJCC v8\|Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8\|Clinical Stage IVA Gastric Cancer AJCC v8\|Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8\|Clinical Stage IVB Gastric Cancer AJCC v8\|Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8\|Metastatic Gastric Adenocarcinoma\|Metastatic Gastroesophageal Junction Adenocarcinoma\|Pathologic Stage IV Gastric Cancer AJCC v8\|Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8\|Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8\|Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8\|Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8\|Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8\|Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8\|Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8	NCT04220827
Locally Advanced Pancreatic Cancer (LAPC) (GCC 1886)	Recruiting	Locally Advanced Pancreatic Cancer	NCT03652428
Paclitaxel for the Treatment of Upper-Extremity Arteriovenous Access Fistula Stenosis	Terminated	Fistula Stenosis	NCT01868984
The Effect of Gemcitabine Plus Nab-paclitaxel as Secondary Chemotherapy in Advanced Pancreatic Cancer	Unknown status	Pancreatic Adenocarcinoma\|Chemotherapy Effect	NCT03401827
Trametinib in Combination With Paclitaxel in the Treatment of Anaplastic Thyroid Cancer	Recruiting	Anaplastic Thyroid Cancer	NCT03085056
Lenalidomide and Paclitaxel in Prostate Cancer	Terminated	Prostate Cancer	NCT00933426
Galunisertib and Paclitaxel in Treating Patients With Metastatic Androgen Receptor Negative (AR-) Triple Negative Breast Cancer	Recruiting	Estrogen Receptor Negative\|HER2/Neu Negative\|Progesterone Receptor Negative\|Recurrent Breast Carcinoma\|Stage IV Breast Cancer\|Triple-Negative Breast Carcinoma	NCT02672475
Phase I/II NabPaclitaxel, Paclitaxel&Carboplatin w RTX Followed by Consolidation in Patients w Favorable Prognosis Inoperable Stage IIIA/B NSCLC	Active, not recruiting	STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER	NCT01757288
Fosbretabulin or Placebo in Combination With Carboplatin/Paclitaxel in Anaplastic Thyroid Cancer	Withdrawn	Anaplastic Thyroid Cancer	NCT01701349
Bioequivalence Study of IG-001 Versus Nab-paclitaxel in Metastatic or Locally Recurrent Breast Cancer	Completed	Metastatic Breast Cancer\|Locally Recurrent Breast Cancer	NCT02064829
Study of Vemurafenib, Carboplatin, and Paclitaxel	Active, not recruiting	Advanced Cancers	NCT01636622
Efficacity of Weekly Paclitaxel in Association or Not With Bevacizumab in Metastatic or Locally Advanced Angiosarcomas	Completed	Angiosarcoma	NCT01303497
A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With or Without LCL161 in Patients With Triple Negative Breast Cancer	Completed	Breast Cancer	NCT01617668
Dose-dense (Biweekly) Carboplatin Plus Paclitaxel With or Without Trastuzumab as Neoadjuvant Treatment for Breast Cancer	Unknown status	Breast Cancer	NCT02059876
Phase II Trial of Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With Cholangiocarcinoma	Completed	Cholangiocarcinoma	NCT02181634
Neoadjuvant Nab-Paclitaxel and S-1 in Borderline Resectable Pancreatic Cancer	Recruiting	Borderline Resectable Pancreatic Cancer	NCT03850769
Paricalcitol Plus Gemcitabine and Nab-paclitaxel in Metastatic Pancreatic Cancer	Active, not recruiting	Pancreatic Cancer	NCT03520790
Paclitaxel Eluting Covered Metallic Stent for Unresectable Malignant Bile Duct Obstruction	Completed	Bile Duct Obstruction	NCT00453076
A Study of Napabucasin (BBI-608) Plus Weekly Paclitaxel Versus Weekly Paclitaxel Alone in Patients With Advanced, Previously Treated, Non-Squamous Non-Small Cell Lung Cancer	Terminated	Carcinoma, Non-Small-Cell Lung	NCT02826161
Nab-paclitaxel and S-1 in Patients With Locally Advanced Pancreatic Cancer	Recruiting	Locally Advanced Pancreatic Cancer	NCT03885219
Nab-paclitaxel Combined With S-1 Treating Diffuse Type of Stage â…˘ Gastric Cancer	Not yet recruiting	Gastric Cancer	NCT03977220
Avoiding Growth Factor During Paclitaxel Treatment in Breast Cancer	Active, not recruiting	Early Stage Breast Cancer	NCT02698891
Paclitaxel/Pazopanib for Platinum Resistant/Refractory Ovarian Cancer	Active, not recruiting	Ovarian Cancer	NCT02383251
Ph3 Study To Determine Safety,Tolerability&Tumor Response Of Oraxol Compared To Taxol In Metastatic Breast Cancer	Active, not recruiting	Metastatic Breast Cancer	NCT02594371
Paclitaxel in Patients With GIST With Low P-glycoprotein Expression After Failure of at Least Imatinib and Sunitinib, and Regorafenib.	Recruiting	Gastrointestinal Stromal Tumors	NCT03944304
Safety Study of ABT-263 in Combination With Paclitaxel in Subjects With Solid Tumors	Completed	Solid Tumors	NCT00891605
Phase I/Ib Study of Paclitaxel in Combination With VS-6063 in Patients With Advanced Ovarian Cancer	Completed	Ovarian Cancer	NCT01778803
Study of Weekly Paclitaxel, Carboplatin and Irinotecan to Treat Lung Cancer	Terminated	Lung Cancer	NCT00465907
Trial of Lapatinib and Weekly Paclitaxel for Advanced Urothelial Cancer	Withdrawn	Urothelial Cancer\|Bladder Cancer	NCT01700010
Dose-escalating, Safety, Tolerability and PK Study of TAS-119 in Combination With Paclitaxel in Patients With Advanced Solid Tumors	Terminated	Advanced Solid Tumors	NCT02134067
Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin for Stage â…ˇ-â…˘ Esophageal Cancer Patients	Completed	Esophageal Squamous Cell Carcinoma	NCT01258192
Intraperitoneal tgDCC-E1 and Intravenous Paclitaxel in Women With Platinum-Resistant Ovarian Cancer	Terminated	Ovarian Cancer	NCT00102622
First-line Treatment of Metastatic Pancreatic Cancer With Nab-paclitaxel and Gemcitabine	Recruiting	Metastatic Pancreatic Cancer\|Adenocarcinoma of the Pancreas	NCT02564146
Efficacy and Safety of Albumin Paclitaxel Combined With Cisplatin Chemoradiotherapy for Non-resectable Stage III NSCLC	Active, not recruiting	Efficacy and Safety	NCT04284215
MTD Study PXD-101 in Combination With Paclitaxel + Carboplatin in Chemotherapy-Naive Patients With Stage IV NSCLC	Completed	Stage IV Non-small Cell Lung Cancer	NCT01310244
Study of AMG 386 in Combination With Paclitaxel and Carboplatin in Subjects With Ovarian Cancer	Completed	Carcinoma\|Fallopian Tube Cancer\|Ovarian Cancer\|Primary Peritoneal Cancer	NCT01253681
Effects of Paclitaxel on Intimal Hyperplasia	Completed	Peripheral Vascular Disease	NCT01454778
Paclitaxel-trastuzumab in EGFR-mutated NSCLC Patients	Unknown status	NSCLC\|HER2-expression\|EGFR-mutation	NCT02226757
Oral Paclitaxel Trial In Recurrent and Metastatic Breast Cancer As 1st Line Therapy	Recruiting	Recurrent or Metastatic Breast Cancer	NCT03315364
Safety and Efficacy Study of NabÂ®-Paclitaxel With CC-486 or NabÂ®-Paclitaxel With Durvalumab, and NabÂ®-Paclitaxel Monotherapy as Second/Third-line Treatment for Advanced Non-small Cell Lung Cancer	Active, not recruiting	Carcinoma, Non-Small-Cell Lung	NCT02250326
Study of IDO Inhibitor in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer	Completed	Metastatic Pancreatic Adenocarcinoma\|Metastatic Pancreatic Cancer	NCT02077881
A Study of Chemoradiotherapy Using Gem Plus Nab-paclitaxel for Pancreatic Cancer	Completed	Pancreatic Cancer	NCT02272738
PH I SRC Kinase, Dasatinib Combo Paclitaxel & Carboplatin in Pts w Ovarian, Peritoneal, & Tubal Cancer	Completed	Ovarian Cancer\|Peritoneal Cancer\|Fallopian Tube Cancer	NCT00672295
Paclitaxel With Trastuzumab and Lapatinib in HER2-Positive Early Stage Breast Cancer	Completed	HER2-Positive Early Stage Breast Cancer	NCT01827163
Primary Paclitaxel Plus Gemcitabine in Patients With Stage II and III Breast Cancer	Terminated	Breast Cancer	NCT00532285
A Study of Atezolizumab (Tecentriq) Plus Nab-Paclitaxel or Paclitaxel in the Treatment of Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer	Recruiting	Triple-Negative Breast Cancer	NCT04148911
Dasatinib, Bevacizumab, Paclitaxel in Patients With Advanced Malignancies	Active, not recruiting	Advanced Cancer	NCT01015222
Observational Post-authorization Studies Carboplatin, Paclitaxel and Bevacizumab	Completed	Nonsquamous Nonsmall Cell Neoplasm of Lung	NCT01814163
A Study of BIIB022 in Combination With Paclitaxel and Carboplatin in Subjects With Non-Small Cell Lung Cancer	Completed	Non-Small Cell Lung Cancer	NCT00970580
Carboplatin and Paclitaxel in Elderly Women With Newly Diagnosed Ovarian, Peritoneal, or Fallopian Cancer	Terminated	Ovarian Cancer\|Primary Peritoneal Carcinoma\|Fallopian Tube Cancer\|Mixed Tumor, Mesodermal	NCT00322881
Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer	Not yet recruiting	Metastatic Pancreatic Adenocarcinoma\|Stage IV Pancreatic Cancer AJCC v8	NCT04115163
A Feasibility Study Of NAB-Paclitaxel In Combination With Carboplatin As First Line Treatment Of Gastrointestinal Neuroendocrine Carcinomas	Active, not recruiting	Gastrointestinal Neuroendocrine Carcinomas	NCT02215447
Defining an Exposure Target for Weekly Paclitaxel Infusion in Breast Cancer Patients	Completed	Breast Cancer	NCT02338115
Trial of Afatinib in Combination With Weekly Paclitaxel in the Second Line Treatment	Withdrawn	HER-2 Positive Gastric Cancer\|Gastrooesophageal Cancer\|Esophageal Cancer	NCT02274012
Paclitaxel for the Treatment of Distal Radial Artery Arteriovenous Access Fistula Stenosis (PaciFIST-2)	Withdrawn	Arteriovenous Access Fistula Stenosis	NCT02040454
Weekly Paclitaxel Plus Carboplatin in Preoperative Treatment of Breast Cancer	Completed	Breast Cancer	NCT01203267
Weekly Nanoparticle Albumin-Bound Paclitaxel (Abraxane) + Weekly Cetuximab + Radiation Therapy (IMRT, Intensity-Modulated Radiation Therapy) in Patients With Stage III-IVB Head and Neck Squamous Cell Carcinoma (HNSCC)	Completed	HEAD & NECK Cancer	NCT00736619
Phase I, Pharmacokinetic, Pharmacodynamic Trial of PTK787 and Paclitaxel in Combination for Advanced Solid Tumors	Completed	Neoplasm Metastasis\|Carcinoma	NCT00731861
Central European Society for Anticancer Research (CESAR) Study of Paclitaxel Therapeutic Drug Monitoring	Completed	Carcinoma, Non-Small-Cell Lung	NCT01326767
Folfirinox or Gemcitabine-Nab Paclitaxel Followed by Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Cancer	Recruiting	Locally Advanced Pancreatic Cancer\|Borderline Pancreatic Inoperable Cancer\|Pancreatic Cancer	NCT03600623
Albumin Bound Paclitaxel Plus S-1 as the First Line Chemotherapy in Advanced or Recurrent Gastric Cancer	Completed	Gastric Cancer	NCT02229058
Temsirolimus + Weekly Paclitaxel + Carboplatin for Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC)	Completed	Squamous Cell Cancer\|Head and Neck Cancer	NCT01016769
Phase II Study of Combination of Paclitaxel Poliglumex and Alimta for Advanced Non-small Cell Lung Cancer (NSCLC)	Completed	Advanced Non-small Cell Lung Cancer	NCT00487669
Topical Cryotherapy in Reducing Pain in Patients With Chemotherapy Induced Peripheral Neuropathy or Paclitaxel Induced Acute Pain Syndrome	Completed	Breast Carcinoma	NCT02640053
Weekly Paclitaxel and Cyclophosphamide in Metronomic Administration : Dose Escalation Study of Weekly Paclitaxel	Completed	Cancer	NCT01374620
Prospective, Multicenter, Non-randomized, Single Arm Clinical Trial to Evaluate the Safety and Efficacy of e-PTFE Grafts Inner Surface-treated With Paclitaxel as an Access for Hemodialysis in Patients With End-stage Renal Disease.	Recruiting	Hemodialysis Access Failure	NCT04285073
Regorafenib in Combination With Paclitaxel in Advanced Oesophagogastric Carcinoma	Completed	Esophageal Neoplasms\|Stomach Neoplasms\|Neoplasm Metastasis	NCT02406170
Efficacy and Safety Study of Nab-Paclitaxel Combined With Cisplatin in Second or Later-Line Treatment in Advanced Biliary Tract Cancers	Recruiting	Advanced Biliary Tract Cancers	NCT04111380
Treatment of Pancreatic Cancer With Abraxane	Active, not recruiting	Metastatic Pancreatic Cancer	NCT02555813
A Non Interventional Study With Paclitaxel Onkovis (Paclitaxel) Utilized for the Treatment of Cancer	Completed	Carcinoma	NCT01668108
Efficacy and Safety Study of ABI-007 Plus Capecitabine as First-line Chemotherapy for Advanced Gastric Cancer Patients	Unknown status	Gastric Adenocarcinoma	NCT01641783
Combination Anticancer Therapy of Paclitaxel and Everolimus for Relapsed or Refractory Small Cell Lung Cancer	Completed	Small Cell Lung Cancer	NCT01079481
Camrelizumab, Apatinib and Nab-paclitaxel as Second-line Treatment in Advanced Gastric Cancer	Recruiting	Advanced Gastric Cancer	NCT04182724
Evaluation of the Efficacy and Safety of a Paclitaxel Eluting PTCA Balloon Catheter in Coronary In-stent Restenosis	Recruiting	Coronary In-stent Restenosis	NCT04213378
Efficacy and Safety of Bevacizumab (AvastinÂ®) Combined to Weekly Paclitaxel Followed by Bevacizumab (AvastinÂ®) Alone in Patients With Relapsed Ovarian Sex-cord Stromal Tumours (ALIENOR)	Active, not recruiting	Ovarian Sex-cord Stromal Tumor	NCT01770301
Effect of Tumor Treating Fields (TTFields, 200 kHz) Concomitant With Weekly Paclitaxel for the Treatment of Recurrent Ovarian Cancer (ENGOT-ov50 / GOG-3029 / INNOVATE-3)	Recruiting	Ovarian Cancer	NCT03940196
Belgian-Italian Trial to Evaluate the Efficacy and Safety of Below The Knee (BTK) Treatment With the Luminor 14 Paclitaxel Coated Percutaneous Transluminal Angioplasty Balloon Catheter of iVascular	Not yet recruiting	Peripheral Arterial Disease	NCT03845543
Raltitrexed and Paclitaxel for Gastric or Gastroesophageal Junction Adenocarcinoma	Unknown status	Gastric Cancer\|Gastroesophageal Junction Adenocarcinoma	NCT03083613
Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma	Completed	Uterine Cancer	NCT00506779
BKM120 + Carboplatin + Paclitaxel for Patients With Advanced Solid Tumors	Completed	Solid Tumors	NCT01297452
Second-line CM082 Combined With Paclitaxel For Patients With Advanced Gastric Cancer	Recruiting	Advanced Gastric Cancer	NCT03286244
Nab-paclitaxel, Gemcitabine, and Bevacizumab in Advanced Malignancies	Active, not recruiting	Advanced Cancer	NCT01113476
A Study of Ramucirumab (IMC-1121B) and Paclitaxel in Participants With Solid Tumors	Active, not recruiting	Malignant Solid Tumor	NCT01515306
Sorafenib and Paclitaxel in Treating Patients With Metastatic Breast Cancer	Terminated	Breast Cancer	NCT00622466
Pharmacokinetic and Safety Study of NabÂ®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia	Terminated	Pancreatic Neoplasms\|Cholestasis	NCT02267707
A Study of LCL161 in Combination With Weekly Paclitaxel in Adult Patients With Advanced Solid Tumors	Completed	Solid Tumors	NCT01240655
Paclitaxel and Nortriptyline Hydrochloride in Treating Patients With Relapsed Small Cell Carcinoma	Completed	Small Cell Carcinoma	NCT02881125
Carboplatin, Nab-Paclitaxel and Pembrolizumab for Metastatic Triple-Negative Breast Cancer	Active, not recruiting	Metastatic Triple Negative Breast Cancer	NCT03121352
This Study Was a Prospective, One-arm Open Phase II Clinical Trial. A Systematic Review of the pCR of Apatinib in Combination With the Albumin Paclitaxel and Carboplatin Regimens for the Neoadjuvant Therapy of Triple-negative Breast Cancer, as Well as the Safety of Treatment	Recruiting	Systematic Review of the pCR Rate of Apatinib Combined With Albumin Paclitaxel and Carboplatin Regimen for Neoadjuvant Therapy of Triple-negative Breast Cancer	NCT03650738
Second-Line Chemotherapy With Ramucirumab +/- Paclitaxel in Elderly Advanced Gastric or Gastroesophageal Junction Cancer Patients	Recruiting	Stomach Cancer\|Stomach Neoplasm\|Gastric Cancer\|Gastroesophageal Junction Adenocarcinoma	NCT03760822
Rebastinib Plus Antitubulin Therapy With Paclitaxel or Eribulin in Metastatic Breast Cancer	Recruiting	Breast Cancer\|Breast Adenocarcinoma\|Human Epidermal Growth Factor 2 Negative Carcinoma of Breast\|Recurrent Breast Carcinoma\|Stage IV Breast Cancer	NCT02824575
Paclitaxel (Albumin-bound) and Oxaliplatin for Advanced Hepatobiliary and Malignant Tumors	Not yet recruiting	Advanced Hepatobiliary and Malignant Tumors	NCT04060472
Study to Compare Alisertib With Paclitaxel vs. Paclitaxel Alone in Metastatic or Locally Recurrent Breast Cancer	Active, not recruiting	Breast Cancer\|Breast Carcinoma\|Breast Tumors\|Malignant Neoplasm of Breast	NCT02187991
Dose Dense Paclitaxel With Pembrolizumab (MK-3475) in Platinum Resistant Ovarian Cancer	Active, not recruiting	Ovarian Cancer	NCT02440425
Pyrotinib in Combination With Nab-paclitaxel in Patients With HER2-positive Advanced Breast Cancer: an Exploratory Study	Not yet recruiting	HER2-positive Breast Cancer	NCT03919253
Afatinib, Paclitaxel, 2nd Line, Advanced Gastric Cancer	Recruiting	Gastric Cancer\|Gastroesophageal Junction Cancer	NCT02501603
A Study of First-line JS001 and Nab-paclitaxel Versus Palcelbo and Nab-Paclitaxel in Participants With Advanced Recurrent or Metastatic TNBC	Suspended	Triple Negative Breast Cancer	NCT03777579
A Study to See the Effects That a New Combination of the Three Drugs, Nab-paclitaxel, Gemcitabine, and Cisplatin Has on Biliary Tract Cancer	Recruiting	Unresectable Biliary Tract Cancer	NCT02632305
Phase I Dose Escalation of Oral BAY1161909 in Combination With Intravenous Paclitaxel	Terminated	Medical Oncology	NCT02138812
Study to Evaluate Bi-weekly Dosing of Gemcitabine Plus Nab-Paclitaxel to Treat Metastatic Pancreatic Cancer	Terminated	Pancreatic Carcinoma Non-resectable\|Stage IV Pancreatic Cancer	NCT01851174
Paclitaxel Plus Cetuximab After First-line Checkpoint Inhibitor Failure	Recruiting	Head and Neck Squamous Cell Carcinoma	NCT04278092
Liposomal Paclitaxel Combined Nedaplatin in Treatment of Advanced or Recurrent Esophageal Carcinoma	Completed	Esophageal Carcinoma	NCT02861690
Study of Pazopanib, Paclitaxel, and Carboplatin in Patients With Advanced Solid Tumors	Completed	Unspecified Adult Solid Tumor - Protocol Specific\|Breast Cancer - Female	NCT01407562
Paclitaxel in Combination With Carboplatin Versus Paclitaxel Plus Epirubicin in Metastatic Breast Cancer	Unknown status	Metastatic Breast Cancer	NCT02207361
A Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast Cancer	Completed	ER Positive, Her2 Negative Breast Cancer Patients\|Triple Negative Breast Cancer Patients	NCT01421472
Phase Ib/II Study of Primary Chemotherapy With Paclitaxel, Gemcitabine, and Sunitinib	Completed	Breast Cancer	NCT01070706
Paclitaxel Releasing Balloon in Patients Presenting With In-Stent Restenosis	Completed	In-stent Coronary Artery Restenosis	NCT00961181
A Phase I/II Study of Paclitaxel Plus Carboplatin Plus Vorinostat in Recurrent Ovarian Cancer	Unknown status	Ovarian Cancer	NCT00772798
Nab-paclitaxel Plus PD-1 Inhibitor Versus Nab-paclitaxel as Second-line Treatment in Advanced Gastric Cancer	Not yet recruiting	Gastric Cancer\|GastroEsophageal Cancer	NCT04294784
Phase 2 Trial of Gemcitabine vs S-1 vs Gemcitabine Plus Nab-paclitaxel as Adjuvant Chemotherapy of Post-operative Pancreatic Cancer Patients	Unknown status	Cancer of Pancreas	NCT03278015
Metformin Plus Paclitaxel for Metastatic or Recurrent Head and Neck Cancer	Terminated	Head and Neck Neoplasms\|Squamous Cell Carcinoma	NCT01333852
Pazopanib and Paclitaxel for Non-Small Cell Lung Cancer	Withdrawn	Non-small Cell Lung Cancer	NCT01179269
Phase II Breast Ca Carboplatin + Paclitaxel With Pertuzumab + Trastuzumab or Bevacizumab	Recruiting	Breast Carcinoma	NCT02436993
Study of Weekly Paclitaxel and Cisplatin in FIGO IB2 and IIA2 Cervical Cancer Followed by Radical Hysterectomy	Recruiting	Cervical Cancer	NCT02432365
Paclitaxel, Bevacizumab and Pemetrexed in Patients With Untreated, Advanced Non-Small Cell Lung Cancer Using Web-Based Data Collection, Patient Self-Reporting of Adverse Effects and Automated Response Assessment	Completed	Lung Cancer	NCT00807573
Study on Paclitaxel Plus Topotecan in Comparison With Topotecan Plus Cisplatin in Recurrent or Persistent Cervical Carcinoma	Unknown status	Recurrent, Persistent or Metastasized Cervical Cancer	NCT01405235
Phase 2 NabÂ® -Paclitaxel (AbraxaneÂ®) Plus Gemcitabine in Subjects With Locally Advanced Pancreatic Cancer (LAPC)	Completed	Pancreatic Neoplasms	NCT02301143
Study of Gemcitabine and Abraxane for Pancreas Cancer	Terminated	Pancreatic Cancer	NCT02242409
Study of Paclitaxel in Combination With BOS172722 in Patients With Advanced Nonhaematologic Malignancies	Recruiting	Advanced Nonhaematologic Malignancies	NCT03328494
Toripalimab Combined With S1 and Albumin Paclitaxel in Patients With Advanced Biliary Tract Cancer	Recruiting	Advanced Biliary Tract Cancer	NCT04027764
A Biomarker Study in Patients With HER2-negative Metastatic Breast Cancer Treated With Bevacizumab and Paclitaxel	Completed	Breast Cancer	NCT01722968
Study of Combined SGT-53 Plus Gemcitabine/Nab-Paclitaxel for Metastatic Pancreatic Cancer	Recruiting	Metastatic Pancreatic Cancer	NCT02340117
Pembrolizumab and Nab Paclitaxel in Patients With Metastatic Urothelial Carcinoma	Not yet recruiting	Metastatic Urothelial Carcinoma	NCT03464734
Intraperitoneal Paclitaxel and Carboplatin With IV Avastin Therapy in Patients With Carcinomas of Mullerian Origin	Active, not recruiting	Ovarian Cancer\|Peritoneal Cancer\|Fallopian Tube Cancer	NCT00652119
Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma	Completed	Esophageal Cancer	NCT02133612
Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed By Surgery	Completed	Intraocular Melanoma	NCT00738361
SHR- 1210 Combined With Paclitaxel (Albumin Bound) and Gemcitabine as First-line Therapy in Patients With Metastatic Pancreatic Cancer	Recruiting	Pancreatic Cancer Stage IV	NCT04181645
Weekly Carboplatin, Paclitaxel and Cetuximab Treatment for Patients With Recurrent or Metastatic SCCHN	Active, not recruiting	Head and Neck Cancer\|Squamous Cell Carcinoma of the Head and Neck	NCT02124707
Phase I Study of Oral BAY 1217389 in Combination With Intravenous Paclitaxel	Completed	Medical Oncology	NCT02366949
Feasibility Study of Intraperitoneal Paclitaxel	Unknown status	Gastric Cancer	NCT01739894
Paclitaxel vs Paclitaxel + Cetuximab in Recurrent - Metastatic Head & Neck Carcinoma After Failure of a 1Âş Chemotherapy	Terminated	Head and Neck Cancer	NCT03887442
Study of Safety and Efficacy of Durvalumab in Combination With Paclitaxel in Metastatic Triple Negative Breast Cancer Patients	Active, not recruiting	Breast Cancer	NCT02628132
Study of Afuresertib Combined With Paclitaxel in Gastric Cancer	Completed	Cancer	NCT02240212
[18F]Fluciclatide-PET, Pazopanib and Paclitaxel in Ovarian Cancer	Completed	Ovarian Neoplasm	NCT01608009
AbraxaneÂ® With or Without Mifepristone for Advanced, Glucocorticoid Receptor-Positive, Triple-Negative Breast Cancer	Recruiting	Breast Cancer	NCT02788981
Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer	Completed	Pancreatic Cancer\|Stage IV Pancreatic Cancer	NCT02050178
Carboplatin-Paclitaxel-Pembrolizumab in Neoadjuvant Treatment of Locally Advanced Cervical Cancer	Not yet recruiting	Locally Advanced Cervical Cancer	NCT04238988
BYL719 and Nab-Paclitaxel in Locally Recurrent or Metastatic HER-2 Negative Breast Cancer	Active, not recruiting	Breast Cancer	NCT02379247
Effect on Tumor Perfusion of a Chemotherapy Combining Gemcitabine and Nab-paclitaxel (Abraxane) in Pancreatic Cancer	Unknown status	Pancreatic Adenocarcinoma Resectable\|Pancreatic Adenocarcinoma Locally Advanced\|Pancreatic Adenocarcinoma Metastatic	NCT01715142
S 81694 Plus Paclitaxel in Metastatic Breast Cancer	Active, not recruiting	Metastatic Breast Cancer\|Metastatic Triple Negative Breast Cancer	NCT03411161
Nab-Paclitaxel in Patients With ER+/HER2- Recurrent Metastatic Breast Cancer	Not yet recruiting	Breast Cancer	NCT04194684
Neoadjuvant Chomotherapy With Paclitaxel-albumin and S-1 for Advanced Gastric Cancer	Not yet recruiting	Gastric Cancer	NCT04258657
Safety Study of PLX3397 and Paclitaxel in Patients With Advanced Solid Tumors	Completed	Solid Tumors	NCT01525602
Study of Trametinib and Nab-paclitaxel in Patients With Melanoma	Withdrawn	Melanoma	NCT02300935
Ph 1 Study of VS-4718, a FAK Inhibitor, in Combination With Nab-paclitaxel and Gemcitabine in Advanced Cancer Subjects	Terminated	Pancreatic Cancer	NCT02651727
Ganetespib, Paclitaxel, Trastuzumab and Pertuzumab for Metastatic Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer	Completed	HER2-positive Breast Cancer\|Male Breast Cancer\|Recurrent Breast Cancer\|Stage IIIA Breast Cancer\|Stage IIIB Breast Cancer\|Stage IIIC Breast Cancer\|Stage IV Breast Cancer	NCT02060253
Docetaxel or Paclitaxel in Reducing Chemotherapy-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer	Recruiting	Anatomic Stage I Breast Cancer AJCC v8\|Anatomic Stage IA Breast Cancer AJCC v8\|Anatomic Stage IB Breast Cancer AJCC v8\|Anatomic Stage II Breast Cancer AJCC v8\|Anatomic Stage IIA Breast Cancer AJCC v8\|Anatomic Stage IIB Breast Cancer AJCC v8\|Anatomic Stage III Breast Cancer AJCC v8\|Anatomic Stage IIIA Breast Cancer AJCC v8\|Anatomic Stage IIIB Breast Cancer AJCC v8\|Anatomic Stage IIIC Breast Cancer AJCC v8\|Invasive Breast Carcinoma\|Prognostic Stage I Breast Cancer AJCC v8\|Prognostic Stage IA Breast Cancer AJCC v8\|Prognostic Stage IB Breast Cancer AJCC v8\|Prognostic Stage II Breast Cancer AJCC v8\|Prognostic Stage IIA Breast Cancer AJCC v8\|Prognostic Stage IIB Breast Cancer AJCC v8\|Prognostic Stage III Breast Cancer AJCC v8\|Prognostic Stage IIIA Breast Cancer AJCC v8\|Prognostic Stage IIIB Breast Cancer AJCC v8\|Prognostic Stage IIIC Breast Cancer AJCC v8	NCT04001829
Paclitaxel-Carboplatin-Bevacizumab +/- Nitroglycerin in Metastatic Non-Squamous-Non-Small Cell Lung Cancer	Unknown status	Non Small Cell Lung Cancer	NCT01171170
Nab-paclitaxel Combined With S-1 as Adjuvant Chemotherapy for Stage â…˘ Gastric Cancer	Recruiting	Stomach Cancer	NCT04135781
Dexamethasone Regimens for Prophylaxis of Paclitaxel-associated Hypersensitivity Reaction	Unknown status	Hypersensitivity Reaction	NCT02349763
Trial of Combination ABI-007, Carboplatin, and Gemcitabine for First Line Treatment of Advanced Urothelial Cancer	Terminated	Urothelial Cancer\|Bladder Cancer	NCT00995488
Afatinib and Paclitaxel in Patients With Advanced HER2-Positive Trastuzumab-Refractory Advanced Esophagogastric Cancer	Active, not recruiting	Esophageal Cancer\|Gastric Cancer	NCT01522768
Local Paclitaxel Delivery for SFA Disease	Completed	Atherosclerosis\|Angioplasty\|Peripheral Arterial Disease	NCT00821028
Pembro/Carbo/Taxol in Endometrial Cancer	Recruiting	Endometrial Cancer\|Endometrial Adenocarcinoma	NCT02549209
A Study of the Experimental Drug BKM120 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer, With or Without PI3K Activation	Completed	Breast Cancer	NCT01572727
QUILT-3.010: A Study of Gemcitabine and Nab-paclitaxel With or Without NPC-1C to Treat Patients With Pancreatic Cancer	Terminated	Pancreatic Cancer, Adult	NCT01834235
Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Gemcitabine and Nab-paclitaxel) in Locally Advanced Pancreatic Cancer	Recruiting	Pancreatic Cancer Non-resectable	NCT03941093
Pembrolizumab, Paclitaxel, and Carboplatin in Patients With Advanced Stage Epithelial Ovarian Cancer (EOC).	Recruiting	Fallopian Tube Carcinoma\|Peritoneal Carcinoma\|Epithelial Ovarian Cancer	NCT02834975
Imatinib Mesylate (Gleevec) and Paclitaxel in Recurrent Patients of Ovarian and Other Cancers of Mullerian Origin	Terminated	Ovarian Cancer	NCT00840450
A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Adults With Previously Untreated, Advanced Non-Small Cell Lung Cancer	Completed	Non-small Cell Lung Cancer	NCT01268059
A Phase 1b/2a, Open-Label, Multi-Center Study of Tivozanib (AV-951) in Combination With Paclitaxel in Subjects With Advanced or Metastatic Breast Cancer	Completed	Metastatic Breast Cancer	NCT00717340
Nal-iri/lv5-fu Versus Paclitaxel as Second Line Therapy in Patients With Metastatic Oesophageal Squamous Cell Carcinoma	Recruiting	Squamous Cell Carcinoma	NCT03719924
Trial of Afatinib With Paclitaxel for Neoadjuvant Therapy of TNBC and Research of Biomarkers of Afatinib	Unknown status	Triple Negative Breast Cancer	NCT02511847
A Phase 3 Study to Compare Efficacy and Safety of DHP107 Versus TaxolÂ® in Patients With Metastatic or Recurrent Gastric Cancer After Failure of First-line Chemotherapy	Completed	Stage IV Gastric Cancer	NCT01839773
Prevalence of Paclitaxel Induced CIPN-Related Pain and CIPN in Indian Patients With Breast Cancer	Unknown status	Breast Cancer Female\|Neuropathic Pain	NCT03022162
Phase 2 Trial of Nab-paclitaxel Plus S-1 vs Gemcitabine Plus Cisplatin as 1-line Chemotherapy of Patients With Local Advanced and/or Metastatic Transitional Cell Carcinoma of Urothelial Tract	Not yet recruiting	Carcinoma, Transitional Cell	NCT03051373
Apatinib With Albumin-bound Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer	Not yet recruiting	Ovarian Cancer	NCT03942068
Ph I/II Nab-Paclitaxel & Carboplatin w/Concurrent Radiation Therapy for Unresectable Stg III NSCLC	Terminated	Lung Cancer	NCT00544648
A Phase 1b Study With Volociximab in Combination With Carboplatin, Paclitaxel, and Bevacizumab in First-line, Advanced Non-small Cell Lung Cancer (NSCLC)	Completed	Non-small Cell Lung Cancer	NCT00666692
Study of Gleevec and Weekly Paclitaxel in Patients Aged 70 or Older With Advanced Non-small Cell Lung Cancer	Completed	Non-small Cell Lung Cancer	NCT01011075
Study Of AbraxaneÂ® And Carboplatin As First-Line Treatment For Triple Negative Metastatic Breast Cancer	Terminated	Metastatic Breast Cancer	NCT01207102
Safety Study of Individual Paclitaxel Dose Adjustment Based on Pharmacokinetics in Non-Small Cell Lung Cancer (NSCLC)	Unknown status	Non-Small Cell Lung Cancer	NCT02058433
A Study Of Changes In PD-L1 Expression During Preoperative Treatment With Nab-Paclitaxel And Pembrolizumab In Hormone Receptor-Positive Breast Cancer	Recruiting	Breast Cancer	NCT02999477
Paclitaxel and Ganetespib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer	Terminated	Recurrent Fallopian Tube Cancer\|Recurrent Ovarian Epithelial Cancer\|Recurrent Primary Peritoneal Cavity Cancer	NCT01962948
Inolitazone Dihydrochloride and Paclitaxel in Treating Patients With Advanced Anaplastic Thyroid Cancer	Active, not recruiting	Anaplastic Thyroid Cancer\|Recurrent Thyroid Cancer	NCT02152137
Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma	Recruiting	Osteosarcoma\|Ewing Sarcoma\|Rhabdomyosarcoma\|Soft Tissue Sarcoma	NCT02945800
Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)	Completed	Breast Tumor\|Breast Cancer\|Cancer of the Breast\|Estrogen Receptor- Negative Breast Cancer\|HER2- Negative Breast Cancer\|Progesterone Receptor- Negative Breast Cancer\|Recurrent Breast Cancer\|Stage IV Breast Cancer\|Triple-negative Breast Cancer\|Triple-negative Metastatic Breast Cancer\|Metastatic Breast Cancer	NCT01881230
Nab-paclitaxel (Abraxane) With or Without Mifepristone in Patients With Advanced Breast Cancer	Completed	Male Breast Cancer\|Recurrent Breast Cancer\|Stage IIIA Breast Cancer\|Stage IIIB Breast Cancer\|Stage IIIC Breast Cancer\|Stage IV Breast Cancer	NCT01493310
Biological Effect of Nab-paclitaxel Combined to Gemcitabine in Metastatic Pancreatic Cancer	Completed	Pancreatic Adenocarcinoma	NCT02174887
Neoadjuvant Pembrolizumab(Pbr)/Nab-Paclitaxel Followed by Pbr/Epirubicin/Cyclophosphamide in TNBC	Active, not recruiting	Malignant Neoplasm of Breast	NCT03289819
M402 in Combination With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer	Terminated	Metastatic Pancreatic Cancer	NCT01621243
Role of Biomarkers in Muscle Pain and Joint Pain in Patients With Solid Tumors Receiving Paclitaxel	Terminated	Arthralgia\|Pain\|Unspecified Adult Solid Tumor, Protocol Specific	NCT01096407
Phase II Pazopanib in Combination With Weekly Paclitaxel in Refractory Urothelial Cancer	Completed	Bladder Cancer\|Bladder (Urothelial, Transitional Cell) Cancer\|Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive)\|Bladder (Urothelial, Transitional Cell) Cancer Resectable (Pre-Cystectomy)\|Bladder (Urothelial, Transitional Cell) Cancer Metastatic or Unresectable	NCT01108055
Clinical Trial of the Safety and Efficacy of the Addition of Ramucirumab to Nab-paclitaxel in Previously Treated Patients With Advanced Non-small Cell Lung Cancer (NSCLC)	Completed	Non-small Cell Lung Cancer	NCT02730247
A Study of Atezolizumab in Combination With Nab-Paclitaxel Compared With Placebo With Nab-Paclitaxel for Participants With Previously Untreated Metastatic Triple-Negative Breast Cancer (IMpassion130)	Active, not recruiting	Triple Negative Breast Cancer	NCT02425891
Neoadjuvant Paclitaxel Versus BIBF 1120 Priming Followed by BIBF 1120 Plus Paclitaxel in Early HER-2 Negative Breast Cancer With Proteomic and Dynamic Imaging Correlates	Completed	Breast Cancer	NCT01484080
A Phase 1b Study With Volociximab in Combination With Carboplatin and Paclitaxel in First-line, Advanced Non-Small Cell Lung Cancer (NSCLC)	Completed	Non-small Cell Lung Cancer	NCT00654758
Phase Ib/II Trial of BEZ235 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer	Completed	Inoperable Locally Advanced Breast Cancer\|Metastatic Breast Cancer (MBC)	NCT01495247
A Study of Nab-Paclitaxel and Carboplatin Plus Necitumumab (LY3012211) in Participants With Stage IV Squamous NSCLC	Completed	Carcinoma, Non-small-Cell Lung	NCT02392507
A Phase I Trial of Abraxane, Cisplatin and 5-Fluorouracil Along With Chemoradiotherapy in Advanced Head and Neck Cancer	Completed	Head and Neck Cancer	NCT00731380
Testing the Addition of Radium Therapy (Radium-223 Dichloride) to the Usual Chemotherapy Treatment (Paclitaxel) for Advanced Breast Cancer Spread to the Bones	Recruiting	Anatomic Stage IV Breast Cancer AJCC v8\|Breast Carcinoma Metastatic in the Bone\|Metastatic Breast Carcinoma\|Metastatic Triple-Negative Breast Carcinoma\|Prognostic Stage IV Breast Cancer AJCC v8	NCT04090398
Pilot Study to Evaluate Reparixin With Weekly Paclitaxel in Patients With HER 2 Negative Metastatic Breast Cancer (MBC)	Completed	Metastatic Breast Cancer	NCT02001974
Sintilimab and Nab-paclitaxel in Second-line Treatment of Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma	Not yet recruiting	Advanced Gastric and Gastro-esophageal Junction Adenocarcinoma	NCT04140318
A Randomized, Double Blind Study Evaluating Paclitaxel With and Without RAD001 in Patients With Gastric Carcinoma After Prior Chemotherapy	Completed	Advanced Gastric Cancer\|Esophagogastric Junction Cancer	NCT01248403
Dose Escalation Study of HBI-8000 in Combination With Paclitaxel and Trastuzumab in Women With Advanced or Metastatic HER2+ Breast Cancer	Withdrawn	Breast Cancer	NCT02569489
Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Breast Cancer	Completed	Breast Cancer	NCT01023204
Endostar Combined With Paclitaxel and Nedaplatin in Treating Patients With Recurrent or Metastatic Esophageal Cancer	Recruiting	Esophageal Squamous Cell Carcinoma	NCT02350517
PAKT: AZD5363 in Combination With Paclitaxel in Triple-Negative Advanced or Metastatic Breast Cancer	Active, not recruiting	Metastatic Breast Cancer	NCT02423603
Pharmacokinetics Study of Liposomal Paclitaxel in Humans	Completed	Cancer	NCT00606515
Phase 2 Study With Abraxane (NabÂ®Paclitaxel) in Metastatic Colorectal Cancer	Completed	Colorectal Neoplasms	NCT02103062
Paclitaxel, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer	Completed	Breast Cancer	NCT01276041
Phase II Study of Oxaliplatine-Paclitaxel in Patients With Metastatic Germ Cell Tumor Refractory to Cisplatin	Completed	Neoplasms, Germ Cell and Embryonal	NCT00611962
Paclitaxel/Carboplatin (PC) Followed by Gefitinib Versus PC in Advanced Non-small Cell Lung Cancer	Completed	Non Small Cell Lung Cancer	NCT01196234
Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Head and Neck Cancer	Completed	Head and Neck Cancer	NCT00851877
A Study of VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL)	Recruiting	Recurrent Platinum Resistant Ovarian Cancer	NCT03398655
Study of AZD6738, DNA Damage Repair/Novel Anti-cancer Agent, in Combination With Paclitaxel, in Refractory Cancer	Recruiting	Refractory Cancer	NCT02630199
EFficacy and Impact on Function of Two Different Doses of Nab-paclitaxEl in Elderly With advanCed breasT Cancer	Completed	Breast Cancer	NCT02783222
Phase 2, Nab Paclitaxel/Gemcitabine Alone and in Combination With ACP-196 in Subjects With Metastatic Pancreatic Cancer	Terminated	Metastatic Pancreatic Cancer	NCT02570711
Exploratory Study on the S-1 + Paclitaxel Chemotherapy for Unresectable Gastric Cancer	Unknown status	Surgically-Created Resection Cavity\|Drug Safety	NCT01756183
Efficacy Study of Paclitaxel Versus Irinotecan in Patients With Recurrent or Metastatic Gastric Cancer Who Progress Following First-line Therapy	Unknown status	Gastric Cancer	NCT01224652
Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Non-Small Cell Lung Cancer (NSCLC)	Completed	Non-Small Cell Lung Cancer	NCT01024062
Nab-paclitaxel in Combination With Gemcitabine in Fragile Patients With Advanced Pancreatic Cancer	Completed	Advanced Pancreatic Cancer	NCT02382263
A Study of SHR-1210 in Combination With Carboplatin+Paclitaxel-albumin in Subjects With Resectable NSCLC	Not yet recruiting	Lung Cancer Stage II\|PD-1 Antibody\|Non-small Cell Lung Cancer	NCT04108013
Nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine For The First Line Treatment of Pancreas Cancer	Completed	Pancreatic Neoplasm	NCT03807999
Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced Breast Cancer	Completed	Breast Cancer	NCT00971945
Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Head and Neck Cancer	Completed	Head and Neck Cancer	NCT00971867
Study to Assess Safety and Tolerability of AZD0530 in Combination With Carboplatin and Paclitaxel	Withdrawn	Cancer\|Non Small Cell Lung Cancer\|Epithelial Ovarian Cancer	NCT01000896
Early Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Advanced or Recurrent Head and Neck Cancer	Completed	Head and Neck Cancer	NCT01024101
Efficacy and Safety of Paclitaxel for Injection (Albumin-bound) for First-line Chemotherapy of Ovarian Cancer	Not yet recruiting	Ovarian Cancer	NCT03818282
Lapatinib in Combination With Weekly Paclitaxel in Patients With ErbB2 Amplified Advanced Gastric Cancer	Completed	Neoplasms, Gastrointestinal Tract	NCT00486954
Efficacy and Safety of Modified Nab-Paclitaxel Plus Gemcitabine Chemotherapy for Metastatic Pancreatic Cancer	Recruiting	Metastatic Pancreatic Cancer	NCT03502343
Clinical Study of Liposomal Paclitaxel in Chinese Patients	Unknown status	Solid Tumor	NCT00881101
Dose-confirmation Study of ASLAN001 Combined With Weekly Paclitaxel and Carboplatin in Advanced Solid Tumours, Followed by a Study in Patients With Stage I-III HER2 Positive Breast Cancer	Unknown status	Breast Cancer	NCT02396108
PI3KÎ˛ Selective Inhibitor With Paclitaxel, Advanced Gastric Adenocarcinoma	Active, not recruiting	Advanced Gastric Adenocarcinoma	NCT02615730
Onalespib and Paclitaxel in Treating Patients With Advanced Triple Negative Breast Cancer	Active, not recruiting	Advanced Breast Carcinoma\|Metastatic Breast Carcinoma\|Stage III Breast Cancer AJCC v7\|Stage IIIA Breast Cancer AJCC v7\|Stage IIIB Breast Cancer AJCC v7\|Stage IIIC Breast Cancer AJCC v7\|Stage IV Breast Cancer AJCC v6 and v7\|Triple-Negative Breast Carcinoma	NCT02474173
Nab-paclitaxel Combined With S-1 as Induction Therapy for Locally Advanced Pancreatic Cancer	Not yet recruiting	Locally Advanced Pancreatic Cancer	NCT03815461
Study to Determine Efficacy and Safety of CC-486 With Nab-Paclitaxel Versus Nab-Paclitaxel in Patients With Chemotherapy naĂŻve Metastatic Melanoma	Withdrawn	Metastatic Melanoma	NCT01933061
Trial of Paclitaxel, Gemcitabine and Cisplatin in Patients With Relapsing Germ Cell Cancer	Terminated	Testicular Cancer	NCT00531687
Albumin-bound Paclitaxel Plus S-1 Versus SOX as First-line Treatment in Advanced or Recurrent Gastric Adenocarcinoma	Recruiting	Gastric Cancer	NCT03801668
A Phase I-II Study of HM781-36B Combined With Paclitaxel and Trastuzumab in HER-2 Positive Advanced Gastric Cancer	Completed	HER-2 Positive Advanced Gastric Cancer	NCT01746771
The Paclitaxel-Eluting Percutaneous Transluminal Coronary Angioplasty (PTCA) - Balloon Catheter in Coronary Artery Disease to Treat Chronic Total Occlusions	Completed	Coronary Artery Disease\|Chronic Total Occlusion\|Native Coronary Artery	NCT00670436
Paclitaxel Eluting Balloon Catheter in Coronary De-novo Lesions Treatment in China	Recruiting	Coronary Disease	NCT03466749
Phase I Trial of LCL161 and Gemcitabine Plus Nab-Paclitaxel in Metastatic Pancreatic Cancer	Unknown status	Metastatic Pancreatic Cancer	NCT01934634
Local Delivery of Paclitaxel Via the TAPAS Catheter to Prevent Restenosis From Percutaneous Femoropopliteal Intervention	Unknown status	Restenosis\|Peripheral Arterial Disease	NCT01599078
Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced or Recurrent Esophageal Cancer	Completed	Esophageal Cancer	NCT00971841
Study of Metformin With Carboplatin/Paclitaxel Chemotherapy in Patients With Advanced Ovarian Cancer	Completed	Epithelial Ovarian Cancer	NCT02312661
Late Phase II Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced or Recurrent Head and Neck Cancer	Completed	Head and Neck Cancer	NCT00855764
Study of Everolimus With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma	Completed	Metastatic Melanoma	NCT01014351
Paclitaxel and Pembrolizumab in Treating Patients With Refractory Metastatic Urothelial Cancer	Recruiting	Transitional Cell Carcinoma	NCT02581982
Treatment of Moderate Vein Graft Lesions With Paclitaxel Drug Eluting Stents: The VELETI Trial	Completed	Coronary Artery Bypass Grafting	NCT00289835
AZD1775 Plus Carboplatin-Paclitaxel in Squamous Cell Lung Cancer	Recruiting	Lung Cancer	NCT02513563
The Effect of Food on the Pharmacokinetics of Paclitaxel Administered Orally as Oraxol	Recruiting	Solid Tumor, Adult	NCT03892018
AZD8186 and Paclitaxel in Advanced Gastric Cancer	Recruiting	Solid Tumor\|Stomach Cancer	NCT04001569
Dose-finding Study of Weekly Paclitaxel and Cisplatin in FIGO IB2 and Bulky IIA Cervical Cancer	Unknown status	Cervical Cancer	NCT00823186
Paclitaxel, Pembrolizumab and Olaparib in Previously Treated Advanced Gastric Adenocarcinoma	Not yet recruiting	Advanced Gastric Adenocarcinoma	NCT04209686
Study Of SU011248 In Combination With Paclitaxel/Carboplatin In Patients With Advanced Solid Tumors	Completed	Neoplasms	NCT00511849
Phase II Trial of Neoadjuvant Treatment and Minimal Invasive Surgery for Esophageal and GEJ Cancer	Recruiting	Esophageal Cancer\|Induction Chemotherapy	NCT02924909
Study of Albumin Bound-Paclitaxel for Treatment of Recurrent or Metastatic Head and Neck Cancer With Cetuximab	Terminated	Head and Neck Cancer	NCT00319839
Paclitaxel-coated Balloon Angioplasty Versus Standard Angioplasty for the Treatment of Stenosis of Arteriovenous Fistula	Recruiting	Angioplasty\|Stenosis of Arteriovenous Fistula	NCT02753998
Paclitaxel and Carboplatin in Women With Malignant Mixed Mullerian Tumors (MMMT) of the Uterus	Completed	Mixed Tumor, Mullerian	NCT00502203
Treatment of Locally Advanced VULvar CArcinoma in a Neoadjuvant Setting With Carboplatin and Paclitaxel Chemotherapy (VULCANize)	Not yet recruiting	Locally Advanced, Squamous Cell Carcinoma of the Vulva	NCT04192253
Trial of Paclitaxel/Carboplatin + PF-3512676 vs Paclitaxel/Carboplatin Alone in Patients With Advanced Non-Small Cell Lung Cancer	Terminated	Carcinoma, Non-Small-Cell Lung	NCT00254891
Treatment of Metastatic Vulvar Carcinoma With Carboplatin and Paclitaxel Chemotherapy	Not yet recruiting	Metastatic Squamous Cell Carcinoma of the Vulva	NCT04161664
Pulsed Abraxane and Radiotherapy for Improving and Maintaining Ambulation After Cancer-Related Cord Compression	Recruiting	Cord Compression	NCT03655080
Study With Paclitaxel +/- Ramucirumab in Patients With Squamous-cell Carcinoma of the Esophagus After Prior Therapy	Recruiting	Squamous Cell Carcinoma of the Esophagus	NCT03762564
Afatinib and Gemcitabine/Nab-paclitaxel in Metastatic Pancreatic Cancer	Active, not recruiting	Metastatic Pancreatic Cancer	NCT02975141
Intraperitoneal and Intravenous Paclitaxel Chemotherapy With Oral Capecitabine for Gastric Adenocarcinoma With Peritoneal Carcinomatosis	Not yet recruiting	Gastric Adenocarcinoma\|Gastric Cancer\|Esophagogastric Junction\|Peritoneal Carcinomatosis	NCT04034251
Paclitaxel Therapeutic Drug Monitoring in Cancer Patients	Suspended	Solid Tumor, Adult\|Metastatic Nonsmall Cell Lung Cancer\|Anatomic Stage IV Breast Cancer AJCC v8\|Metastatic Cervical Carcinoma\|Metastatic Ovarian Carcinoma\|Malignant Uterine Neoplasm\|Vulvar Cancer\|Invasive Breast Cancer\|Metastatic Breast Carcinoma\|Prognostic Stage IV Breast Cancer AJCC v8\|Recurrent Breast Carcinoma\|Recurrent Cervical Carcinoma\|Recurrent Lung Non-Small Cell Carcinoma\|Recurrent Ovarian Carcinoma\|Recurrent Vulvar Carcinoma\|Stage IV Cervical Cancer AJCC v8\|Stage IV Lung Cancer AJCC v8\|Stage IV Vulvar Cancer AJCC v8\|Stage IV Ovarian Cancer AJCC v8\|Stage IVA Cervical Cancer AJCC v8\|Stage IVA Lung Cancer AJCC v8\|Stage IVA Ovarian Cancer AJCC v8\|Stage IVA Vulvar Cancer AJCC v8\|Stage IVB Cervical Cancer AJCC v8\|Stage IVB Lung Cancer AJCC v8\|Stage IVB Ovarian Cancer AJCC v8\|Stage IVB Vulvar Cancer AJCC v8\|Vulva Squamous Cell Carcinoma	NCT03987555
A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies	Recruiting	Cancer	NCT01325441
Study of TRC105 + Paclitaxel/Carboplatin and Bevacizumab in Patients With NSCLC	Completed	Non Small Cell Lung Cancer	NCT03780010
Satraplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer	Completed	Non-small Cell Lung Cancer	NCT00268970
Study of Cetuximab With and Without Weekly Paclitaxel for Patients With Previously Treated Advanced Urothelial Cancer	Completed	Urologic Neoplasm	NCT00350025
Cyclosporine A in Combination With Nab-Paclitaxel in Patients With Metastatic Breast Cancer	Completed	Metastatic Breast Cancer	NCT00983424
A Study of Gentuximab + Paclitaxel in Patients With Advanced Gastric or Gastroesophageal Junction Cancer	Not yet recruiting	Advanced Gastric or Gastroesophageal Junction Cancer	NCT04053205
Nab-paclitaxel in Metastatic Breast Cancer Patients Failing Solvent Based Taxane (Tiffany)	Terminated	Metastatic Breast Cancer	NCT01416558
A Study to Assess Clinical an Patient Reported Outcomes With Nab-paclitaxel in Combination With Gemcitabine in Route Clinical Practice Treating Pancreatic Cancer	Terminated	Pancreatic Neoplasms	NCT02670746
Dose Finding Study Of PF-05212384 With Paclitaxel And Carboplatin In Patients With Advanced Solid Tumor	Completed	Breast Cancer\|NSCLC\|Ovary Cancer\|Endometrial Cancer\|Small Cell Lung Cancer (SCLC)\|Head and Neck (HNSCC)	NCT02069158
FIrst Line Treatment of Metastatic Pancreatic Cancer: Sequential Nab-paclitaxel + Gemcitabine/FOLFIRI.3 VS Nab-paclitaxel + Gemcitabine	Active, not recruiting	Metastatic Pancreatic Cancer	NCT02827201
Evaluation of Safety and Efficacy of TOCOSOL(R) Paclitaxel as Initial Treatment for Metastatic Breast Cancer	Completed	Breast Cancer	NCT00096668
Carboplatin/Nab-Paclitaxel and Pembrolizumab in NSCLC	Active, not recruiting	Non-Small Cell Lung Cancer	NCT02382406
Phase I/II Study to Evaluate Nab-paclitaxel in Substitution of CPT11 or Oxaliplatin in FOLFIRINOX Schedule as First Line Treatment in Metastatic Pancreatic Cancer	Completed	Metastatic Pancreatic Cancer	NCT02109341
LCI-LUN-ABR-001: Carbo With Nab-Paclitaxel in Patients With Advanced NSCL Cancer	Completed	Lung Cancer	NCT02328105
Bevacizumab and Paclitaxel for Neuroendocrine Tumors of the Cervix	Terminated	Cervical Cancer\|Uterine Cancer	NCT00626561
Study of Relacorilant in Combination With Nab-Paclitaxel for Patients With Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer	Recruiting	Recurrent Ovarian Cancer\|Recurrent Fallopian Tube Carcinoma\|Recurrent Primary Peritoneal Carcinoma	NCT03776812
Abraxane Therapy in Patients With Pancreatic Cancer Who Failed First-Line Gemcitabine Therapy	Completed	Pancreatic Cancer	NCT00691054
Study Assessing the Efficacy and Safety of Alpelisib + Nab-paclitaxel in Subjects With Advanced TNBC Who Carry Either a PIK3CA Mutation or Have PTEN Loss Without PIK3CA Mutation	Not yet recruiting	Triple Negative Breast Neoplasms	NCT04251533
A Study of RO5509554 as Monotherapy and in Combination With Paclitaxel in Participants With Advanced Solid Tumors	Completed	Advanced Solid Tumors	NCT01494688
A Study of Ramucirumab (LY3009806) in Combination With Paclitaxel in Participants With Gastric Cancer	Completed	Gastric Adenocarcinoma\|Gastroesophageal Junction Adenocarcinoma	NCT02514551
Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer	Completed	Chemotherapeutic Agent Toxicity\|Neuropathy\|Neurotoxicity Syndrome\|Pain\|Stage IIIA Fallopian Tube Cancer\|Stage IIIA Ovarian Cancer\|Stage IIIA Primary Peritoneal Cancer\|Stage IIIB Fallopian Tube Cancer\|Stage IIIB Ovarian Cancer\|Stage IIIB Primary Peritoneal Cancer\|Stage IIIC Fallopian Tube Cancer\|Stage IIIC Ovarian Cancer\|Stage IIIC Primary Peritoneal Cancer\|Stage IV Fallopian Tube Cancer\|Stage IV Ovarian Cancer\|Stage IV Primary Peritoneal Cancer	NCT02311907
Use of Nanoparticle Paclitaxel (ABI-007) for the Prevention of In-Stent Restenosis	Completed	Coronary Restenosis	NCT00124943
Combination Treatment of S-1 With Paclitaxel in Advanced Esophageal Cancer	Terminated	Esophageal Cancer	NCT01704690
Nab-Paclitaxel + Cisplatin + Gemcitabine in Untreated Metastatic Pancreatic Adenocarcinoma	Recruiting	Pancreatic Ductal Adenocarcinoma	NCT03915444
ONC201 and Paclitaxel in Treating Patients With Platinum-Resistant Refractory or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer	Not yet recruiting	Malignant Ovarian Epithelial Tumor\|Platinum-Resistant Fallopian Tube Carcinoma\|Platinum-Resistant Ovarian Carcinoma\|Platinum-Resistant Primary Peritoneal Carcinoma\|Recurrent Fallopian Tube Carcinoma\|Recurrent Ovarian Carcinoma\|Recurrent Primary Peritoneal Carcinoma\|Refractory Fallopian Tube Carcinoma\|Refractory Ovarian Carcinoma\|Refractory Primary Peritoneal Carcinoma	NCT04055649
Neoadjuvant MPDL3280A, Nab-paclitaxel and Carboplatin (MAC) in NSCLC	Active, not recruiting	Carcinoma, Non-Small-Cell Lung	NCT02716038
Paclitaxel, Cisplatin,5-FU vs. Radiotherapy Plus Paclitaxel, Cisplatin as Preoperative Therapy for Locally Advanced ESC	Not yet recruiting	Esophageal Cancer Stage IIB\|Esophageal Cancer Stage III	NCT03366883
LBH589, Paclitaxel, Carboplatin +/- Bevacizumab for Solid Tumors	Completed	Solid Tumors	NCT00556088
Efficacy Study of Gemcitabine, Paclitaxel, and Irradiation in the Treatment of Pancreatic Cancer	Completed	Carcinoma, Pancreatic Ductal	NCT00226746
Study of the Paclitaxel-Coated Balloon Catheter in Bifurcated Coronary Lesions	Unknown status	Coronary Artery Disease	NCT01278186
Taladegib, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Localized Esophageal or Gastroesophageal Junction Cancer	Active, not recruiting	Gastroesophageal Junction Adenocarcinoma\|Stage IB Esophageal Adenocarcinoma AJCC v7\|Stage II Esophageal Adenocarcinoma AJCC v7\|Stage IIA Esophageal Adenocarcinoma AJCC v7\|Stage IIB Esophageal Adenocarcinoma AJCC v7\|Stage IIIA Esophageal Adenocarcinoma AJCC v7\|Stage IIIB Esophageal Adenocarcinoma AJCC v7	NCT02530437
A Study to Assess Overall Response Rate by Inducing an Inflammatory Phenotype in Metastatic BReast cAnCEr With the Oncolytic Reovirus PeLareorEp in CombinaTion With Anti-PD-L1 Avelumab and Paclitaxel - BRACELET-1 Study	Not yet recruiting	Breast Cancer Metastatic	NCT04215146
Concurrent Chemoradiotherapy (CCRT) With Paclitaxel Plus Cisplatin in LA Non-small-cell Lung Cancer (NSCLC)	Completed	Non-small-cell Lung Cancer	NCT00686322
Cisplatin and Nab-paclitaxel for (N2) Defined NSCLC	Terminated	Stage IIIA Non-Small Cell Lung Cancer	NCT02276560
Lenalidomide and Paclitaxel in Advanced Solid Tumors	Unknown status	Advanced Solid Tumors	NCT01155505
Conventional Prophylactic Oral Dexamethasone vs Short-course IV Dexamethasone in Paclitaxel Hypersensitivity	Recruiting	Hypersensitivity Reactions	NCT03598426
A Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer	Recruiting	Endometrial Cancer	NCT03981796
A Phase 3 Randomized, Placebo-controlled Trial of Carboplatin and Paclitaxel With or Without Veliparib (ABT-888) in HER2-negative Metastatic or Locally Advanced Unresectable BRCA-associated Breast Cancer	Active, not recruiting	Metastatic Breast Cancer	NCT02163694
Dasatinib In Combination With Trastuzumab And Paclitaxel In First Line Treatment Of Her2-Positive MBC Patients	Completed	Metastatic Breast Cancer	NCT01306942
A Trial of Camrelizumab in Combination With Nab-paclitaxel and Famitinib as a First Line Treatment in Patients With Unresectable Locally Advanced or Metastatic Immunomodulatory Triple Negative Breast Cancer(FUTURE-C-PLUS)	Recruiting	Triple-Negative Breast Cancer	NCT04129996
Camrelizumab in Combination With Apatinib Mesylate, Paclitaxel-albumin and S-1 for Translational Treatment of Gastric Cancer	Not yet recruiting	Gastric Cancer	NCT04258644
A Phase 1b Study of OMP-305B83 Plus Paclitaxel in Subjects With Ovarian, Peritoneal or Fallopian Tube Cancer	Active, not recruiting	Cancer Ovaries\|Cancer Peritoneal\|Cancer, Fallopian Tube	NCT03030287
An Early Phase Study of Abraxane Combined With Phenelzine Sulfate in Patients With Metastatic or Advanced Breast Cancer	Completed	Metastatic Breast Cancer	NCT03505528
Comparing the Safety and Efficacy of Paclitaxel Controlled Release Balloon Catheter in the Treatment of In-stent Restenosis of Coronary Artery Lesion With Paclitaxel Release Coronary Balloon Catheter	Unknown status	In-stent Restenosis	NCT02891018
Nab-paclitaxel Dose Schedual for HER-2 Negative Advanced Breast Cancer	Recruiting	Breast Cancer	NCT04192331
Capivasertib+Paclitaxel as First Line Treatment for Patients With Locally Advanced or Metastatic TNBC	Recruiting	Triple Negative Breast Neoplasms	NCT03997123
Combination Nab-paclitaxel (N-P) and Nintedanib or N-P and Placebo in Relapsed NSCLC Adenocarcinoma	Not yet recruiting	NSCLC, Recurrent\|Adenocarcinoma of Lung	NCT03361319
Randomized Ph 2 Trial Of Paclitaxel/Carboplatin /Bevacizumab + PF-3512676 And P/C/B Alone In Advanced Nonsquamous NSCLC	Terminated	Carcinoma, Non-Small-Cell Lung	NCT00313768
RANGERâ„˘ Paclitaxel Coated Balloon vs Standard Balloon Angioplasty	Active, not recruiting	Peripheral Artery Disease\|Atherosclerosis\|Artery Diseases, Peripheral\|Plaque, Atherosclerotic\|Occlusive Arterial Disease	NCT03064126
Albumin-Bound Paclitaxel and Gemcitabine in Patients With Untreated Stage IV or Recurrent Squamous Cell Lung Cancers	Completed	Lung Cancer\|Untreated Stage IV or Recurrent Squamous Cell Lung Cancers	NCT02525653
Abraxane and Gemcitabine Versus Gemcitabine Alone in Locally Advanced Unresectable Pancreatic Cancer.	Completed	Pancreatic Cancer Stage II	NCT02043730
Vorinostat, Paclitaxel, and Radiation Therapy in Treating Patients Unable to Tolerate Cisplatin With Stage III Non-Small Lung Cancer That Cannot Be Removed By Surgery	Terminated	Stage IIIA Non-small Cell Lung Cancer\|Stage IIIB Non-small Cell Lung Cancer	NCT00662311
Genasense, Carboplatin, Paclitaxel (GCP) Combination in Uveal Melanoma	Terminated	Melanoma	NCT01200342
Nab-paclitaxel Based Regimens VS Paclitaxel Based Regimens in Neoadjuvant Treatment for TNBC	Recruiting	Triple Negative Breast Cancer	NCT04067102
Safety Study of Combination of Hormone Therapy, Paclitaxel and Radiation Therapy to Treat Prostate Cancer	Completed	Prostate Cancer	NCT02911350
Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab in Pancreatic Cancer Patients	Recruiting	Unresectable Pancreatic Carcinoma	NCT02767557
Phase II Study of Primary Chemotherapy With Paclitaxel, Gemcitabine, and Trastuzumab	Completed	Breast Cancer	NCT00532857
Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid Tumors	Completed	Cancer\|Non-Small Cell Lung Cancer\|Endometrial Carcinoma\|Ovarian Carcinoma	NCT00756847
TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid Tumors	Completed	Pancreatic Cancer\|Colorectal Cancer\|Rectal Cancer\|Gastric Cancer\|Esophageal Cancer\|Gastrointestinal Stromal Tumor (GIST)	NCT02574663
CFI-402257 in Combination With Paclitaxel in Patients With Advanced/Metastatic HER2-Negative Breast Cancer	Recruiting	Breast Cancer	NCT03568422
Weekly Paclitaxel and Trastuzumab in Metastatic Breast Cancer	Completed	Metastatic Breast Cancer	NCT01423695
Nab-Paclitaxel in Combination With Carboplatin as First-line Therapy in Patients With NSCLC	Active, not recruiting	Carcinoma, Non-Small-Cell Lung	NCT02799862
ARQ-761 Treatment With Gemcitabine/Nab-Paclitaxel Chemotherapy In Pancreatic Cancer	Suspended	Pancreatic Cancer	NCT02514031
Pilot Study of Cabazitaxel and Paclitaxel in HER2 Negative Breast Cancer	Recruiting	HER2 Negative Metastatic Breast Cancer	NCT03048942
Shorter Scalp Cooling Time in Paclitaxel	Recruiting	Neoplasm Malignant\|Breast Cancer\|Ovarian Cancer	NCT03266185
TAK-659 and Paclitaxel in Treating Patients With Advanced Solid Tumors	Recruiting	Advanced Malignant Solid Neoplasm\|KRAS Gene Mutation\|Ovarian Carcinoma\|Refractory Malignant Solid Neoplasm\|Refractory Ovarian Carcinoma	NCT03756818
Paclitaxel in Treating Patients With Ovarian Stromal Cancer	Completed	Adult Type Ovarian Granulosa Cell Tumor\|Ovarian Gynandroblastoma\|Ovarian Sertoli-Leydig Cell Tumor\|Ovarian Sex Cord Tumor With Annular Tubules\|Ovarian Steroid Cell Tumor	NCT00006227
Efficacy and Safety of Nintedanib Combined With Paclitaxel Chemotherapy for Patients With BRAF wt Metastatic Melanoma	Completed	Cutaneous Malignant Melanoma	NCT02308553
Neoadjuvant Chemotherapy IV Carboplatin With Weekly Paclitaxel \Bevacizumab for Primary Ovarian	Completed	Ovarian Cancer\|Primary Peritoneal Cancer\|Fallopian Tube Cancer	NCT01219777
A Phase 1, Dose Escalation Study to Assess the Safety and Tolerability of ASP9853 With Either Docetaxel or Paclitaxel in Patients With Advanced Non-hematologic Malignancies	Terminated	Pharmacokinetics of ASP9853\|Non-hematologic Malignancies	NCT01705483
Safety and Effectiveness of Agent Paclitaxel-Coated PTCA Balloon Catheter. (AGENT Japan SV)	Recruiting	Coronary Artery Disease	NCT04058990
MK-2206, Paclitaxel and Trastuzumab in Treating Patients With HER2-overexpressing Solid Tumor Malignancies	Completed	Advanced Solid Tumors\|Tumors\|Cancer	NCT01235897
Nab-paclitaxel (Abraxane), Gemcitabine, and Capecitabine (Xeloda) for Pancreatic Adenocarcinoma	Completed	Pancreatic Neoplasms\|Pancreatic Cancer\|Adenocarcinoma	NCT01161186
Safety Study of Itacitinib (INCB039110) in Combination With Gemcitabine and Nab-Paclitaxel in Subjects With Advanced Solid Tumors	Completed	Solid Tumors\|Pancreatic Cancer	NCT01858883
Hedgehog Inhibitors for Metastatic Adenocarcinoma of the Pancreas	Completed	Metastatic Pancreatic Cancer	NCT01088815
A Study of PEGylated Recombinant Human Hyaluronidase in Combination With Nab-Paclitaxel Plus Gemcitabine Compared With Placebo Plus Nab-Paclitaxel and Gemcitabine in Participants With Hyaluronan-High Stage IV Previously Untreated Pancreatic Ductal Adenocarcinoma	Terminated	Pancreatic Ductal Carcinoma	NCT02715804
Abraxane Combined With Xeloda as Neo-Adjuvant Chemotherapy in Early Breast Cancer	Not yet recruiting	Breast Cancer	NCT03647514
GC 2nd Line Durvalumab(MEDI4736)/Tremelimumab Plus Paclitaxel Study	Recruiting	Metastatic Gastric Cancer	NCT03751761
Study of Nab-paclitaxel in Sensitive and Refractory Relapsed SCLC	Unknown status	Small Cell Lung Cancer	NCT03219762
A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer or Carcinosarcoma	Recruiting	Endometrial Cancer\|Uterine Cancer\|Ovarian Cancer\|Carcinosarcoma	NCT03395080
Toripalimab in Combination With Nab-Paclitaxel For Patients With Metastatic or Recurrent Triple-Negative Breast Cancer (TNBC) With or Without Systemic Treatment	Recruiting	Triple-Negative Breast Cancer	NCT04085276
Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer	Completed	Squamous Cell Carcinoma, Non-Small-Cell Lung	NCT02027428
Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer	Completed	Chemotherapeutic Agent Toxicity\|Endometrial Adenocarcinoma\|Fallopian Tube Carcinoma\|Gastrointestinal Complication\|Malignant Ovarian Mixed Epithelial Tumor\|Neurotoxicity Syndrome\|Ovarian Brenner Tumor\|Ovarian Clear Cell Cystadenocarcinoma\|Ovarian Mucinous Cystadenocarcinoma\|Ovarian Serous Cystadenocarcinoma\|Primary Peritoneal Carcinoma\|Stage II Ovarian Cancer\|Stage III Ovarian Cancer\|Stage IV Ovarian Cancer\|Undifferentiated Ovarian Carcinoma	NCT00814086
Dose Escalation Study of Liposomal Paclitaxel Plus Capecitabine in Chinese Patients With Advanced Gastric Carcinoma	Unknown status	Advanced Gastric Carcinoma	NCT00881816
Enzalutamide in Combination With Gemcitabine and Nab-Paclitaxel for the Treatment of Advanced Pancreatic Cancer	Completed	Pancreatic Cancer	NCT02138383
A Study of Napabucasin in Combination With Weekly Paclitaxel and Low-dose Gemcitabine in Patients With Pancreatic Cancer	Recruiting	Metastatic Pancreatic Cancer	NCT03721744
Study to Assess the Efficacy and Safety of Nivolumab in Combination With Paclitaxel in Subjects With Head and Neck Cancer Unable for Cisplatin-based Chemotherapy (NIVOTAX)	Not yet recruiting	Recurrent Head and Neck Squamous Cell Carcinoma\|Head and Neck Cancer Stage IV	NCT04282109
Comparing the Safety and Efficacy of Paclitaxel Controlled Release Balloon Catheter (VasoguardTM) in the Treatment of Small Coronary Vessel Stenosis With a Common Coronary Balloon Catheter (Maverick2)	Unknown status	Small Vessel Lesion	NCT02891005
Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Patients With LA-NPC	Recruiting	Nasopharyngeal Carcinoma	NCT04015661
Efficacy and Safety of TPFinduction Chemotherapy Boundary Resectable Local Advanced Esophageal Squamous Cell Carcinoma	Unknown status	Esophageal Squamous Cell Carcinoma	NCT02976909
Albumin-bound Paclitaxel and Carboplatin Versus Epirubicin and Docetaxel for Triple-negative Breast Cancer	Not yet recruiting	Breast Cancer	NCT04136782
CS-7017 in Combination With Carboplatin/Paclitaxel in Subjects With Stage IIIb/IV Non-small Cell Lung Cancer (NSCLC)	Completed	Carcinoma, Non-Small-Cell Lung	NCT01199055
Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus or Stomach	Completed	Esophageal Cancer\|Gastric Cancer	NCT00020761
Phase I Study of PI3(Phosphoinositol 3)-Kinase Inhibitor BAY80-6946 With Paclitaxel in Patients With Advanced Cancer	Completed	Neoplasms	NCT01411410
Gemcitabine + Nab-paclitaxel With LDE-225 (Hedgehog Inhibitor) as Neoadjuvant Therapy for Pancreatic Adenocarcinoma	Terminated	Pancreatic Ductal Adenocarcinoma	NCT01431794
Selinexor, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Metastatic Pancreatic Cancer	Active, not recruiting	Acinar Cell Adenocarcinoma of the Pancreas\|Duct Cell Adenocarcinoma of the Pancreas\|Stage IV Pancreatic Cancer	NCT02178436
Paclitaxel/Carboplatin + Galunisertib for Patients With Carcinosarcoma of the Uterus or Ovary	Recruiting	Carcinosarcoma, Ovarian	NCT03206177
Nab-Paclitaxel Plus Gemcitabine With Concurrent MR-Guided IMRT in Patients With Locally Advanced Pancreatic Cancer	Completed	Pancreatic Cancer	NCT02283372
Adjuvant Paclitaxel and Trastuzumab for Node-Negative HER2-Positive Breast Cancer	Active, not recruiting	Breast Cancer\|Carcinoma of the Breast	NCT00542451
Phase I Study of the Combination of Satraplatin and Abraxane in Advanced Cancers	Completed	Advanced Cancers	NCT00473720
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection	Terminated	HIV Infection\|Recurrent Anal Cancer\|Recurrent Breast Cancer\|Recurrent Esophageal Cancer\|Recurrent Gastric Cancer\|Recurrent Metastatic Squamous Neck Cancer With Occult Primary\|Recurrent Non-small Cell Lung Cancer\|Recurrent Ovarian Epithelial Cancer\|Recurrent Salivary Gland Cancer\|Recurrent Squamous Cell Carcinoma of the Hypopharynx\|Recurrent Squamous Cell Carcinoma of the Larynx\|Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity\|Recurrent Squamous Cell Carcinoma of the Nasopharynx\|Recurrent Squamous Cell Carcinoma of the Oropharynx\|Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity\|Recurrent Verrucous Carcinoma of the Larynx\|Recurrent Verrucous Carcinoma of the Oral Cavity\|Salivary Gland Squamous Cell Carcinoma\|Stage IV Anal Cancer\|Stage IV Breast Cancer\|Stage IV Esophageal Cancer\|Stage IV Gastric Cancer\|Stage IV Non-small Cell Lung Cancer\|Stage IV Ovarian Epithelial Cancer\|Stage IV Salivary Gland Cancer\|Stage IV Squamous Cell Carcinoma of the Hypopharynx\|Stage IV Squamous Cell Carcinoma of the Larynx\|Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity\|Stage IV Squamous Cell Carcinoma of the Nasopharynx\|Stage IV Squamous Cell Carcinoma of the Oropharynx\|Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity\|Stage IV Verrucous Carcinoma of the Larynx\|Stage IV Verrucous Carcinoma of the Oral Cavity\|Unspecified Adult Solid Tumor, Protocol Specific	NCT01249443
Study of Pazopanib and Paclitaxel in Advanced Non-small Cell Lung Cancer	Completed	Lung Cancer, Non-Small Cell	NCT00866528
Combining MLN8237 With Nab-Paclitaxel in Patients With Advanced Solid Malignancies	Completed	Adenocarcinoma\|Pancreatic Neoplasms	NCT01677559
Evaluation of Paclitaxel in Patients With CLI and Femoropopliteal Occlusive Disease Treated With DCB Angioplasty	Recruiting	Ischemia	NCT02758847
Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian or Primary Peritoneal Cancer	Recruiting	Low Grade Ovarian Serous Adenocarcinoma\|Primary Peritoneal Low Grade Serous Adenocarcinoma\|Stage II Ovarian Cancer AJCC v8\|Stage IIA Ovarian Cancer AJCC v8\|Stage IIB Ovarian Cancer AJCC v8\|Stage III Ovarian Cancer AJCC v8\|Stage IIIA Ovarian Cancer AJCC v8\|Stage IIIA1 Ovarian Cancer AJCC v8\|Stage IIIA2 Ovarian Cancer AJCC v8\|Stage IIIB Ovarian Cancer AJCC v8\|Stage IIIC Ovarian Cancer AJCC v8\|Stage IV Ovarian Cancer AJCC v8\|Stage IVA Ovarian Cancer AJCC v8\|Stage IVB Ovarian Cancer AJCC v8	NCT04095364
Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women	Recruiting	Tubular Breast Cancer\|Mucinous Breast Cancer\|Invasive Duct Carcinoma of Breast	NCT03201861
A Phase 1b/2 Study of Rebastinib (DCC-2036) in Combination With Paclitaxel in Patients With Advanced or Metastatic Solid Tumors	Recruiting	Locally Advanced or Metastatic Solid Tumor	NCT03601897
Tivozanib Hydrochloride in Combination With Paclitaxel Versus Placebo With Paclitaxel in Patients With Locally Recurrent or Metastatic Triple Negative Breast Cancer	Terminated	Triple Negative Breast Cancer	NCT01745367
The Efficacy and Safety of Abraxane Combined With Epirubicin as Neoadjuvant Chemotherapy in Breast Cancer	Not yet recruiting	Breast Cancer	NCT03647280
A Phase I/II Study of Radiation Therapy, Paclitaxel Poliglumex and Cetuximab in Advanced Head and Neck Cancer	Unknown status	Carcinoma, Squamous Cell	NCT00660218
IMP321 (Eftilagimod Alpha) as Adjunctive to a Standard Chemotherapy Paclitaxel Metastatic Breast Carcinoma	Active, not recruiting	Adenocarcinoma Breast Stage IV	NCT02614833
A Safety and Efficacy Study of BCD-022 With Paclitaxel Compared to Herceptin With Paclitaxel in HER2+ Metastatic Breast Cancer Patients	Completed	Human Epithelial Receptor (HER)-2 Positive Breast Cancer	NCT01764022
Trial of Neoadjuvant EndoTAG-1 in Combination With Paclitaxel in HER2-negative Breast Cancer	Completed	Breast Cancer	NCT01537536
Biomarker-oriented Study of Durvalumab (MEDI4736) in Combination With Olaparib and Paclitaxel in Gastric Cancer	Recruiting	Advanced Gastric Cancer	NCT03579784
Efficacy and Safety Evaluation of IBI308 Versus Paclitaxel/Irinotecan in Patients With Advanced/Metastatic Esophageal Squamous Cell Carcinoma After Failure of First-line Treatment: a Randomized, Open-label, Multicenter, Phase 2 Study (ORIENT-2)	Active, not recruiting	Efficacy and Safety	NCT03116152
Evaluation of the Safety and Tolerability of TAK-228 With TAK-117 and Paclitaxel in Advanced Solid Tumors	Recruiting	Advanced Solid Tumor	NCT03154294
A Double-blind Study of Paclitaxel in Combination With Reparixin or Placebo for Metastatic Triple-Negative Breast Cancer	Active, not recruiting	Metastatic Breast Cancer	NCT02370238
SHR-1210 Combined With Albumin-bound Paclitaxel and Epirubicin Neoadjuvant for Triple Negative Breast Cancer	Not yet recruiting	Triple-negative Breast Cancer	NCT04213898
Phase II Trial Comparing ABI-007 (AbraxaneÂ®, NabÂ®-Paclitaxel) to Taxotere in First Line Therapy of Patients With Stage IV Breast Cancer	Completed	Metastatic Breast Cancer	NCT00274456
Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer	Completed	Fallopian Tube Carcinoma\|Primary Peritoneal Carcinoma\|Recurrent Ovarian Carcinoma	NCT00499252
QUILT-2.001: ALT-803 in Patients With Advanced Pancreatic Cancer in Conjunction With Gemcitabine and Nab-Paclitaxel	Completed	Advanced Pancreatic Cancer	NCT02559674
Phase 2 Study of Alisertib (MLN8237) in Combination With Paclitaxel Versus Placebo in Combination With Paclitaxel as Second Line Therapy for Small Cell Lung Cancer (SCLC)	Completed	Small Cell Lung Cancer	NCT02038647
Apatinib Combined With Paclitaxel and Carbopatin Intensive Regimen in Neoadjuvant Therapy for Locally Advanced Triple-negative Breast Cancer	Recruiting	Breast Cancer	NCT03735082
Treatment of Coronary In-stent Restenosis (ISR) by a Sirolimus Coated or a Paclitaxel Coated Balloon	Unknown status	Coronary Restenosis	NCT03242096
Efficacy and Safety Study of Enzalutamide in Combination With Paclitaxel Chemotherapy or as Monotherapy Versus Placebo With Paclitaxel in Patients With Advanced, Diagnostic-Positive, Triple-Negative Breast Cancer	Withdrawn	Breast Cancer	NCT02929576
A Study of Nivolumab +/- Nab-paclitaxel in Non-small Cell Lung Cancer	Active, not recruiting	Non-Small-Cell Lung Cancer Metastatic\|Non-Small Cell Carcinoma of Lung, TNM Stage 4\|Nonsmall Cell Lung Cancer\|Non Small Cell Lung Cancer Recurrent	NCT02967133
BVD-523 Plus Nab-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Cancer	Active, not recruiting	Pancreatic Cancer\|Cancer of Pancreas\|Cancer of the Pancreas\|Pancreas Cancer	NCT02608229
Gemcitabine, Cisplatin, and Nab-Paclitaxel Before Surgery in Patients With High-Risk Liver Bile Duct Cancer	Recruiting	Resectable Cholangiocarcinoma\|Stage IB Intrahepatic Cholangiocarcinoma AJCC v8\|Stage II Intrahepatic Cholangiocarcinoma AJCC v8\|Stage III Intrahepatic Cholangiocarcinoma AJCC v8\|Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8\|Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8	NCT03579771
A Combination of Abraxane and Cisplatin in Metastatic Breast Cancer	Completed	Metastatic Breast Cancer	NCT01149798
VMAT Concurrent Cisplatin Plus Nab-paclitaxel for Local Advanced Cervical Cancer	Not yet recruiting	Cervical Cancer	NCT04017377
Paclitaxel Plus Raltitrexed Plug Compare With Taxol Second-line Treatment for Advanced Gastric Cancer	Unknown status	Advanced Gastric Cancer	NCT02072317
Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma	Recruiting	Carcinoma, Squamous Cell\|Oral Cancer\|Oropharynx Cancer\|Larynx Cancer\|Lip Cancer\|Esophageal Cancer	NCT03174275
A Study to Determine the Bioequivalence of Oraxol in Cancer Patients Treated With Intravenous Paclitaxel	Completed	Solid Tumor	NCT04035473
CAELYX Versus Paclitaxel HCl in Patients With Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy	Terminated	Ovarian Neoplasms	NCT00653952
Study of Crenolanib With Ramucirumab and Paclitaxel for Advanced Esophagogastric Adenocarcinoma	Recruiting	Esophagogastric Adenocarcinoma	NCT03193918
Sequential Paclitaxel Chemotherapy and Radiotherapy as 1st Line Treatment for Elderly Esophageal Squamous Cell Cancer	Unknown status	Esophageal Squamous Cell Cancer\|Elderly Patients	NCT02016287
Alisertib (MLN8237) in Participants With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breast Cancer	Completed	Ovarian Carcinoma\|Fallopian Tube Cancer\|Peritoneal Cancer\|Breast Carcinoma	NCT01091428
Phase I/II Study of Lapatinib in Combination With Paclitaxel as 1L Chemotherapy for ErbB2-positive MBC	Completed	Neoplasms, Breast	NCT01138046
Efficacy and Safety With Albumin-bound Paclitaxel (Abraxane) in the TAC as Neoadjuvant Chemotherapy in Breast Cancer	Unknown status	Breast Cancer	NCT01647672
Effectiveness of Paclitaxel-coated LuminorÂ® Balloon Catheter Versus Uncoated Balloon Catheter in the Arteria Femoralis Superficialis	Unknown status	Peripheral Arterial Disease	NCT02540018
A Study of Atezolizumab and Paclitaxel Versus Placebo and Paclitaxel in Participants With Previously Untreated Locally Advanced or Metastatic Triple Negative Breast Cancer (TNBC)	Recruiting	Triple-Negative Breast Cancer	NCT03125902
Paclitaxel or S1 Plus Cisplatin in Concurrent Chemoradiotherapy for Squamous Cell Carcinoma of Esophagus	Unknown status	Esophageal Squamous Cell Carcinoma	NCT02586753
Neoadjuvant Plus Adjuvant or Only Adjuvant Nab- Paclitaxel Plus Gemcitabine for Resectable Pancreatic Cancer	Active, not recruiting	Resectable Pancreatic Cancer\|Ductal Adenocarcinoma of the Pancreas	NCT02047513
A Randomized Controlled Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY 43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC)	Terminated	Carcinoma, Non-Small Cell Lung	NCT00300885
Study of Efficacy and Safety of Buparlisib (BKM120) Plus Paclitaxel Versus Placebo Plus Paclitaxel in Recurrent or Metastatic Head and Neck Cancer Previously Pre-treated With a Platinum Therapy	Terminated	Head and Neck Squamous Cell Carcinoma	NCT01852292
Treatment of Coronary In-Stent Restenosis by a Sirolimus (Rapamycin) Coated Balloon or a Paclitaxel Coated Balloon	Recruiting	DES In-stent Stenosis	NCT02996318
Evaluation of Paclitaxel Eluting Stent vs Paclitaxel Eluting Balloon Treating Peripheral Artery Disease of the Femoral Artery	Completed	Peripheral Artery Disease	NCT01728441
A Clinical Study to Evaluate Efficacy and Safety of HLX10 Combined With Albumin-Bound Paclitaxel in Patients With Advanced Cervical Cancer Who Have Progressive Disease or Intolerable Toxicity After First-Line Standard Chemotherapy	Not yet recruiting	Cervical Cancer	NCT04150575
MK2206 and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Metastatic Breast Cancer	Completed	Adult Solid Neoplasm\|Recurrent Breast Carcinoma\|Stage IV Breast Cancer	NCT01263145
CS-1008 With Carboplatin/Paclitaxel in Chemotherapy naĂŻve Subjects With Metastatic or Unresectable Non-small Cell Lung Cancer (NSCLC)	Completed	Non-small Cell Lung Cancer	NCT00991796
Trial of PTK787/ZK 222584 Plus Paclitaxel	Unknown status	Metastatic Non-hematologic Malignancies	NCT00358163
A Study of BBI608 Plus Weekly Paclitaxel to Treat Gastric and Gastro-Esophageal Junction Cancer	Completed	Gastric Cancer\|Gastroesophageal Junction Cancer	NCT02178956
Phase II Study of Pembrolizumab and Nab-paclitaxel in HER-2 Negative Metastatic Breast Cancer	Recruiting	Breast Cancer	NCT02752685
Genetic Testing in Predicting Response to Paclitaxel in Women With Breast Cancer	Terminated	Breast Cancer	NCT00088829
Albumin-bound Paclitaxel (ABI-007) for Patients With Advanced Non-Small Cell Lung Cancer	Completed	Non-Small Cell Lung Carcinoma	NCT00540514
Lapatinib Combined With Paclitaxel For Patients With First-Line ErbB2-Amplified Metastatic Breast Cancer	Completed	Neoplasms, Breast	NCT00356811
Epirubicin and Paclitaxel, Alone or Together With Capecitabine as First Line Treatment in Metastatic Breast Cancer	Completed	Metastatic Breast Cancer	NCT01433614
Abraxane in CIMP-High Colorectal and Small Bowel Adenocarcinomas	Completed	Colorectal Cancer\|Cancer of Gastrointestinal Tract	NCT01730586
Alisertib (MLN8237) in Combination With Weekly Paclitaxel in East Asian Patients With Advanced Solid Tumors	Terminated	Advanced Solid Tumors\|Ovarian Cancer\|Small Cell Lung Cancer	NCT02367352
Paclitaxel Eluting Balloon in St Elevation Myocardial Infarction	Completed	Acute Myocardial Infarction	NCT01839890
Weekly Paclitaxel Plus Gemcitabine as Second-line in Small Cell Lung Cancer	Completed	Lung Cancer	NCT00453167
Study of Intraperitoneal Carboplatin With IV Paclitaxel and Bevacizumab in Untreated Ovarian Cancer	Active, not recruiting	Ovarian Cancer\|Fallopian Tube Cancer\|Primary Peritoneal Cancer\|No Prior Chemotherapy	NCT01220154
Ph1b/2 Study of PF-04136309 in Combination With Gem/Nab-P in First-line Metastatic Pancreatic Patients	Terminated	Metastatic Pancreatic Ductal Adenocarcinoma	NCT02732938
Safety and Efficacy of Bevacizumab in Combination With Carboplatin and Paclitaxel for Metastatic, Recurrent or Persistent Cervical Cancer	Completed	Cervical Cancer	NCT02467907
Angioplasty With Paclitaxel-coated Balloon Only Strategy for Coronary de Novo Lesions	Recruiting	Coronary Disease	NCT04022200
Combination Paclitaxel, Carboplatin and Temozolomide	Completed	Lung Diseases\|Cancer	NCT00249964
Neoadjuvant Sunitinib With Paclitaxel/Carboplatin in Patients With Triple-Negative Breast Cancer	Completed	Breast Cancer	NCT00887575
Study of Cetuximab in Combination With Carboplatin-Paclitaxel in Non-Small Cell Lung Cancer	Completed	Carcinoma, Non-Small-Cell Lung	NCT00034541
Induction Chemotherapy With Afatinib, Ribavirin, and Weekly Carboplatin/Paclitaxel for Stage IVA/IVB HPV Associated Oropharynx Squamous Cell Cancer (OPSCC)	Completed	Head and Neck Cancer\|Squamous Cell Cancer	NCT01721525
Efficacy and Safety Study of Olaparib in Combination With Paclitaxel to Treat Advanced Gastric Cancer.	Active, not recruiting	Gastric Cancer	NCT01924533
A Study of First Line Treatment With Avastin (Bevacizumab) in Combination With Carboplatin and Weekly Paclitaxel in Patients With Ovarian Cancer	Completed	Ovarian Cancer	NCT00937560
Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer	Completed	Fallopian Tube Clear Cell Adenocarcinoma\|Fallopian Tube Endometrioid Adenocarcinoma\|Fallopian Tube Mucinous Adenocarcinoma\|Fallopian Tube Serous Adenocarcinoma\|Fallopian Tube Transitional Cell Carcinoma\|Fallopian Tube Undifferentiated Carcinoma\|Ovarian Brenner Tumor\|Ovarian Clear Cell Adenocarcinoma\|Ovarian Endometrioid Adenocarcinoma\|Ovarian Mucinous Adenocarcinoma\|Ovarian Seromucinous Carcinoma\|Ovarian Serous Adenocarcinoma\|Ovarian Transitional Cell Tumor\|Ovarian Undifferentiated Carcinoma\|Primary Peritoneal Serous Adenocarcinoma\|Recurrent Fallopian Tube Carcinoma\|Recurrent Ovarian Carcinoma\|Recurrent Primary Peritoneal Carcinoma	NCT00888615
Paclitaxel Albumin-Stabilized Nanoparticle Formulation After Cisplatin-Based Chemotherapy and Surgery in Treating Patients With High-Risk Bladder Cancer	Withdrawn	Recurrent Bladder Urothelial Carcinoma\|Stage IV Bladder Urothelial Carcinoma	NCT02718742
A Study of Ipatasertib (GDC-0068) in Combination With Paclitaxel as Neoadjuvant Treatment for Participants With Early Stage Triple Negative Breast Cancer	Completed	Breast Cancer	NCT02301988
Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer)	Completed	Brenner Tumor\|Fallopian Tube Cancer\|Ovarian Carcinosarcoma\|Ovarian Clear Cell Cystadenocarcinoma\|Ovarian Endometrioid Adenocarcinoma\|Ovarian Mixed Epithelial Carcinoma\|Ovarian Mucinous Cystadenocarcinoma\|Ovarian Serous Cystadenocarcinoma\|Ovarian Undifferentiated Adenocarcinoma\|Primary Peritoneal Cavity Cancer\|Stage II Ovarian Epithelial Cancer\|Stage III Ovarian Epithelial Cancer\|Stage IV Ovarian Epithelial Cancer	NCT00085358
Sutent + Taxol for Advanced Esophageal Cancer	Completed	Esophageal Cancer	NCT00730353
Preoperative Epirubicin Paclitaxel Aranesp Study (PREPARE)	Completed	Breast Cancer	NCT00544232
ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast Cancer	Completed	Metastatic Breast Cancer	NCT00394082
Avelumab + Paclitaxel/ Ramucirumab (RAP) as Second Line Treatment in Gastro-esophageal Adenocarcinoma	Recruiting	Gastroesophageal Junction Adenocarcinoma\|Adenocarcinoma of the Stomach	NCT03966118
A Study of MK-1775 in Combination With Paclitaxel and Carboplatin Versus Paclitaxel and Carboplatin Alone for Participants With Platinum-Sensitive Ovarian Tumors With the P53 Gene Mutation (MK-1775-004)	Completed	Ovarian Cancer	NCT01357161
Gemcitabine and Paclitaxel vs Gemcitabine Alone After FOLFIRINOX Failure in Metastatic Pancreatic Ductal Adenocarcinoma	Recruiting	Metastatic Pancreatic Adenocarcinoma	NCT03943667
Dose-finding Study in Platinum-Resistant Ovarian Cancer	Completed	Recurrent Platinum-resistant Ovarian Cancer	NCT01653912
Study of Paclitaxel, Carboplatin and Oral Metformin in the Treatment of Advanced Stage Ovarian Carcinoma	Recruiting	Epithelial Ovarian Carcinoma	NCT02437812
Nab-Paclitaxel Treatment in Advanced Squamous Cell Carcinoma of Lung	Completed	Carcinoma, Non-Small-Cell Lung	NCT01236716
Sealing Moderate Coronary Saphenous VEin Graft Lesions With Paclitaxel-Eluting Stents	Terminated	Coronary Artery Bypass Grafting	NCT01223443
A Phase 1/2 Study of HKI-272 (Neratinib) in Combination With Paclitaxel (Taxol) in Subjects With Solid Tumors and Breast Cancer	Completed	Advanced Breast Cancer\|Advanced Malignant Solid Tumors\|Breast Neoplasms	NCT00445458
Paclitaxel and Carboplatin in Treating Women Who Are Undergoing Surgery for Newly Diagnosed, Locally Advanced Breast Cancer	Completed	Breast Cancer	NCT00096343
Paclitaxel in Treating Patients With Locally Advanced or Metastatic Soft Tissue Angiosarcoma or Lymphangiosarcoma That Cannot Be Removed By Surgery	Completed	Sarcoma	NCT00217607
Neoadjuvant TDM1 With Lapatinib and Abraxane Compared With Trastuzumab Plus Pertuzumab With Paclitaxel	Completed	Breast Cancer	NCT02073487
Belinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer of Unknown Primary	Completed	Carcinoma of Unknown Primary	NCT00873119
Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung Cancer	Completed	Non-Squamous Non-Small Cell Lung Cancer	NCT01160601
Comparison of Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) and TaxolÂ® Pharmacokinetics in Patients With Advanced Cancer	Completed	Neoplasm	NCT00100139
Assess the Efficacy of AZD8931 in Combination With Paclitaxel Versus Paclitaxel Alone in Patients With Gastric Cancer	Terminated	Metastatic, Gastric or Gastro-oesophageal Junction, Cancer	NCT01579578
Sequential Paclitaxel Plus Cisplatin Chemotherapy and Radiotherapy as 1st Line Treatment for Esophageal Squamous Cell Cancer	Unknown status	Esophageal Squamous Cell Cancer	NCT02016274
Pilot Study of Paclitaxel Plus Pembrolizumab in Metastatic HER2-Negative Breast Cancer	Recruiting	Breast - Female\|Male Breast Cancer	NCT03018080
Paclitaxel Plus Bevacizumab for Older Patients With Breast Cancer	Terminated	Breast Cancer	NCT01120158
Paclitaxel, Carboplatin Plus Bevacizumab in Pretreated, Advanced or Metastatic Non Small Cell Lung Cancer	Completed	Non Small Cell Lung Cancer	NCT00753909
Paclitaxel and Irinotecan in Advanced Gastric Cancer	Completed	Advanced Gastric Cancer	NCT01136031
Sapanisertib, Carboplatin, and Paclitaxel in Treating Patients With Recurrent or Refractory Malignant Solid Tumors	Recruiting	Recurrent Malignant Solid Neoplasm\|Refractory Malignant Solid Neoplasm	NCT03430882
A Study Assessing the Safety and Efficacy of Adding Ipatasertib to Paclitaxel Treatment in Participants With Breast Cancer That Has Spread Beyond the Initial Site, and the Cancer Does Not Have Certain Hormonal Receptors	Completed	Breast Neoplasms	NCT02162719
Drug-Eluting Balloon Catheters and the Treatment of Peripheral Arterial Occlusive Disease	Completed	Peripheral Arterial Disease\|Stenotic Femoro-popliteal Arteries\|Occluded Femoro-popliteal Arteries\|Atherosclerosis	NCT01007578
Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast Cancer	Completed	Breast Neoplasms\|Pancreatic Neoplasms	NCT02309177
Clinical Study of Decitabine and Paclitaxel Combination Therapy	Unknown status	Advanced Breast Cancer	NCT03282825
A Study DHP107, a Novel Oral Paclitaxel Formulation, in Patients With Advanced Solid Tumours or Gastric Cancer	Completed	Solid Tumor\|Stage IV Gastric Cancer	NCT02890511
Intraperitoneal Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Cancer of the Peritoneal Cavity	Completed	Ovarian Cancer\|Peritoneal Cavity Cancer\|Unspecified Adult Solid Tumor, Protocol Specific	NCT00825201
Efficacy and Safety of IBI308 and Paclitaxel/Albumin Paclitaxel for SCLC Patients Who Failed Etoposide Chemotherapy	Recruiting	Extensive-Stage Small Cell Lung Cancer	NCT04056949
Radiotherapy, Carboplatin/Paclitaxel and Nivolumab for High Risk HPV-related Head and Neck Cancer	Recruiting	Oropharynx Squamous Cell Carcinoma	NCT03829722
Nab-Paclitaxel in Treating Older Patients With Locally Advanced or Metastatic Breast Cancer	Active, not recruiting	Locally Advanced Breast Carcinoma\|Metastatic Breast Carcinoma\|Recurrent Breast Carcinoma\|Stage III Breast Cancer AJCC v7\|Stage IIIA Breast Cancer AJCC v7\|Stage IIIB Breast Cancer AJCC v7\|Stage IIIC Breast Cancer AJCC v7\|Stage IV Breast Cancer AJCC v6 and v7	NCT01463072
Pazopanib Hydrochloride, Paclitaxel, and Carboplatin in Treating Patients With Refractory or Resistant Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer	Active, not recruiting	Fallopian Tube Cancer\|Ovarian Cancer\|Primary Peritoneal Cavity Cancer	NCT01402271
Study of Combretastatin and Paclitaxel/Carboplatin in the Treatment of Anaplastic Thyroid Cancer	Terminated	Anaplastic Thyroid Cancer	NCT00507429
Weekly Doses of Cilengitide and Paclitaxel in Treating Patients With Advanced Solid Tumors That Cannot Be Removed by Surgery	Completed	Adult Solid Neoplasm\|Estrogen Receptor Negative\|HER2/Neu Negative\|Male Breast Carcinoma\|Progesterone Receptor Negative\|Recurrent Breast Carcinoma\|Stage IIIB Breast Cancer\|Stage IIIC Breast Cancer\|Stage IV Breast Cancer\|Triple-Negative Breast Carcinoma	NCT01276496
Study of Gemcitabine Plus Nab-paclitaxel Versus S1 Plus Nab-paclitaxel in Metastatic Adenocarcinoma of the Pancreas	Recruiting	Pancreatic Cancer\|Nab-paclitaxel\|Gemcitabine\|S1	NCT03779464
A Phase 1/2 Dose Finding Study of an Experimental New Drug CS7017, an Oral PPARÎł Agonist Taken by Mouth Twice Daily in Combination With Paclitaxel Chemotherapy	Completed	Anaplastic Thyroid Cancer	NCT00603941
Neoadjuvant Study of Nab-paclitaxel Plus Carboplatin in Breast Cancer	Unknown status	Breast Cancer	NCT01625429
EP-100 Plus Paclitaxel Versus Paclitaxel Alone in Patients With Ovarian Cancer	Completed	Ovarian Cancer Recurrent	NCT01485848
A Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC)	Terminated	Carcinoma, Non-Small-Cell Lung	NCT00558636
Bortezomib and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors	Completed	Unspecified Adult Solid Tumor, Protocol Specific	NCT00030368
Testing the Combination of MLN4924 (Pevonedistat), Carboplatin, and Paclitaxel for Non-small Cell Lung Cancer (NSCLC)	Recruiting	Metastatic Lung Non-Small Cell Squamous Carcinoma\|Metastatic Lung Non-Squamous Non-Small Cell Carcinoma\|Stage IIIB Lung Cancer AJCC v8\|Stage IV Lung Cancer AJCC v8\|Stage IVA Lung Cancer AJCC v8\|Stage IVB Lung Cancer AJCC v8\|Unresectable Lung Non-Small Cell Carcinoma\|Unresectable Lung Non-Squamous Non-Small Cell Carcinoma	NCT03965689
A Study of Vinflunine Plus Gemcitabine Versus Paclitaxel Plus Gemcitabine in Patients With Advanced Breast Cancer	Terminated	Advanced Breast Cancer	NCT02054338
Safety Feasibility and Effect of TTFields (150 kHz) Concomitant With Gemcitabine or Concomitant With Gemcitabine Plus Nab-paclitaxel for Front-line Therapy of Advanced Pancreatic Adenocarcinoma (PANOVA)	Unknown status	Pancreatic Adenocarcinoma	NCT01971281
Hepatic Arterial Infusion (HAI) of Abraxane	Completed	Liver Cancer\|Advanced Cancers\|Solid Tumors	NCT00732836
A Study of Gemcitabine/Nab-paclitaxel and Radiation Therapy Followed by Surgery in Patients With Advanced Pancreatic Cancer	Active, not recruiting	Pancreatic Cancer	NCT02481635
Trial of ABI-007 Plus S-1 as Second-line Chemotherapy in Advanced Gastric Cancer Patients	Completed	Gastric Adenocarcinoma	NCT01336062
Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Relapsed or Refractory Multiple Myeloma	Terminated	Refractory Plasma Cell Myeloma	NCT01646762
Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer	Completed	Brenner Tumor\|Fallopian Tube Cancer\|Ovarian Clear Cell Cystadenocarcinoma\|Ovarian Endometrioid Adenocarcinoma\|Ovarian Mixed Epithelial Carcinoma\|Ovarian Mucinous Cystadenocarcinoma\|Ovarian Serous Cystadenocarcinoma\|Ovarian Undifferentiated Adenocarcinoma\|Primary Peritoneal Cavity Cancer\|Stage II Ovarian Epithelial Cancer\|Stage III Ovarian Epithelial Cancer\|Stage IV Ovarian Epithelial Cancer	NCT00079430
Pyrotinib Maleate Tablets Combined With Albumin Paclitaxel and Trastuzumab for Her2-positive Breast Cancer	Recruiting	Breast Cancer\|HER2 Positive\|Combination Chemotherapy	NCT04152057
A Study Evaluating RO5479599 in Combination With Carboplatin and Paclitaxel in Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) of Squamous Histology	Terminated	Squamous Non-Small Cell Lung Cancer	NCT02204345
Abraxane With or Without Tigatuzumab in Patients With Metastatic, Triple Negative Breast Cancer	Completed	Breast Cancer\|Triple Negative Breast Cancer\|Stage IV Breast Cancer\|Metastatic Breast Cancer	NCT01307891
Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer	Active, not recruiting	Endometrial Cancer	NCT01367002
Therapy for Locally Advanced Breast Cancer Using Doxil, Paclitaxel, and Cyclophosphamide With Avastin	Completed	Invasive Breast Cancer	NCT00635050
Hydroxychloroquine, Carboplatin, Paclitaxel, and Bevacizumab in Recurrent Advanced Non-Small Cell Lung Cancer	Terminated	Lung Cancer	NCT00728845
Paclitaxel in Treating Older Patients With Solid Tumors	Completed	Unspecified Adult Solid Tumor, Protocol Specific	NCT00003092
Restenosis Treatment With Rapamycin Eluting Stent or Paclitaxel Eluting Balloon Catheter (RESTENOZA)	Unknown status	In-Stent Restenosis	NCT01255956
Cisplatin and Radiation Therapy Followed by Paclitaxel and Carboplatin in Treating Patients With Stage IB-IVA Cervical Cancer	Active, not recruiting	Cervical Adenocarcinoma\|Cervical Adenosquamous Carcinoma\|Cervical Squamous Cell Carcinoma, Not Otherwise Specified\|Stage IB Cervical Cancer AJCC v6 and v7\|Stage IIA Cervical Cancer AJCC v7\|Stage IIB Cervical Cancer AJCC v6 and v7\|Stage IIIA Cervical Cancer AJCC v6 and v7\|Stage IIIB Cervical Cancer AJCC v6 and v7\|Stage IVA Cervical Cancer AJCC v6 and v7	NCT01295502
Cetuximab/Paclitaxel/Cisplatin Concurrent Chemoradiotherapy Followed by Esophagectomy for Loco-regional Esophageal Cancer	Unknown status	Esophageal Cancer	NCT01034189
Paclitaxel in Treating Women With Recurrent Solid Tumors	Completed	Unspecified Adult Solid Tumor, Protocol Specific	NCT00003130
Efficacy of ABI-007 Plus Gemcitabine or sLV5FU2 as First-line Therapy in Patients With Metastatic Pancreatic Cancer	Unknown status	Metastatic Pancreatic Cancer	NCT01964534
A Comparison of Paclitaxel-based Three Regimens Concurrent With Radiotherapy for Patients With Local Advanced Esophageal Cancer	Active, not recruiting	Stage III Esophageal Squamous Cell Carcinoma	NCT02459457
Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast Cancer	Active, not recruiting	Inflammatory Breast Cancer\|Stage IIA Breast Cancer\|Stage IIIA Breast Cancer\|Stage IIIB Breast Cancer\|Stage IIIC Breast Cancer\|Triple-negative Breast Cancer\|Stage IIB Breast Cancer\|Estrogen Receptor Negative\|Progesterone Receptor Negative\|HER2/Neu Negative	NCT01525966
Nanoparticle Albumin-Bound (Nab) Paclitaxel/Cyclophosphamide in Early-Stage Breast Cancer	Completed	Breast Cancer	NCT00629499
AlimtaÂ® Plus Cisplatin & Paclitaxel Given Intraperitonelly	N/A	N/A	NCT00702299
A Study of DKN-01 in Combination With Paclitaxel or Pembrolizumab	Active, not recruiting	Esophageal Neoplasms\|Adenocarcinoma of the Gastroesophageal Junction\|Gastroesophageal Cancer\|Squamous Cell Carcinoma\|Gastric Adenocarcinoma	NCT02013154
Paclitaxel With / Without GW572016 (Lapatinib) As First Line Therapy For Women With Advanced Or Metastatic Breast Cancer	Completed	Neoplasms, Breast	NCT00075270
Neoadjuvant Therapy for Ovarian Cancer	Terminated	Epithelial Ovarian Cancer\|Primary Peritoneal Cancer\|Fallopian Tube Cancer	NCT01146795
Nivolumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery	Recruiting	Name Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma\|Stage II Oropharyngeal Squamous Cell Carcinoma\|Stage III Hypopharyngeal Squamous Cell Carcinoma\|Stage III Laryngeal Squamous Cell Carcinoma\|Stage III Oral Cavity Squamous Cell Carcinoma\|Stage III Oropharyngeal Squamous Cell Carcinoma\|Stage IV Hypopharyngeal Squamous Cell Carcinoma\|Stage IV Laryngeal Squamous Cell Carcinoma\|Stage IV Oral Cavity Squamous Cell Carcinoma\|Stage IV Oropharyngeal Squamous Cell Carcinoma\|Stage IVA Hypopharyngeal Squamous Cell Carcinoma\|Stage IVA Laryngeal Squamous Cell Carcinoma\|Stage IVA Oral Cavity Squamous Cell Carcinoma\|Stage IVA Oropharyngeal Squamous Cell Carcinoma\|Stage IVB Hypopharyngeal Squamous Cell Carcinoma\|Stage IVB Laryngeal Squamous Cell Carcinoma\|Stage IVB Oral Cavity Squamous Cell Carcinoma\|Stage IVB Oropharyngeal Squamous Cell Carcinoma\|Stage IVC Hypopharyngeal Squamous Cell Carcinoma\|Stage IVC Laryngeal Squamous Cell Carcinoma\|Stage IVC Oral Cavity Squamous Cell Carcinoma\|Stage IVC Oropharyngeal Squamous Cell Carcinoma	NCT03342911
Paclitaxel + Bevacizumab (Avastin) for the Treatment of Metastatic or Unresectable Angiosarcoma	Terminated	Angiosarcomas\|Soft Tissue Sarcoma	NCT01055028
Omega-3 Fatty Acid in Treating Pain in Patients With Breast or Ovarian Cancer Receiving Paclitaxel	Completed	Breast Cancer\|Ovarian Neoplasm\|Pain	NCT01821833
Combined Treatment of Cetuximab and Paclitaxel in Basal Like Breast Carcinoma	Unknown status	Breast Neoplasms	NCT00353717
A Safety, Tolerability, and Pharmacokinetics Study of MLN0128 as a Single Agent and in Combination With Paclitaxel in Adults With Advanced Nonhematologic Malignancies	Completed	Non-hematologic Malignancy	NCT02412722
Oxaliplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Cervical Cancer	Completed	Cervical Adenocarcinoma\|Cervical Adenosquamous Carcinoma\|Cervical Squamous Cell Carcinoma\|Recurrent Cervical Carcinoma\|Stage IVA Cervical Cancer\|Stage IVB Cervical Cancer	NCT00057863
A Phase 2 Study of MM-141 Plus Nab-paclitaxel and Gemcitabine in Front-line Metastatic Pancreatic Cancer	Completed	Pancreatic Cancer	NCT02399137
Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer	Completed	Unspecified Adult Solid Tumor, Protocol Specific	NCT00002939
The OPC for Optimal Delivery of Paclitaxel for the Prevention of Endovascular Restenosis - Above and Below the Knee	Completed	Peripheral Arterial Disease\|Cardiovascular Disease\|Peripheral Vascular Disease	NCT02464501
A Phase II Trial Neoadjuvant Paclitaxel and Cisplatin in Patients With Locally Advanced Head and Neck Cancer	Completed	Head and Neck Cancer	NCT00337532
S9701 Paclitaxel in Treating Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission	Completed	Fallopian Tube Cancer\|Ovarian Cancer\|Peritoneal Cavity Cancer	NCT00003120
Maintenance Versus Observation After 6 Cycles of Gemcitabine Plus Paclitaxel in Pts With Advanced Breast Cancer	Completed	Advanced Breast Cancer	NCT00561119
Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer	Completed	Lung Cancer	NCT00005646
Suramin and Paclitaxel in Treating Women With Stage IIIB-IV Breast Cancer	Completed	Recurrent Breast Cancer\|Stage IIIB Breast Cancer\|Stage IV Breast Cancer	NCT00054028
Bevacizumab and Abraxane as Second-line Therapy in Triple Negative Metastatic Breast Cancer	Completed	Breast Cancer	NCT00472693
Single Arm Study With a Nitinol Self-Expanding Paclitaxel-Eluting Stent to Treat BTK Arteries	Completed	Peripheral Arterial Disease	NCT01630070
Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates	Recruiting	Pancreatic Cancer\|Pancreatic Adenocarcinoma\|Pancreas Ductal Adenocarcinoma	NCT02723331
First Line Therapy for Patients With Metastatic Breast Cancer	Terminated	Metastatic Breast Cancer	NCT00456846
Phase II Study of Abraxane Plus Ipilimumab in Patients With Metastatic Melanoma	Active, not recruiting	Melanoma	NCT01827111
STREAMER : STent Restenosis And MEdicaments Release	Completed	Critical Ischemia	NCT02835586
Nab-Paclitaxel Versus Paclitaxel Plus Carboplatin in Advanced Squamous Cell Non Small Cell Lung Cancer	Not yet recruiting	Non-small Cell Lung Cancer	NCT03262948
Comparison Study of Neoadjuvant Paclitaxel Plus Carboplatin/Epirubicin Treatment in Triple-negative Breast Cancer	Unknown status	Triple Negative Breast Cancer	NCT01276769
EWOC-1 Trial: Carboplatin +/- Paclitaxel in Vulnerable Elderly Patients With Stage III-IV Advanced Ovarian Cancer	Active, not recruiting	Ovarian Cancer	NCT02001272
Paclitaxel Eluting Balloon for SFA In-stent Restenosis	Unknown status	In-stent Arterial Restenosis	NCT01616888
Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer	Active, not recruiting	Recurrent Fallopian Tube Carcinoma\|Recurrent Ovarian Carcinoma\|Recurrent Primary Peritoneal Carcinoma	NCT01199263
Phase I Study of Lurbinectedin (PM01183) in Combination With Paclitaxel, With or Without Bevacizumab, in Selected Advanced Solid Tumors	Completed	Breast Cancer\|Ovarian Cancer\|Gynecological Cancer\|Head and Neck Carcinoma\|Non-small Cell Lung Cancer\|Small Cell Lung Cancer\|Non-squamous Cell Lung Cancer	NCT01831089
Paclitaxel,Cyclophosphamide and Dexamethasone for Relapsed or Refractory Multiple Myeloma	Withdrawn	Relapse/Refractory Multiple Myeloma	NCT02985333
Everolimus, Carboplatin, and Paclitaxel in Locally Advanced Head and Neck Cancer That Cannot Be Removed by Surgery	Completed	Head and Neck Cancer	NCT01333085
Efficacy and Safety of Cabazitaxel Versus Weekly Paclitaxel as Neo-adjuvant Treatment in Patients With Triple Negative or Luminal B/HER2 Normal BC (GENEVIEVE)	Completed	Primary Breast Cancer	NCT01779479
Sorafenib and Bevacizumab in Combination With Paclitaxel in Patients With Solid Tumors	Completed	SOLID TUMORS	NCT00572078
A Study of Paclitaxel/Carboplatin With or Without CDP791 in Patients With Lung Cancer	Completed	Carcinoma\|Non-Squamous Non-Small-Cell Lung Cancer	NCT00152477
Paclitaxel, Carboplatin, and Dimethylxanthenone Acetic Acid in Treating Patients With Extensive-Stage Small Cell Lung Cancer	Completed	Lung Cancer	NCT01057342
Carboplatin and Paclitaxel in Patients With Metastatic, Castrate-Resistant Prostate Cancer	Terminated	Prostate Cancer	NCT01558492
Intravenous and Intraperitoneal Paclitaxel, Intraperitoneal Cisplatin, and Intravenous Bevacizumab for the Initial Treatment of Optimal Stage II or III Ovarian, Primary Peritoneal, and Fallopian Tube Cancer	Completed	Ovarian Cancer\|Primary PERITONEUM\|Fallopian Tube Cancer	NCT00588237
Scheduling Nab-paclitaxel With Gemcitabine	Completed	Pancreatic Adenocarcinoma Metastatic	NCT03529175
Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction	Active, not recruiting	Breast Carcinoma\|Carcinoma of Unknown Primary\|Endometrial Carcinoma\|Esophageal Carcinoma\|Liver Failure\|Lung Carcinoma\|Malignant Head and Neck Neoplasm\|Malignant Testicular Neoplasm\|Melanoma\|Metastatic Malignant Neoplasm\|Ovarian Carcinoma\|Renal Failure\|Unresectable Malignant Neoplasm\|Urothelial Carcinoma	NCT01366144
Paclitaxel Eluting Balloon After Bare Metal Stent Implantation vs. Drug-Eluting Stent in St Elevation Myocardial Infarction	Recruiting	Acute Myocardial Infarction	NCT03610347
Carboplatin and Paclitaxel With or Without Ramucirumab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Thymic Cancer That Cannot Be Removed by Surgery	Recruiting	Locally Advanced Thymic Carcinoma\|Metastatic Thymic Carcinoma\|Recurrent Thymic Carcinoma\|Unresectable Thymic Carcinoma	NCT03694002
OCT- Versus Angiography-guided Paclitaxel Drug-Coated Balloon Angioplasty in De Novo Coronary Artery	Recruiting	Coronary Artery Disease	NCT04276389
A Study of the Safety and Tolerability of the Addition of CHR-2797 to Paclitaxel in Patients With Advanced or Refractory Tumours	Completed	Solid Tumor	NCT00737555
Study of Convernsion Therapy Using S1/Paclitaxel Chemotherapy Plus Apatinib in Unresectable Gastric Cancer	Unknown status	Gastric Cancer	NCT02529878
A Study of Radiation Therapy and Paclitaxel and Carboplatin in Patients With Uterine Papillary Serous Carcinoma	Completed	Uterine Cancer	NCT00231868
RX-3117 in Combination With AbraxaneÂ® in Subjects With Metastatic Pancreatic Cancer	Completed	Metastatic Pancreatic Cancer	NCT03189914
Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma	Active, not recruiting	Nasopharyngeal Carcinoma	NCT03047265
Carboplatin Taxol Avastin in Ovarian Cancer (OVCA)	Completed	Ovarian Cancer	NCT00129727
Dose-Dense Epirubicin and Cyclophosphamide (EC) Followed by Paclitaxel in Breast Cancer: Feasibility	Completed	Breast Cancer\|Adenocarcinoma of the Breast	NCT00617370
Cohort Study of Prospective Validation of Predictive Factors and Biological Imaging of Response to Bevacizumab and Paclitaxel in Patients With Metastatic Breast Cancer	Active, not recruiting	Metastatic\|Breast Cancer	NCT01745757
Erlotinib Plus Carboplatin and Paclitaxel in Ovarian Carcinoma	Completed	Brenner Tumor\|Fallopian Tube Cancer\|Ovarian Clear Cell Cystadenocarcinoma\|Ovarian Endometrioid Adenocarcinoma\|Ovarian Mucinous Cystadenocarcinoma\|Ovarian Serous Cystadenocarcinoma\|Ovarian Undifferentiated Adenocarcinoma\|Stage III Ovarian Epithelial Cancer\|Stage IV Ovarian Epithelial Cancer	NCT00059787
Study of Paclitaxel, Carboplatin, and PF-05212384 in Advanced or Metastatic NSCLC (UF-STO-LUNG-002)	Terminated	Non-Small Cell Lung Cancer	NCT02920450
Paclitaxel in Patients With Metastatic or Advanced Gastrointestinal Stromal Tumors (GIST) After Failure to Imatinib and Sunitinib	Completed	Gastrointestinal Stromal Tumors	NCT02607332
Carboplatin Combined With Paclitaxel in Treating Patients With Advanced Thymoma	Completed	Thymoma\|Thymic Carcinoma	NCT00010257
Nab-paclitaxel Compared With Docetaxel Followed by Anthracyclines and Cyclophosphamide in the Neoadjuvant Breast Cancer	Recruiting	Breast Cancer	NCT04182568
Phase Ib Study AZD1775 in Combination With Carboplatin and Paclitaxel in Adult Asian Patients With Solid Tumours	Completed	Advanced Solid Tumours	NCT02341456
Paclitaxel and Bryostatin 1 in Treating Patients With Advanced Pancreatic Cancer	Completed	Acinar Cell Adenocarcinoma of the Pancreas\|Duct Cell Adenocarcinoma of the Pancreas\|Recurrent Pancreatic Cancer\|Stage III Pancreatic Cancer\|Stage IV Pancreatic Cancer	NCT00031694
A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinoma	Completed	Gastric Cancer	NCT01170663
Investigating the Preventative Ability of Massage Therapy on Paclitaxel Induced Peripheral Neuropathy	Terminated	Breast Cancer\|Neuropathy\|Neuropathy	NCT03557554
Nab-Paclitaxel and Atezolizumab Before Surgery in Treating Patients With Triple Negative Breast Cancer	Recruiting	Breast Adenocarcinoma\|Estrogen Receptor Negative\|HER2/Neu Negative\|Invasive Breast Carcinoma\|Progesterone Receptor Negative\|Triple-Negative Breast Carcinoma	NCT02530489
Use of ABI-007 for the Prevention of Vascular Access Graft Failure in Patients Undergoing Hemodialysis	Terminated	Hemodialysis Graft Dysfunction	NCT00249002
A Phase 1/2 Trial of Gemcitabine Plus Nab-paclitaxel With or Without FG-3019 as Neoadjuvant Chemotherapy in Locally Advanced, Unresectable Pancreatic Cancer	Active, not recruiting	Pancreatic Cancer (Unresectable)	NCT02210559
Local Paclitaxel or Balloon Angioplasty Below the Knee	Recruiting	Stenosis\|Occlusion\|Restenosis	NCT03149913
Paclitaxel-bevacizumab in Advanced Lung Cancer	Completed	Non-squamous Non-small Cell Lung Cancer	NCT01763671
EGFR/FGFR-targeted Therapy for Gastric Cancer	Not yet recruiting	Adenocarcinoma of the Stomach	NCT04077255
Nab-P and Gem Compared With Gem and Tegafur in Adjuvant Chemotherapy After Radical Resection of Pancreatic Cancer	Not yet recruiting	Stage IA Pancreatic Adenocarcinoma\|Stage IB Pancreatic Adenocarcinoma\|Stage IIA Pancreatic Adenocarcinoma\|Stage IIB Pancreatic Adenocarcinoma	NCT04216758
Intensity-Modulated Radiation Therapy and Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Anaplastic Thyroid Cancer	Active, not recruiting	Thyroid Gland Anaplastic Carcinoma	NCT01236547
Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors	Completed	Bladder Cancer\|Brain and Central Nervous System Tumors\|Breast Cancer\|Esophageal Cancer\|Extragonadal Germ Cell Tumor\|Gastric Cancer\|Lung Cancer\|Ovarian Cancer\|Prostate Cancer	NCT00313599
Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage II or Stage III Triple-Negative Breast Cancer	Terminated	Estrogen Receptor Negative\|HER2/Neu Negative\|Progesterone Receptor Negative\|Stage IIA Breast Cancer\|Stage IIB Breast Cancer\|Stage IIIA Breast Cancer\|Stage IIIB Breast Cancer\|Stage IIIC Breast Cancer\|Triple-Negative Breast Carcinoma	NCT01238133
S-1 in Combination With Abraxane in Treating Cholangiocarcinoma	Completed	Cholangiocarcinoma	NCT01963325
Study of Bavituximab Plus Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung Cancer	Completed	Non-small Cell Lung Cancer	NCT00687817
Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Previously Treated Advanced Non-small Cell Lung Cancer	Active, not recruiting	Recurrent Non-Small Cell Lung Carcinoma\|Stage IV Non-Small Cell Lung Cancer	NCT01620190
Phase I/II Study of Abraxane in Recurrent and Refractory Lymphoma	Terminated	Lymphoma, Non-Hodgkin\|Hodgkin Disease	NCT01555853
Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3)	Recruiting	Pancreas Adenocarcinoma	NCT03377491
Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer	Unknown status	Stage III Ovarian Cancer\|Stage IV Ovarian Cancer\|Uterine Cancer	NCT01650376
Study of Gemcitabine and Abraxane to Treat Potentially Operable Pancreatic Cancer	Completed	Resectable Pancreatic Cancer	NCT01298011
Gemcitabine/Nab-Paclitaxel With HIGRT in Resectable Pancreatic Cancer	Active, not recruiting	Resectable Pancreatic Cancers	NCT02318095
Phase I-II Study of Vorinostat, Paclitaxel, and Bevacizumab in Metastatic Breast Cancer	Completed	Male Breast Cancer\|Stage IIIB Breast Cancer\|Stage IIIC Breast Cancer\|Stage IV Breast Cancer	NCT00368875
Study of XL147 (SAR245408) in Combination With Trastuzumab or Paclitaxel and Trastuzumab in Subjects With Metastatic Breast Cancer Who Have Progressed on a Previous Trastuzumab-based Regimen	Completed	Breast Cancer\|Breast Neoplasms	NCT01042925
Efficacy and Safety Study of Pembrolizumab (MK-3475) Versus Paclitaxel in Asian Participants With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Who Progressed After First-line Therapy With Platinum and Fluoropyrimidine (MK-3475-063/KEYNOTE-063)	Active, not recruiting	Gastric Neoplasms\|Gastroesophageal Junction Adenocarcinoma	NCT03019588
A Study of Paclitaxel Plus Bevacizumab in Patients With Chemosensitive Relapsed Small Cell Lung Cancer	Completed	Small Cell Lung Cancer	NCT00317200
Study of Lonsurf in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Advanced (PDAC)	Not yet recruiting	Pancreatic Cancer\|Pancreatic Ductal Adenocarcinoma	NCT04046887
Safety, Pharmacodynamics, Pharmacokinetics, and Efficacy of Tomivosertib Combined With Paclitaxel in Advanced Breast Cancer	Not yet recruiting	Breast Cancer	NCT04261218
Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Paclitaxel in Triple Negative Breast Cancer (TNBC)	Completed	Breast Cancer	NCT01287624
Olanzapine Against Delayed Nausea and Vomiting in Women Receiving Carboplatin Plus Paclitaxel	Unknown status	Nausea\|Vomiting	NCT02290470
Phase I TH-302 Plus Gemcitabine Plus Nab-Paclitaxel in Pancreatic Cancer	Terminated	Pancreatic Cancer	NCT02047500
Sorafenib/ Carboplatin/ Paclitaxel in Patients With Solid Tumors	Completed	Neoplasms	NCT00606125
Does Cediranib With Paclitaxel, or Cediranib and Olaparib, Treat Advanced Endometrial Cancer Better Than Paclitaxel?	Recruiting	Carcinosarcoma\|Endometrial Neoplasms	NCT03570437
Effects of (Licochalcone A) and Paclitaxel on Human Oral Squamous Cell Carcinoma Cell Line	Unknown status	Squamous Cell Carcinoma	NCT03292822
Study on Neoadjuvant Chemotherapy for Advanced Gastric Cancer	Unknown status	Advanced Gastric Carcinoma	NCT02163291
ACY 241 in Combination With Paclitaxel in Patients With Advanced Solid Tumors	Completed	Advanced Solid Tumors	NCT02551185
A Trial of Weekly Paclitaxel With Oncothermia and Weekly cisPlatin With Oncothermia in Patients With Recurrent or Persistent Ovarian Cancer	Unknown status	Epithelial Ovarian Carcinoma\|Fallopian Tube Carcinoma\|Primary Peritoneal Carcinoma	NCT02344095
Study of Preoperative Weekly Paclitaxel and Carboplatin With Lapatinib (TykerbÂ®) in Patients With ErbB2-Positive Stage I-III Breast Cancer	Unknown status	ErbB2-Positive Stage I-III Breast Cancer	NCT01309607
Neoadjuvant Chemotherapy Using Doxorubicin and Paclitaxel in Treating Women With Large Breast Cancer	Completed	Breast Cancer	NCT00096291
Vandetanib, Carboplatin, and Paclitaxel in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed by Surgery	Terminated	Lung Cancer	NCT00459121
A Dose Escalation Study of BIBF 1120 Together With Paclitaxel and Carboplatin in Patients With Advanced Stage Non-small-cell Lung Cancer	Completed	Carcinoma, Non-Small-Cell Lung	NCT02182232
Imetelstat in Combination With Paclitaxel (With or Without Bevacizumab) in Patients With Locally Recurrent or Metastatic Breast Cancer	Completed	Locally Recurrent or Metastatic Breast Cancer	NCT01256762
A Phase 1-2, XIAP Antisense AEG35156 With Weekly Paclitaxel in Patients With Advanced Breast Cancer	Terminated	Human Mammary Carcinoma	NCT00558545
Apatinib and Etoposide Capsule Versus Weekly Paclitaxel in Patients With Platinum Resistant Ovarian Cancer	Recruiting	Ovarian Cancer	NCT04000295
Paclitaxel and DDP Combined With Anlotinib in the First-line Treatment for Patients With Advanced Esophageal Squamous Cell CarcinomaďĽESCCďĽ‰.	Not yet recruiting	Esophageal Squamous Cell Carcinoma	NCT04063683
VISION and VQI Paclitaxel Safety Analysis	Active, not recruiting	PAD	NCT04204564
Cyclophosphamide, Paclitaxel, and Trastuzumab in Treating Patients With Stage I-II HER2/Neu Positive Breast Cancer After Surgery	Active, not recruiting	HER2 Positive Breast Carcinoma\|Stage I Breast Cancer AJCC v7\|Stage IA Breast Cancer AJCC v7\|Stage IB Breast Cancer AJCC v7\|Stage II Breast Cancer AJCC v6 and v7\|Stage IIA Breast Cancer AJCC v6 and v7\|Stage IIB Breast Cancer AJCC v6 and v7	NCT02654119
Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Plus Paclitaxel and Carboplatin Versus Placebo Plus Paclitaxel and Carboplatin	Completed	Lung Cancer (NSCLC)	NCT02279732
Ramucirumab/Paclitaxel as Second-line Treatment in Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma With Integrative Genomic Analysis	Recruiting	Gastric Adenocarcinoma\|Gastroesophageal Junction Adenocarcinoma	NCT02628951
Dose Dense Abraxane in Adjuvant Chemotherapy for Breast Cancer	Completed	Breast Cancer	NCT00308178
Intraperitoneal Therapy For Ovarian Cancer With Carboplatin Trial	Active, not recruiting	Epithelial Ovarian Cancer\|Fallopian Tube Cancer\|Primary Peritoneal Carcinoma	NCT01506856
Paclitaxel and BMS-214662 in Treating Patients With Advanced Solid Tumors	Completed	Unspecified Adult Solid Tumor, Protocol Specific	NCT00006018
AZD2014 and Weekly Paclitaxel in Squamous NSCLC	Terminated	Squamous Non Small Cell Lung Cancer	NCT02403895
Evaluation of Carboplatin/Paclitaxel/Bevacizumab in the Treatment of Advanced Stage Endometrial Carcinoma	Completed	Endometrial Cancer	NCT00513786
Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell Carcinoma	Recruiting	Head and Neck Cancer\|Head and Neck Squamous Cell Carcinoma\|Cancer of the Head and Neck	NCT02270814
Paclitaxel-HDFL for Locally Advanced and Recurrent/Metastatic Gastric Cancers	Completed	Locally Advanced and Recurrent/Metastatic Gastric Cancer	NCT00154726
Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery	Active, not recruiting	Lung Adenocarcinoma\|Lung Adenocarcinoma, Mixed Subtype\|Lung Large Cell Carcinoma\|Lung Squamous Cell Carcinoma\|Minimally Invasive Lung Adenocarcinoma\|Stage III Lung Non-Small Cell Cancer AJCC v7\|Stage IIIA Lung Non-Small Cell Cancer AJCC v7\|Stage IIIB Lung Non-Small Cell Cancer AJCC v7	NCT01386385
A Study of Atezolizumab in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin+Nab-Paclitaxel in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)	Active, not recruiting	Carcinoma, Non-Squamous Non-Small Cell Lung	NCT02367781
Carboplatin, Paclitaxel, Bevacizumab and Vorinostat for Patients With Advanced Non-Small Cell Lung Cancer	Terminated	Non-small Cell Lung Cancer	NCT00702572
Adjuvant Sequential & Concurrent CarboTaxol + Radiotherapy for High Risk Endometrial Cancer	Recruiting	Endometrial Cancer	NCT03935256
Selumetinib and Paclitaxel as Second-Line Treatment in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer	Active, not recruiting	Stage IIIB Non-Small Cell Lung Cancer AJCC v7\|Stage IV Non-Small Cell Lung Cancer AJCC v7	NCT02503358
Safety and Efficacy Study of the DANUBIO Paclitaxel Eluting Balloon in In-Stent Restenosis Lesions (DEBREST)	Completed	In-stent Coronary Artery Restenosis	NCT01485068
Oxaliplatin and Paclitaxel Plus Bevacizumab in Advanced Peritoneal Carcinomatosis	Completed	Peritoneal Cancer	NCT00491855
Cryoablation, Atezolizumab/Nab-paclitaxel for Locally Advanced or Metastatic Triple Negative Breast Cancer	Recruiting	Anatomic Stage III Breast Cancer AJCC v8\|Anatomic Stage IIIA Breast Cancer AJCC v8\|Anatomic Stage IIIB Breast Cancer AJCC v8\|Anatomic Stage IIIC Breast Cancer AJCC v8\|Anatomic Stage IV Breast Cancer AJCC v8\|Locally Advanced Breast Carcinoma\|Metastatic Triple-Negative Breast Carcinoma\|Prognostic Stage III Breast Cancer AJCC v8\|Prognostic Stage IIIA Breast Cancer AJCC v8\|Prognostic Stage IIIB Breast Cancer AJCC v8\|Prognostic Stage IIIC Breast Cancer AJCC v8\|Prognostic Stage IV Breast Cancer AJCC v8	NCT04249167
LBH589 Oral in Combination With Carboplatin and Paclitaxel in Advanced Solid Tumors	Unknown status	Advanced Solid Tumors	NCT01159418
Phase I/II Study of AZD2281 Given in Combination With Paclitaxel in Metastatic Triple Negative Breast Cancer	Completed	Breast Cancer\|Triple Negative Breast Cancer\|Metastatic Breast Cancer	NCT00707707
N-acetyl Cysteine Effect in Peripheral Neuropathy in Cancer Patients	Completed	Peripheral Neuropathy Due to Chemotherapy	NCT03492047
Uterine Serous Carcinoma and Adjuvant Combined Intraperitoneal Chemotherapy and Radiation	Not yet recruiting	Uterine Carcinoma	NCT04030000
ACY-1215 + Nab-paclitaxel in Metastatic Breast Cancer	Active, not recruiting	Metastatic Breast Cancer\|Breast Carcinoma	NCT02632071
Pulsed Paclitaxel And Daily Thoracic Radiotherapy For Inoperable (Stage I/II) Or Unresectable Lung Cancer	Completed	Carcinoma, Non-Small-Cell Lung	NCT00178256
Clinical Trial to Determine the Maximum Tolerated Dose and to Assess the Safety and Pharmacokinetic Profile of Oral Paclitaxel in Patients With Advanced Solid Cancer	Completed	Advanced Solid Tumors	NCT01491204
Genexol-PM Versus Paclitaxel in Anthracycline-pretreated Metastatic Breast Cancer Patients	Withdrawn	Breast Cancer	NCT01169870
Objective Evaluation of Paclitaxel/Docetaxel-induced Neuropathy in Breast Cancer Patients	Recruiting	Breast Cancer\|Chemotherapy Induced Peripheral Neuropathy\|Paclitaxel Induced Neuropathy	NCT03872141
A Study on Toripalimab Plus Nab-Paclitaxel With or Without Cisplatin as First-line Treatment of Urothelial Carcinoma	Not yet recruiting	Urothelial Carcinoma	NCT04211012
Study of Nab-paclitaxel (AbraxaneÂ®) Treatment in Patients With Metastatic Breast Cancer in Routine Clinical Practice	Terminated	Breast Neoplasms	NCT02655159
Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer	Completed	Pancreatic Cancer	NCT00003591
First-in-man Evaluation of a Novel, Microcrystalline Paclitaxel Coated Balloon for Treatment of Femoropopliteal Artery Disease (PAX-r)	Completed	Peripheral Artery Disease\|Femoropopliteal Artery Disease	NCT02145065
Cabozantinib or Paclitaxel in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer	Completed	Recurrent Fallopian Tube Carcinoma\|Recurrent Ovarian Carcinoma\|Recurrent Primary Peritoneal Carcinoma	NCT01716715
Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer	Active, not recruiting	Esophageal Adenocarcinoma\|Esophageal Squamous Cell Carcinoma\|Gastroesophageal Junction Adenocarcinoma\|Recurrent Esophageal Carcinoma\|Stage IV Esophageal Cancer AJCC v7	NCT01142388
RAD001 With Paclitaxel and Carboplatin in First Line Treatment of Patients With Advanced Large Cell Lung Cancer With Neuroendocrine Differentiation	Completed	Carcinoma, Large Cell\|Neuroendocrine Tumors	NCT01317615
Single Agent Abraxane as Second Line Therapy in Bladder Cancer	Completed	Transitional Cell Carcinoma	NCT00683059
Geriatric Assessment Directed Trial to Evaluate Gemcitabine +/- Nab-paclitaxel in Elderly Pancreatic Cancer Patients	Active, not recruiting	Adenocarcinoma Pancreas	NCT02812992
A Study of Nab-paclitaxel-based Doublet as First Line Therapy in Patients With Cancer of Unknown Primary (CUP)	Unknown status	Unknown Primary Tumors	NCT02607202
Neoadjuvant Paclitaxel Plus Epirubicin Versus Vinorelbine Plus Epirubicin in Breast Cancer With TEKT4 Variations	Completed	Breast Cancer	NCT02628613
Paclitaxel Micelles for Injection / Paclitaxel Injection in Combination With Cisplatin for First-line Therapy of Advanced NSCLC	Active, not recruiting	Non-Small Cell Lung Cancer(NSCLC)	NCT02667743
Efficacy Study of Olaparib With Paclitaxel Versus Paclitaxel in Gastric Cancer Patients	Active, not recruiting	Gastric Cancer	NCT01063517
Induction Chemotherapy With Nab-paclitaxel, Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma	Not yet recruiting	Nasopharyngeal Carcinoma\|Nasopharyngeal Cancer\|Nasopharynx Cancer	NCT04004871
Quality of Life in Locally Advanced or Metastatic Pancreatic Cancer Treated With Gemcitabine and Nab-paclitaxel	Completed	Pancreatic Cancer	NCT02106884
A Phase I/II Trial of VB-111 and Paclitaxel for Recurrent Platinum-Resistant MĂĽllerian Cancer	Completed	Platinum Resistant Ovarian Cancer	NCT01711970
Neoadjuvant Therapy With Nab-paclitaxel and Cisplatin for Locally Advanced Esophageal Squamous Cell Carcinoma	Recruiting	Esophageal Squamous Cell Carcinoma	NCT03964753
Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In-Stent Restenosis 4	Completed	Restenosis\|Stable Angina Pectoris\|Acute Coronary Syndrome	NCT01632371
Ibrutinib Combined With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer	Active, not recruiting	Metastatic Pancreatic Adenocarcinoma	NCT02562898
Abraxane and Alimta in Advanced Solid Tumors	Terminated	Breast Cancer\|Lung Cancer\|Unspecified Adult Solid Tumor, Protocol Specific	NCT00470548
A Study of Atezolizumab in Combination With Carboplatin + Paclitaxel or Carboplatin + Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower131]	Active, not recruiting	Squamous Non-Small Cell Lung Cancer	NCT02367794
Paclitaxel, Cisplatin, Gefitinib, and Radiation Therapy Followed by Surgery and Gefitinib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction That Can Be Removed By Surgery	Terminated	Esophageal Cancer	NCT00493025
Gemcitabine Plus Albumin-bound Paclitaxel In Patients With Advanced Metastatic Pancreatic Cancer	Completed	Metastatic Pancreatic Cancer	NCT00398086
Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian Cancer	Completed	Brenner Tumor\|Ovarian Clear Cell Cystadenocarcinoma\|Ovarian Endometrioid Adenocarcinoma\|Ovarian Mixed Epithelial Carcinoma\|Ovarian Mucinous Cystadenocarcinoma\|Ovarian Serous Cystadenocarcinoma\|Ovarian Undifferentiated Adenocarcinoma\|Stage III Ovarian Epithelial Cancer\|Stage IV Ovarian Epithelial Cancer	NCT00002913
A Study of Pembrolizumab (MK-3475) Versus Paclitaxel for Participants With Advanced Gastric/Gastroesophageal Junction Adenocarcinoma That Progressed After Therapy With Platinum and Fluoropyrimidine (MK-3475-061/KEYNOTE-061)	Active, not recruiting	Gastric Adenocarcinoma\|Gastroesophageal Junction Adenocarcinoma	NCT02370498
Phase I/II Study of Weekly Abraxane and RAD001 in Women With Locally Adv. or Metastatic Breast Ca	Terminated	Breast Cancer	NCT00934895
Paclitaxel/Carboplatin With or Without Cetuximab in CUP	Unknown status	Neoplasms, Unknown Primary\|Carcinoma	NCT00894569
Assessing the Efficacy of Paclitaxel and Olaparib in Comparison to Paclitaxel / Carboplatin Followed by Epirubicin/Cyclophosphamide as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer and Homologous Recombination Deficiency	Completed	Breast Cancer\|Triple Negative Breast Neoplasms\|HRpos Breast Neoplasms\|BRCA 1 /2 and / or HRD	NCT02789332
Trial of Concurrent Chemoradiotherapy for Locally Advanced Esophageal Cancer	Unknown status	Esophageal Cancer	NCT02762474
Study of 5-fluorouracil (5-FU), NabÂ®1-paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin in Patients With Metastatic Pancreatic Cancer	Completed	Metastatic Pancreas Adenocarcinoma	NCT02620800
A Study of Intraperitoneal and Intravenous Paclitaxel Plus Apatinib and S-1 Conversion Therapy for Gastric Cancer With Positive Exfoliative Cancer Cells	Not yet recruiting	Gastric Cancer With Positive Exfoliative Cancer Cells	NCT03718624
Comparison of Safety and Efficacy of TOCOSOL(R) Paclitaxel Versus Taxol(R) for Treatment of Metastatic Breast Cancer	Terminated	Breast Neoplasm	NCT00251095
Paclitaxel and Carboplatin With Or Without Sorafenib In The First-Line Treatment Of Patients With Ovarian Cancer	Completed	Ovarian Cancer	NCT00390611
Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer	Completed	Breast Cancer	NCT00654836
A Study of Tasisulam-sodium Versus Paclitaxel as Treatment for Metastatic Melanoma	Terminated	Melanoma	NCT01006252
EST)	London	United Kingdom\|For additional information regarding investigative sites for this trial	1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours
A Safety and Efficacy Study of Paclitaxel-eluting Balloon to Paclitaxel-eluting Stent	Completed	Coronary Instent Restenosis	NCT01622075
Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers	Recruiting	Stage III Distal Bile Duct Cancer AJCC v8\|Stage III Gallbladder Cancer AJCC v8\|Stage III Intrahepatic Cholangiocarcinoma AJCC v8\|Stage IIIA Distal Bile Duct Cancer AJCC v8\|Stage IIIA Gallbladder Cancer AJCC v8\|Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8\|Stage IIIB Distal Bile Duct Cancer AJCC v8\|Stage IIIB Gallbladder Cancer AJCC v8\|Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8\|Stage IV Distal Bile Duct Cancer AJCC v8\|Stage IV Gallbladder Cancer AJCC v8\|Stage IV Intrahepatic Cholangiocarcinoma AJCC v8\|Stage IVA Gallbladder Cancer AJCC v8\|Stage IVB Gallbladder Cancer AJCC v8\|Unresectable Extrahepatic Bile Duct Carcinoma\|Unresectable Gallbladder Carcinoma\|Unresectable Intrahepatic Cholangiocarcinoma	NCT03768414
United States\|Grady Memorial Hospital	Ohio	Dublin	Ohio
Addition of Cisplatin to Neoadjuvant Therapy for T Locally Advanced Breast Cancer	Completed	Tubular Breast Cancer\|Mucinous Breast Cancer\|Invasive Ductal Breast Cancer\|Inflammatory Breast Cancer	NCT02199418
Paclitaxel and Cisplatin for Thymic Neoplasm	Terminated	Thymoma\|Thymic Carcinoma	NCT00818090
Treatment of Drug-eluting Stent (DES) In-Stent Restenosis With SeQuentÂ® Please Paclitaxel Eluting Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheter	Unknown status	In-Stent Restenosis	NCT00998439
A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Participants With Locally Recurrent or Metastatic Breast Cancer	Completed	Breast Cancer	NCT01740336
A Study of Carboplatin and Paclitaxel Chemotherapy With Nivolumab in Patients With Ovarian Cancer	Active, not recruiting	High Grade Serous Ovarian\|Fallopian Tube\|Primary Peritoneal Cancer	NCT03245892
Cisplatin Combined With S-1 or Paclitaxel as First-line Treatment for Metastatic Esophageal Squamous Cell Carcinoma	Unknown status	Esophageal Squamous Cell Carcinoma	NCT02677597
T-DM1 With Abraxane and Lapatinib for Metastatic HER2 Positive Breast Cancer	Completed	Metastatic Breast Cancer	NCT02073916
Pegylated Liposomal Doxorubicin Plus Albumin-Bound Paclitaxel and Trastuzumab in HER-2 Positive Breast Cancer	Recruiting	Breast Cancer	NCT03994107
Efficacy and Safety of AZD4547 Versus Paclitaxel in Patients With Advanced Gastric or Gastro-oesophageal Cancer	Terminated	Gastro-oesophageal Junction Cancer\|Gastric Cancer	NCT01457846
Safety and Efficacy Study of the DANUBIO Paclitaxel Eluting Balloon in Side Branches of de Novo Bifurcation Lesions (DEBSIDE)	Completed	Coronary Disease	NCT01485081
Pembrolizumab With Carboplatin/Paclitaxel in Patients With Metastatic Melanoma	Active, not recruiting	Metastatic Malignant Melanoma	NCT02617849
Comparison of Two Regimens of Dexamethasone in the Prevention of Hypersensitivity Reactions to Paclitaxel, a Pilot Study	Completed	Prevention of Hypersensitivity Reactions to Paclitaxel	NCT01797991
Trial Comparing Nab-Paclitaxel to Paclitaxel in Patients With Advanced Urothelial Cancer Progressing on or After Platinum Containing Regimen.	Active, not recruiting	Urothelial Cancer	NCT02033993
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer	Not yet recruiting	Stage III Pancreatic Cancer AJCC v8\|Stage IV Pancreatic Cancer AJCC v8\|Unresectable Pancreatic Carcinoma	NCT04158635
Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Persistent or Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer	Completed	Recurrent Fallopian Tube Carcinoma\|Recurrent Ovarian Carcinoma\|Recurrent Primary Peritoneal Carcinoma	NCT01468909
S0028, Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary Tract	Terminated	Bladder Cancer\|Transitional Cell Cancer of the Renal Pelvis and Ureter\|Urethral Cancer	NCT00022633
Lapatinib With Carboplatin and Paclitaxel in Esophagus and Gastroesophageal Junction (GEJ)	Terminated	Adenocarcinoma of the Esophagus\|Adenocarcinoma of the Gastroesophageal Junction	NCT01395537
Sintilimab in Combination With Nab-paclitaxel in Patients With HNSCC (Head and Neck Squamous Cell Carcinoma )	Not yet recruiting	Head and Neck Squamous Cell Cancer	NCT03975270
Everolimus in Combination With Trastuzumab and Paclitaxel in the Treatment of HER2 Positive Locally Advanced or Metastatic Breast Cancer	Completed	Breast Cancer	NCT00876395
Study Of SU011248 In Combination With Paclitaxel In Patients With Metastatic Breast Cancer	Completed	Breast Neoplasms	NCT00174434
Carboplatin-Paclitaxel Â± Bevacizumab in Advanced (Stage III-IV) or Recurrent Endometrial Cancer	Unknown status	Stage III-IV or Recurrent Endometrial Cancer	NCT01770171
A Trial of ABI-007 Versus Dacarbazine in Previously Untreated Patients With Metastatic Malignant Melanoma	Completed	Malignant Melanoma	NCT00864253
Phase Ib Study of Radium Ra 223 Dichloride in Combination With Paclitaxel in Cancer Subjects With Bone Lesions	Completed	Neoplasms\|Bone Diseases	NCT02442063
Metformin Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer	Withdrawn	Ovarian Papillary Serous Carcinoma\|Ovarian Serous Cystadenocarcinoma\|Recurrent Fallopian Tube Cancer\|Recurrent Ovarian Epithelial Cancer\|Recurrent Ovarian Germ Cell Tumor\|Recurrent Primary Peritoneal Cavity Cancer	NCT02050009
Interferon Alfa, Isotretinoin, and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer	Completed	Lung Cancer	NCT00062010
Trial of Paclitaxel Plus Gemcitabine and Cisplatin in Bladder Cancer	Terminated	Urinary Bladder Neoplasms	NCT02560038
A Study of Neoadjuvant Paclitaxel in Combination With Bavituximab in Early- Stage Triple- Negative Breast Cancer	Withdrawn	Breast Cancer\|Triple Negative Breast Neoplasms\|Triple-Negative Breast Neoplasm\|Triple-Negative Breast Cancer\|Triple Negative Breast Cancer\|ER-Negative PR-Negative HER2-Negative Breast Neoplasms\|ER-Negative PR-Negative HER2-Negative Breast Cancer	NCT02685306
ABI-007 (Nab-Paclitaxel) and Gemcitabine in Treating Women With Metastatic Breast Cancer	Completed	Breast Cancer	NCT00110084
Dovitinib Lactate, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Solid Tumors or Pancreatic Cancer	Withdrawn	Duct Cell Adenocarcinoma of the Pancreas\|Recurrent Pancreatic Cancer\|Stage III Pancreatic Cancer\|Stage IV Pancreatic Cancer\|Unspecified Adult Solid Tumor, Protocol Specific	NCT02048943
A Study of the mTOR Inhibitor Rapamycin (Rapamune, Sirolimus) in Combination With Abraxane in Advanced Solid Cancers	Terminated	Advanced Solid Cancers	NCT00337376
A Study Evaluating the Efficacy and Tolerability of Veliparib in Combination With Paclitaxel/Carboplatin-Based Chemoradiotherapy Followed by Veliparib and Paclitaxel/Carboplatin Consolidation in Subjects With Stage III Non-Small Cell Lung Cancer	Completed	Non-small Cell Lung Cancer Stage III	NCT02412371
S0329, Gemcitabine and Paclitaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer	Completed	Head and Neck Cancer	NCT00100789
Dose Escalation Study of Liposomal Paclitaxel With/Without Capecitabine in Patients With Advanced Gastric Carcinoma	Unknown status	Gastric Carcinoma	NCT00639522
NeoPHOEBE: Neoadjuvant Trastuzumab + BKM120 in Combination With Weekly Paclitaxel in HER2-positive Primary Breast Cancer	Completed	HER2-positive Newly Diagnosed, Primary Breast Cancer	NCT01816594
Phase II Study With Abraxane, Bevacizumab and Carboplatin in Triple Negative Metastatic Breast Cancer	Completed	Breast Cancer	NCT00479674
BMS-813160 With Nivolumab and Gemcitabine and Nab-paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)	Recruiting	Pancreatic Ductal Adenocarcinoma	NCT03496662
Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Versus Placebo in Addition to Paclitaxel and Carboplatin	Completed	Lung Cancer - Non Small Cell Squamous	NCT01285609
Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Carboplatin and/or Paclitaxel	Active, not recruiting	Triple Negative Metastatic Breast Cancer\|Advanced Ovarian Cancer\|Carboplatin\|Paclitaxel	NCT00516724
Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer	Completed	Fallopian Tube Carcinoma\|Infectious Disorder\|Neutropenia\|Ovarian Carcinosarcoma\|Primary Peritoneal Carcinoma\|Stage III Ovarian Cancer\|Stage IV Ovarian Cancer	NCT00352300
Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer	Recruiting	Breast Carcinoma\|Breast Lump\|Edema\|Erythema\|Estrogen Receptor Negative\|HER2/Neu Negative\|Inflammatory Breast Carcinoma\|Invasive Breast Carcinoma\|Peau d'Orange\|Progesterone Receptor Negative\|Triple-Negative Breast Carcinoma	NCT02876107
Erlotinib, Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Cancer	Completed	Advanced Pancreatic Cancer	NCT01010945
Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer	Terminated	Stage IIIA Non-Small Cell Lung Cancer\|Stage IIIB Non-Small Cell Lung Cancer\|Stage IV Non-Small Cell Lung Cancer	NCT01413750
Comparison of Agentâ„˘ and SeQuentÂ® Please Paclitaxel Coated Balloon Catheters in Coronary In-stent Restenosis (AGENT-ISR)	Completed	Coronary Artery Disease\|Coronary Restenosis\|Coronary Atherosclerosis\|Coronary Arteriosclerosis	NCT02151812
A Study of Paclitaxel/Carboplatin With or Without Olaratumab (IMC-3G3) in Previously Untreated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)	Completed	Non-Small Cell Lung Cancer	NCT00918203
A Phase II Study of Therapy With Paclitaxel, Carboplatin and Megesterol Acetate for the Management of Uterine Cancer	Completed	Uterine Cancer	NCT00584857
Phase 2 Study of MLN0128, Combination of MLN0128 With MLN1117, Paclitaxel and Combination of MLN0128 With Paclitaxel in Women With Endometrial Cancer	Active, not recruiting	Endometrial Neoplasms	NCT02725268
A Study of Ramucirumab (IMC-1121B) With Paclitaxel and Carboplatin in Non-small Cell Lung Cancer	Completed	Non Small Cell Lung Cancer	NCT00735696
Study Evaluating Neratinib Plus Paclitaxel VS Trastuzumab Plus Paclitaxel In ErbB-2 Positive Advanced Breast Cancer	Completed	Breast Cancer	NCT00915018
Bevacizumab and Trastuzumab With Weekly Paclitaxel Followed, After Surgery, by Encapsuled Liposomal Doxorubicin, Cyclophosphamide and Trastuzumab as Adjuvant Treatment After Surgery on Women With Her2+ Breast Cancer	Unknown status	Breast Cancer	NCT01321775
Paclitaxel and Carboplatin With or Without Celecoxib Before Surgery in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer	Completed	Lung Cancer	NCT00062179
A Study of LY01008 and Bevacizumab Combined With Paclitaxel and Carboplatin for Treatment of NaĂŻve Subjects With Metastatic or Recurrent Nonsquamous Non-small Cell Lung Cancer	Recruiting	Non Small Cell Lung Cancer\|Non Small Cell Lung Cancer Metastatic\|Non Small Cell Lung Cancer Recurrent	NCT03533127
Bevacizumab and Anetumab Ravtansine or Paclitaxel in Treating Participants With Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer	Recruiting	Fallopian Tube Endometrioid Adenocarcinoma\|High Grade Fallopian Tube Serous Adenocarcinoma\|High Grade Ovarian Serous Adenocarcinoma\|Ovarian Endometrioid Adenocarcinoma\|Platinum-Resistant Ovarian Carcinoma\|Primary Peritoneal High Grade Serous Adenocarcinoma\|Refractory Fallopian Tube Carcinoma\|Refractory Ovarian Carcinoma\|Refractory Primary Peritoneal Carcinoma	NCT03587311
Study of Motesanib (AMG 706) in Combination With Paclitaxel and Carboplatin for Advanced Non-Squamous Non-Small Cell Lung Cancer	Terminated	Carcinoma, Non-Small-Cell Lung	NCT02629848
A COMparison Between PAClitaxel-coated Balloon and pacliTaxel-eluting Stent in the Treatment of In-Stent Restenosis (COMPACT-ISR)	Terminated	Stable Angina\|Unstable Angina	NCT01204320
Paclitaxel/Carboplatin Plus Bevacizumab/Erlotinib in the First Line Treatment of Carcinoma of Unknown Primary Site	Completed	Neoplasm, Unknown Primary	NCT00360360
A Phase II Study of Dose Density Regimen With Fluorouracil, Epirubicin and Cyclophosphamide at Days 1, 4 Every 14 Days With Filgrastim Support Followed by Weekly Paclitaxel in Women With Primary Breast Cancer.	Completed	Women With Primary Breast Cancer	NCT02225652
Gemcitabine Hydrochloride, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Metformin Hydrochloride, and a Standardized Dietary Supplement in Treating Patients With Pancreatic Cancer That Cannot be Removed by Surgery	Active, not recruiting	Pancreatic Adenocarcinoma\|Unresectable Pancreatic Carcinoma\|Stage III Pancreatic Cancer AJCC v6 and v7\|Stage IV Pancreatic Cancer AJCC v6 and v7	NCT02336087
A Study of Ipatasertib in Combination With Paclitaxel as a Treatment for Participants With PIK3CA/AKT1/PTEN-Altered, Locally Advanced or Metastatic, Triple-Negative Breast Cancer or Hormone Receptor-Positive, HER2-Negative Breast Cancer	Recruiting	Breast Cancer	NCT03337724
Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Metastatic Melanoma	Completed	Ciliary Body and Choroid Melanoma, Medium/Large Size\|Extraocular Extension Melanoma\|Iris Melanoma\|Recurrent Intraocular Melanoma\|Recurrent Melanoma\|Stage IV Melanoma	NCT00288041
FASN Inhibitor TVB-2640, Paclitaxel, and Trastuzumab in Treating Patients With HER2 Positive Advanced Breast Cancer	Recruiting	HER2 Positive Breast Carcinoma\|Stage III Breast Cancer\|Stage IIIA Breast Cancer\|Stage IIIB Breast Cancer\|Stage IIIC Breast Cancer\|Stage IV Breast Cancer	NCT03179904
Sorafenib Plus Paclitaxel in Adreno-Cortical-Cancer Patients	Unknown status	Adrenocortical Carcinoma	NCT00786110
Pivotal Trial of a Novel Paclitaxel-Coated Percutaneous Angioplasty Balloon	Active, not recruiting	Peripheral Arterial Disease	NCT01858428
Weekly Paclitaxel With or Without Pazopanib in Platinum Resistant or Refractory Ovarian Cancer	Completed	Ovarian Cancer	NCT01644825
Nab-Paclitaxel and Cisplatin or Nab-paclitaxel as Induction Therapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC)	Recruiting	Squamous Cell Carcinoma of the Head and Neck\|Carcinoma, Squamous Cell of the Head and Neck\|Cancer of Head and Neck\|Cancer of the Head and Neck\|Head and Neck Cancer\|Neoplasms, Head and Neck	NCT02573493
Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial Cancer	Completed	Endometrial Adenosquamous Carcinoma\|Endometrial Clear Cell Adenocarcinoma\|Endometrial Mixed Adenocarcinoma\|Endometrial Serous Adenocarcinoma\|Endometrial Squamous Cell Carcinoma\|Endometrial Undifferentiated Carcinoma\|Recurrent Uterine Corpus Carcinoma\|Stage IIIA Uterine Corpus Cancer\|Stage IIIC Uterine Corpus Cancer\|Stage IVA Uterine Corpus Cancer\|Stage IVB Uterine Corpus Cancer	NCT00575952
The Study Evaluating Efficacy And Tolerability Of Veliparib in Combination With Temozolomide or In Combination With Carboplatin and Paclitaxel Versus Placebo in Subjects With BRCA1 and BRCA2 Mutation and Metastatic Breast Cancer	Active, not recruiting	Metastatic Breast Cancer	NCT01506609
Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors	Completed	Breast Cancer\|Colorectal Cancer\|Head and Neck Cancer\|Lung Cancer\|Melanoma (Skin)\|Ovarian Cancer\|Pancreatic Cancer\|Prostate Cancer\|Unspecified Adult Solid Tumor, Protocol Specific	NCT00667641
A Multicenter, Double-blind, Randomized Controlled Phase II Clinical Study of Monosialic Gangliosides to Prevent Albumin-bound Paclitaxel Neurotoxicity	Not yet recruiting	Early Breast Cancer	NCT04222790
Paclitaxel With or Without Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer	Completed	Breast Cancer	NCT00028990
Phase II Trial of Abraxane in Front Line Therapy of Hormone Refractory Metastatic Prostate Cancer	Completed	Prostate Cancer	NCT00284752
Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast Cancer	Terminated	HER2-negative Breast Cancer\|Inflammatory Breast Cancer\|Male Breast Cancer\|Recurrent Breast Cancer\|Stage IV Breast Cancer	NCT01938833
Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in Melanoma	Terminated	Melanoma	NCT00522834
PH 1 Evaluation Of Oral CI-1033 In Combination With Paclitaxel/ Carboplatin As 1st Line Chemotherapy In NSCLC Patients	Completed	Carcinoma, Non-Small Cell Lung	NCT00174356
Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer	Completed	Sarcoma	NCT00112489
Enzalutamide, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrioid Endometrial Cancer	Recruiting	Recurrent Endometrial Endometrioid Adenocarcinoma\|Recurrent Uterine Corpus Carcinoma\|Stage III Uterine Corpus Cancer AJCC v7\|Stage IIIA Uterine Corpus Cancer AJCC v7\|Stage IIIB Uterine Corpus Cancer AJCC v7\|Stage IIIC Uterine Corpus Cancer AJCC v7\|Stage IV Uterine Corpus Cancer AJCC v7\|Stage IVA Uterine Corpus Cancer AJCC v7\|Stage IVB Uterine Corpus Cancer AJCC v7	NCT02684227
Paclitaxel-Coated Versus Uncoated Balloon for Treatment of Below-the-Knee In-Stent-Restenosis	Withdrawn	In-stent Stenosis of Infrapopliteal Arteries	NCT01398033
Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast Cancer	Active, not recruiting	HER2-positive Breast Cancer\|Recurrent Breast Cancer\|Stage IIA Breast Cancer\|Stage IIB Breast Cancer\|Stage IIIA Breast Cancer\|Stage IIIB Breast Cancer\|Stage IIIC Breast Cancer\|Stage IV Breast Cancer\|Breast Adenocarcinoma\|Inflammatory Breast Carcinoma	NCT01730833
Concurrent Endostar, Paclitaxel/Carboplatin and Radiotherapy for Locally Advanced Non-small Cell Lung (RT0902)	Unknown status	Non-small Cell Lung Cancer	NCT01158144
Study Evaluating the Safety and Efficacy of Onartuzumab And/or Bevacizumab in Combination With Paclitaxel in Participants With Metastatic, Triple Negative Breast Cancer	Completed	Breast Cancer	NCT01186991
Carboplatin and Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Metastatic Pancreatic Cancer	Completed	Pancreatic Acinar Cell Carcinoma\|Pancreatic Ductal Adenocarcinoma\|Recurrent Pancreatic Carcinoma\|Stage IV Pancreatic Cancer	NCT01280058
Assessing the Response Rate of Neo-adjuvant Paclitaxel (Taxol) in Nigerian Women With Breast Cancer	Withdrawn	Breast Cancer\|Breast Cancer Stage II\|Breast Cancer Stage III	NCT03058939
Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer	Recruiting	Bladder Cancer Cell Transitional\|Non-Muscle Invasive Bladder Cancer\|Bladder Cancer\|Urinary Bladder\|Transitional Cell Carcinoma of the Bladder\|Urinary Bladder Neoplasms\|Urologic Neoplasms\|Urogenital Neoplasms\|Urinary Bladder Diseases\|Urologic Diseases	NCT03081858
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer	Recruiting	Breast Cancer	NCT04066790
Pilot Study Investigating the Metabolic Activity and Transcriptional Profiling in Vivo in Tumor Biopsies in Melanoma Patients During Treatment With Pazopanib Alone and in Combination With Paclitaxel	Completed	Melanoma	NCT01666418
A Phase II Study Of Abraxane and Nexavar in the First-Line Treatment of Locally Advanced or Metastatic Breast Cancer	Terminated	Breast Cancer	NCT00607438
Randomized, Double-Blind, Multicenter, Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Previously Untreated Advanced or Metastatic Squamous Non-Small Cell Lung Cancer	Completed	Squamous Non-Small Cell Lung Cancer	NCT02106546
Eribulin Mesylate or Paclitaxel as First- or Second-Line Therapy in Treating Patients With Recurrent Stage IIIC-IV Breast Cancer	Suspended	Breast Adenocarcinoma\|HER2/Neu Negative\|Invasive Breast Carcinoma\|Stage IIIC Breast Cancer AJCC v7\|Stage IV Breast Cancer AJCC v6 and v7	NCT02037529
Safety and Efficacy of Belinostat When Used With Standard of Care Chemotherapy for Untreated Non-small Cell Lung Cancer	Terminated	Non-Small-Cell Lung Carcinoma	NCT01090830
Phase I/II Study of Paclitaxel Plus CPT-11 in Pts. With 2nd Line Chemotherapy of Inoperable or Recurrent GC.	Withdrawn	Gastric Cancer	NCT00209612
Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian Cancer	Completed	Ovarian Cancer	NCT00003644
An Open-Label, Multicenter, Phase 1/2 Study of Poly(ADP-Ribose) Polymerase (PARP) Inhibitor E7449 as Single Agent in Subjects With Advanced Solid Tumors or With B-cell Malignancies and in Combination With Temozolomide (TMZ) or With Carboplatin and Paclitaxel in Subjects With Advanced Solid Tumors	Completed	Malignant Solid Tumour\|Ovarian Cancer\|Triple Negative Breast Cancer\|Advanced Melanoma\|B-cell Malignancy, Low-grade	NCT01618136
First Line Chemotherapy for Advanced Cancer	Terminated	Gastric Cancer	NCT01980810
Paclitaxel and Intraperitoneal Carboplatin Followed by Radiation Therapy in Treating Patients With Stage IIIC-IV Uterine Cancer	Terminated	Endometrial Serous Adenocarcinoma\|Stage IIIA Uterine Corpus Cancer\|Stage IIIB Uterine Corpus Cancer\|Stage IIIC1 Uterine Corpus Cancer\|Stage IIIC2 Uterine Corpus Cancer\|Stage IVA Uterine Corpus Cancer\|Stage IVB Uterine Corpus Cancer	NCT02112552
Role of Tirofiban and the Paclitaxel Eluting Stent in Postfibrinolysis Angioplasty	Completed	Myocardial Infarction	NCT00306228
Weekly Paclitaxel/Carboplatin/Bevacizumab as First Line Therapy for Triple Negative Breast Cancer	Completed	Breast Cancer	NCT00691379
Veliparib in Combination With Carboplatin and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors	Completed	Adult Solid Neoplasm\|Estrogen Receptor Negative\|Estrogen Receptor Positive\|HER2/Neu Negative\|Male Breast Carcinoma\|Progesterone Receptor Negative\|Recurrent Breast Carcinoma\|Stage IIIB Breast Cancer\|Stage IIIC Breast Cancer\|Stage IV Breast Cancer\|Triple-Negative Breast Carcinoma	NCT01281150
Therapy of Metastatic Breast Cancer With Paclitaxel and Liposomal Doxorubicin	Terminated	Metastatic Breast Cancer	NCT00691912
Study of AZD5363 in Combination With Paclitaxel, in Advanced Gastric Adenocarcinoma Patients Harboring PIK3CA Mutation and/or PIK3CA Amplification as a Second-line Chemotherapy	Completed	Advanced Gastric Cancer	NCT02451956
Second-Line Adjuvant Therapy With Nab-Paclitaxel Plus Gemcitabine Versus Oxaliplatin Plus Folinic Acid and Fluorouracil for Gemcitabine-Refractory Pancreatic Cancer After Curative Resection	Unknown status	Stage â… A Pancreatic Cancer\|Stage â… B Pancreatic Cancer\|Stage â…ˇA Pancreatic Cancer\|Stage â…ˇB Pancreatic Cancer	NCT02506842
Study of Paclitaxel in Patients With Ovarian Cancer	Completed	Epithelial Ovarian Cancer\|Primary Peritoneal Cancer\|Fallopian Tube Cancer	NCT00989131
Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin	Completed	Non-small Cell Lung Cancer	NCT00966914
Efficacy and Safety Study of Trastuzumab and Paclitaxel Based Regimens to Treat HER2-positive Breast Cancer	Unknown status	HER-2 Positive Breast Cancer	NCT01428414
Paclitaxel Eluting Balloon Versus Drug Eluting Stent in Native Coronary Artery Stenoses of Diabetic Patients	Completed	Coronary Stenosis\|Diabetes Mellitus	NCT00462631
Two Regimens of SAR240550/Weekly Paclitaxel and Paclitaxel Alone as Neoadjuvant Therapy in Triple Negative Breast Cancer Patients	Completed	Breast Cancer Female	NCT01204125
Eribulin Plus Gemcitabine (EG) vs Paclitaxel Plus Gemcitabine (PG) in HER2-Negative Metastatic Breast Cancer	Completed	Metastatic Breast Cancer	NCT02263495
Trial of Carboplatin-Paclitaxel-Bevacizumab vs Carboplatin-Paclitaxel-Bevacizumab-Rucaparib vs Carboplatin-Paclitaxel-Rucaparib in Patients With Advanced (Stage III B-C-IV) Ovarian, Primary Peritoneal and Fallopian Tube Cancer.	Recruiting	Advanced (Stage IIIB-C-IV) Ovarian, Primary Peritoneal and Fallopian Tube Cancer	NCT03462212
Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial Cancer	Terminated	Endometrial Adenocarcinoma\|Stage IA Uterine Corpus Cancer\|Stage IB Uterine Corpus Cancer\|Stage II Uterine Corpus Cancer\|Stage IIIA Uterine Corpus Cancer\|Stage IIIB Uterine Corpus Cancer\|Stage IIIC Uterine Corpus Cancer\|Stage IVA Uterine Corpus Cancer\|Stage IVB Uterine Corpus Cancer	NCT01041027
BYL719 in Combination With Gemcitabine and (Nab)-Paclitaxel in Locally Advanced and Metastatic Pancreatic Cancer	Completed	Pancreatic Cancer	NCT02155088
Prevention of Restenosis After Genous Stent Implantation Using a Paclitaxel Eluting Balloon in Coronary Arteries	Completed	Coronary Artery Disease	NCT00732953
Combination Chemotherapy With CS-1008 to Treat Ovarian Cancer	Completed	Ovarian Cancer	NCT00945191
Intraperitoneal Paclitaxel and Carboplatin in the Treatment of Women With Carcinoma of Mullerian Origin	Completed	Ovarian Carcinoma	NCT00181701
Phase II Lapatinib Plus Nab-Paclitaxel As First And Second Line Therapy In her2+ MBC	Completed	Neoplasms, Breast	NCT00709761
Study of Albumin-bound Paclitaxel (Abraxane) in Combination With Carboplatin and Herceptin in Patients With Advanced Breast Cancer	Completed	Breast Cancer	NCT00093145
Oxford Ovarian Cancer Predict Chemotherapy Response 01	Unknown status	Ovarian Cancer	NCT01770535
Paclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer	Completed	Cervical Adenocarcinoma\|Cervical Adenosquamous Carcinoma\|Cervical Squamous Cell Carcinoma, Not Otherwise Specified\|Recurrent Cervical Carcinoma\|Stage IVB Cervical Cancer AJCC v6 and v7	NCT01281852
Saracatinib and Paclitaxel in Platinum-resistant Ovarian Cancer	Completed	Ovarian Cancer\|Fallopian Tube Cancer\|Primary Peritoneal Cancer	NCT01196741
Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer	Completed	Endometrial Adenocarcinoma\|Endometrial Clear Cell Adenocarcinoma\|Endometrial Mucinous Adenocarcinoma\|Endometrial Serous Adenocarcinoma\|Endometrial Squamous Cell Carcinoma\|Endometrial Transitional Cell Carcinoma\|Endometrial Undifferentiated Carcinoma\|Endometrioid Adenocarcinoma\|Recurrent Uterine Corpus Carcinoma\|Stage III Uterine Corpus Cancer AJCC v7\|Stage IIIA Uterine Corpus Cancer AJCC v7\|Stage IIIB Uterine Corpus Cancer AJCC v7\|Stage IIIC Uterine Corpus Cancer AJCC v7\|Stage IV Uterine Corpus Cancer AJCC v7\|Stage IVA Uterine Corpus Cancer AJCC v7\|Stage IVB Uterine Corpus Cancer AJCC v7	NCT01440998
PIPAC Nab-pac for Stomach, Pancreas, Breast and Ovarian Cancer	Recruiting	Peritoneal Carcinomatosis\|Ovarian Cancer Stage IIIB\|Ovarian Cancer Stage IIIC\|Ovarian Cancer Stage IV\|Breast Cancer Stage IIIB\|Breast Cancer Stage IIIc\|Breast Cancer Stage IV\|Stomach Cancer Stage III\|Stomach Cancer Stage IV With Metastases\|Pancreas Cancer, Stage III\|Pancreas Cancer, Stage IV	NCT03304210
Paclitaxel and Bevacizumab With or Without Emactuzumab in Treating Patients With Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer	Active, not recruiting	Fallopian Tube Adenocarcinoma\|Fallopian Tube Clear Cell Adenocarcinoma\|Fallopian Tube Endometrioid Adenocarcinoma\|Fallopian Tube Mucinous Adenocarcinoma\|Fallopian Tube Serous Adenocarcinoma\|Fallopian Tube Transitional Cell Carcinoma\|Fallopian Tube Undifferentiated Carcinoma\|Malignant Ovarian Brenner Tumor\|Ovarian Adenocarcinoma\|Ovarian Clear Cell Adenocarcinoma\|Ovarian Endometrioid Adenocarcinoma\|Ovarian Mucinous Adenocarcinoma\|Ovarian Seromucinous Carcinoma\|Ovarian Serous Adenocarcinoma\|Ovarian Transitional Cell Carcinoma\|Ovarian Undifferentiated Carcinoma\|Primary Peritoneal Serous Adenocarcinoma\|Recurrent Fallopian Tube Carcinoma\|Recurrent Ovarian Carcinoma\|Recurrent Primary Peritoneal Carcinoma	NCT02923739
Phase 1b/2 Study of U3-1287 in Combination With Trastuzumab Plus Paclitaxel in Newly Diagnosed Metastatic Breast Cancer (MBC)	Terminated	Metastatic Breast Cancer	NCT01512199
First-Line Treatment of Bevacizumab, Carboplatin, and Paclitaxel in Treating Participants With Stage III-IV Ovarian, Primary Peritoneal, and Fallopian Tube Cancer	Active, not recruiting	Fallopian Tube Carcinoma\|Fallopian Tube Clear Cell Adenocarcinoma\|Fallopian Tube Endometrioid Adenocarcinoma\|Fallopian Tube Mucinous Adenocarcinoma\|Fallopian Tube Serous Adenocarcinoma\|Fallopian Tube Transitional Cell Carcinoma\|Fallopian Tube Undifferentiated Carcinoma\|FIGO Stage III Ovarian Cancer\|FIGO Stage IIIA Ovarian Cancer\|FIGO Stage IIIA1 Ovarian Cancer\|FIGO Stage IIIA1(i) Ovarian Cancer\|FIGO Stage IIIA1(ii) Ovarian Cancer\|FIGO Stage IIIA2 Ovarian Cancer\|FIGO Stage IIIB Ovarian Cancer\|FIGO Stage IIIC Ovarian Cancer\|FIGO Stage IVA Ovarian Cancer\|FIGO Stage IVB Ovarian Cancer\|Malignant Ovarian Brenner Tumor\|Ovarian Clear Cell Adenocarcinoma\|Ovarian Endometrioid Adenocarcinoma\|Ovarian Mucinous Adenocarcinoma\|Ovarian Seromucinous Carcinoma\|Ovarian Serous Adenocarcinoma\|Ovarian Transitional Cell Carcinoma\|Ovarian Undifferentiated Carcinoma\|Primary Peritoneal Carcinoma\|Primary Peritoneal Serous Adenocarcinoma	NCT01097746
SU5416 and Paclitaxel in Treating Patients With Recurrent, Locally Advanced or Metastatic Cancer of the Head and Neck	Completed	Head and Neck Cancer	NCT00005647
Safety and Efficacy of Buparlisib (BKM120) in Patients With Untreated Squamous Non-small Cell Lung Cancer	Terminated	Non-Small Cell Lunch Cancer	NCT01820325
Sorafenib in Combination With Carboplatin and Paclitaxel in Treating Participants With Metastatic or Recurrent Head and Neck Squamous Cell Cancer	Active, not recruiting	Metastatic Head and Neck Squamous Cell Carcinoma\|Metastatic Squamous Cell Carcinoma of the Hypopharynx\|Metastatic Squamous Cell Carcinoma of the Larynx\|Metastatic Squamous Cell Carcinoma of the Oral Cavity\|Metastatic Squamous Cell Carcinoma of the Oropharynx\|Recurrent Head and Neck Squamous Cell Carcinoma\|Recurrent Hypopharyngeal Squamous Cell Carcinoma\|Recurrent Laryngeal Squamous Cell Carcinoma\|Recurrent Oral Cavity Squamous Cell Carcinoma\|Recurrent Oropharyngeal Squamous Cell Carcinoma	NCT00494182
17-N-Allylamino-17-Demethoxygeldanamycin and Paclitaxel in Treating Patients With Metastatic or Unresectable Solid Tumor	Completed	Unspecified Adult Solid Tumor, Protocol Specific	NCT00087217
Vinorelbine Tartrate and Paclitaxel in Treating Older Patients With Advanced Non-Small Cell Lung Cancer	Completed	Recurrent Non-Small Cell Lung Carcinoma\|Stage IV Non-Small Cell Lung Cancer	NCT00602797
Nimotuzumab Plus Nab-paclitaxel and Cisplatin in Treating Patients With Advanced Esophageal Carcinoma	Withdrawn	Stage IV Esophageal Squamous Cell Carcinoma	NCT02034968
Ramucirumab Plus FOLFIRI Versus Ramucirumab Plus Paclitaxel in Patients With Advanced or Metastatic Gastric Cancer, Who Failed One Prior Line of Palliative Chemotherapy	Recruiting	Advanced Gastric or EGJ Cancer	NCT03081143
Study Assessing Safety and Tolerability of AZD8931 Alone or in Combination With Paclitaxel in Japanese Patients.	Completed	Neoplasms\|Metastatic Cancer\|Breast Cancer	NCT01003158
Comparison of Neo-adjuvant Weekly Paclitaxel With or Without Carboplatin in Early Breast Cancer	Completed	Breast Cancer	NCT00919880
BI 860585 Dose Escalation Single Agent and in Combination With Exemestane or With Paclitaxel in Patients With Various Advanced and/or Metastatic Solid Tumors	Completed	Neoplasms	NCT01938846
Phase II Study of Weekly Paclitaxel (BMS-181339)in Patients With Advanced or Recurrent Esophageal Cancer	Completed	Esophageal Cancer	NCT00344552
Carboplatin, Paclitaxel, and Surgery in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer	Terminated	Fallopian Tube Cancer\|Ovarian Cancer\|Peritoneal Cavity Cancer	NCT00331422
A Study of RO5083945 in Combination With Cisplatin and Gemcitabine or Carboplatin and Paclitaxel in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer of Squamous Histology Who Have Not Received Prior Chemotherapy for The Metastatic Disease	Withdrawn	Non-Squamous Non-Small Cell Lung Cancer	NCT01702714
Improve Checkpoint-blockade Response in Advanced Urothelial Cancer	Not yet recruiting	Urothelial Carcinoma	NCT03871036
Phase II Trial of Dose-dense Paclitaxel and Cisplatin as Neo-adjuvant Chemotherapy for Operable Stage II and IIA NSCLC	Terminated	Non-Small Cell Lung Cancer	NCT00291850
Nab-Paclitaxel and Durvalumab With or Without Neoantigen Vaccine in Treating Patients With Metastatic Triple Negative Breast Cancer	Not yet recruiting	Anatomic Stage IV Breast Cancer AJCC v8\|Estrogen Receptor Negative\|HER2/Neu Negative\|Metastatic Triple-Negative Breast Carcinoma\|Progesterone Receptor Negative\|Prognostic Stage IV Breast Cancer AJCC v8	NCT03606967
A Study of the Addition of Avastin (Bevacizumab) to Carboplatin and Paclitaxel Therapy in Patients With Ovarian Cancer	Completed	Ovarian Cancer	NCT01239732
Veliparib in Combination With Carboplatin And Weekly Paclitaxel in Japanese Subjects With Ovarian Cancer	Completed	Ovarian Cancer	NCT02483104
TRINOVA-1: A Study of AMG 386 or Placebo, in Combination With Weekly Paclitaxel Chemotherapy, as Treatment for Ovarian Cancer, Primary Peritoneal Cancer and Fallopian Tube Cancer	Completed	Fallopian Tube Cancer\|Ovarian Cancer\|Primary Peritoneal Cancer	NCT01204749
Ramucirumab and Carbo-Paclitaxel for Untreated Thymic Carcinoma / B3 Thymoma With Carcinoma (RELEVENT)	Recruiting	Thymic Carcinoma\|Thymoma	NCT03921671
S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung Cancer	Completed	Lung Cancer	NCT00661193
A Clinical Study Conducted in Multiple Centers Comparing Veliparib in Combination With Carboplatin and Paclitaxel Versus a Placebo in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer	Completed	Non-Small -Cell Lung Cancer	NCT01560104
Capecitabine, Carboplatin and Weekly Paclitaxel for Patients With Solid Tumors and Adenocarcinoma of Unknown Primary	Terminated	Tumors\|Unknown Primary Tumors\|Adenocarcinoma	NCT00201734
First Line Metastatic Pancreatic Cancer : 5FU/LV+Nal-IRI, Gemcitabine+Nab-paclitaxel or a Sequential Regimen of 2 Months 5FU/LV+Nal-IRI	Recruiting	Metastatic Pancreatic Cancer	NCT03693677
Testing the Addition of the Anti-Cancer Drug Talazoparib to the Combination of Carboplatin and Paclitaxel for the Treatment of Advanced Cancer	Active, not recruiting	Advanced Malignant Solid Neoplasm\|Metastatic Malignant Solid Neoplasm\|Unresectable Malignant Solid Neoplasm	NCT02317874
Carboplatin and Paclitaxel in Treating Older Patients With Metastatic or Recurrent Unresectable Non-small Cell Lung Cancer	Completed	Lung Cancer	NCT00005059
Bevacizumab + Paclitaxel + Capecitabine in Triple Negative Metastatic Breast Cancer	Terminated	Triple Negative Metastatic Breast Cancer	NCT01069796
Nimotuzumab in Combined With Paclitaxel and Cisplatin for Treatment of Metastatic Esophageal Squamous Cell Carcinoma	Unknown status	Esophageal Squamous Cell Carcinomas	NCT02611700
Neoadjuvant Nab-paclitaxel in Triple-negative or HER2-positive Breast Cancer	Recruiting	Breast Cancer\|Triple Negative Breast Cancer\|HER2-positive Breast Cancer	NCT03907800
Concurrent Chemoradiotherapy With Weekly Cisplatin Versus Concurrent Chemoradiotherapy With Weekly Cisplatin and Paclitaxel in Locally Advanced Carcinoma Cervix	Unknown status	Carcinoma Cervix	NCT01593306
Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer Patients	Active, not recruiting	Tubular Breast Cancer\|Mucinous Breast Cancer\|Invasive Ductal Breast Cancer\|Inflammatory Breast Cancer	NCT02221999
Imatinib Mesylate and Paclitaxel in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer	Completed	Malignant Pleural Effusion\|Recurrent Non-small Cell Lung Cancer\|Stage IIIB Non-small Cell Lung Cancer\|Stage IV Non-small Cell Lung Cancer	NCT00408460
Study of NAC of GA Therapy for Patients With BRPC	Recruiting	Pancreatic Ductal Adenocarcinoma	NCT02926183
E7080 in Combination With Carboplatin and Paclitaxel in Patients With Non-small Cell Lung Cancer (NSCLC)	Completed	Non-small-cell Lung Cancer	NCT00832819
A Study of MEK162 and Paclitaxel in Patients With Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer	Completed	Epithelial Ovarian Cancer\|Fallopian Tube Cancer\|Peritoneal Cancer	NCT01649336
A Study of Bevacizumab Versus Placebo in Combination With Carboplatin/Paclitaxel in Participants With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Previous Chemotherapy	Completed	Non-Small Cell Lung Cancer	NCT01364012
Enzalutamide and Paclitaxel Before Surgery in Treating Patients With Stage I-III Androgen Receptor-Positive Triple-Negative Breast Cancer	Recruiting	Androgen Receptor Positive\|Estrogen Receptor Negative\|HER2/Neu Negative\|Invasive Breast Carcinoma\|Progesterone Receptor Negative\|Stage I Breast Cancer AJCC v7\|Stage IA Breast Cancer AJCC v7\|Stage IB Breast Cancer AJCC v7\|Stage II Breast Cancer AJCC v6 and v7\|Stage IIA Breast Cancer AJCC v6 and v7\|Stage IIB Breast Cancer AJCC v6 and v7\|Stage III Breast Cancer AJCC v7\|Stage IIIA Breast Cancer AJCC v7\|Stage IIIB Breast Cancer AJCC v7\|Stage IIIC Breast Cancer AJCC v7\|Triple-Negative Breast Carcinoma	NCT02689427
Carboplatin, Paclitaxel With or Without Avelumab in Advanced or Recurrent Endometrial Cancer	Not yet recruiting	Endometrial Cancer	NCT03503786
Study of AZD1775 in Combination With Paclitaxel, in Advanced Gastric Adenocarcinoma Patients Harboring TP53 Mutation as a Second-line Chemotherapy	Recruiting	Advanced Gastric Adenocarcinoma	NCT02448329
Isotretinoin, Interferon Alpha-2b, and Paclitaxel in Stage IV, Recurrent, or Persistent Cervical Cancer	Terminated	Cervical Cancer	NCT00138151
Carboplatin, Paclitaxel, and Temozolomide for Patients With Metastatic Melanoma	Terminated	Melanoma	NCT01009515
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer	Completed	Cervical Adenocarcinoma\|Cervical Adenosquamous Carcinoma\|Cervical Small Cell Carcinoma\|Cervical Squamous Cell Carcinoma\|Recurrent Cervical Carcinoma	NCT00309959
Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer	Terminated	Lung Cancer	NCT00004859
Randomised Phase II, Cetuximab in Combination With 5FU and Cisplatin or Carboplatin Versus Cetuximab in Combination With Paclitaxel and Carboplatin for Treatment of Patients With Metastatic Squamous Cell Carcinoma of the Head and Neck	Unknown status	Squamous Cell Carcinoma of the Head and Neck	NCT01830556
A Study of Veliparib in Combination With Carboplatin and Paclitaxel in Japanese Subjects With Solid Tumors	Completed	Solid Tumors	NCT01617928
A Trial l of Panobinostat Given in Combination With Trastuzumab and Paclitaxel in Adult Female Patients With HER2 Positive Metastatic Breast Cancer	Completed	HER-2 Positive Breast Cancer\|Metastatic Breast Cancer	NCT00788931
Gemcitabine, Paclitaxel and Oxaliplatin (GemPOx)	Completed	CNS Germ Cell Tumor	NCT01270724
Triple-B Study	N/A	N/A	NCT01898117
Preoperative Trial of Sorafenib in Combination With Cisplatin Followed by Paclitaxel for Early Stage Breast Cancer	Terminated	Breast Cancer	NCT01194869
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer	Active, not recruiting	Bladder Urothelial Carcinoma\|Stage I Bladder Cancer AJCC v6 and v7\|Stage II Bladder Cancer AJCC v6 and v7\|Stage III Bladder Cancer AJCC v6 and v7	NCT00238420
Photoablative Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis in Instent Femoro-popliteal Obstructions	Unknown status	Restenosis	NCT01298947
Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer	Active, not recruiting	Invasive Breast Carcinoma\|Stage II Breast Cancer AJCC v6 and v7\|Stage IIA Breast Cancer AJCC v6 and v7\|Stage IIB Breast Cancer AJCC v6 and v7\|Stage III Breast Cancer AJCC v7\|Stage IIIA Breast Cancer AJCC v7\|Stage IIIB Breast Cancer AJCC v7\|Stage IIIC Breast Cancer AJCC v7\|Triple-Negative Breast Carcinoma	NCT02883062
Paclitaxel, Trastuzumab, and Pertuzumab With or Without Atezolizumab in Treating Patients With Metastatic Breast Cancer	Recruiting	Breast Adenocarcinoma\|Metastatic Breast Carcinoma\|Recurrent Breast Carcinoma\|Stage III Breast Cancer AJCC v7\|Stage IIIA Breast Cancer AJCC v7\|Stage IIIB Breast Cancer AJCC v7\|Stage IIIC Breast Cancer AJCC v7\|Stage IV Breast Cancer AJCC v6 and v7	NCT03199885
https://ClinicalTrials.gov/show/NCT03199885	N/A	N/A	N/A
Dose Escalation Study of MLN0128 in Combination With Paclitaxel, With/Without Trastuzumab, in Subjects With Advanced Solid Malignancies	Completed	Advanced Solid Malignancies\|Hematologic Malignancies	NCT01351350
A Study to Assess the Antitumor Activity and Safety of IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine (Nab-P + GEM) as First Line Treatment in Subjects With Claudin 18.2 (CLDN18.2) Positive, Metastatic Pancreatic Adenocarcinoma	Recruiting	Pancreatic Cancer\|Metastatic Pancreatic Cancer\|Metastatic Pancreatic Adenocarcinoma	NCT03816163
Neurotoxicity Characterization Study of Nab-paclitaxel Versus Conventional Paclitaxel in Metastatic Breast Cancer	Completed	Breast Cancer	NCT01763710
Safety and Efficacy of APX005M With Gemcitabine and Nab-Paclitaxel With or Without Nivolumab in Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma	Active, not recruiting	Metastatic Pancreatic Adenocarcinoma	NCT03214250
Efficacy Study of Chemoradiotherapy With or Without Paclitaxel in Squamous-cell Anal Carcinoma Patients	Enrolling by invitation	Anus Neoplasms\|Carcinoma, Squamous Cell\|Anus Diseases\|Neoplasms\|Neoplasms, Squamous Cell\|Carcinoma	NCT02526953
A Phase 2 Feasibility Study of Abraxane and Carboplatin in Epithelial Neoplasms of the Uterus	Active, not recruiting	Endometrial Cancer	NCT02744898
Carboplatin and Paclitaxel Combined With Cetuximab and/or IMC-A12 in Patients With Advanced Non-Small Cell Lung Cancer	Completed	Recurrent Non-small Cell Lung Cancer\|Stage IIIB Non-small Cell Lung Cancer\|Stage IV Non-small Cell Lung Cancer	NCT00986674
Phase IIb Randomised Trial of ATRA in a Novel Drug Combination for Pancreatic Cancer	Not yet recruiting	Pancreatic Cancer	NCT04241276
A Two Arm Trial of Axitinib and Carboplatin/Paclitaxel in Melanoma	Completed	Melanoma	NCT01174238
Pemetrexed + Paclitaxel in Patients With Recurrent/Advanced Thyroid Cancer	Unknown status	Thyroid Cancer	NCT00786552
Women's MoonShot: Neoadjuvant Treatment With PaCT for Patients With Locally Advanced TNBC	Recruiting	Estrogen Receptor Negative\|HER2/Neu Negative\|Progesterone Receptor Negative\|Stage I Breast Cancer AJCC v7\|Stage IA Breast Cancer AJCC v7\|Stage IB Breast Cancer AJCC v7\|Stage II Breast Cancer AJCC v6 and v7\|Stage IIA Breast Cancer AJCC v6 and v7\|Stage IIB Breast Cancer AJCC v6 and v7\|Stage III Breast Cancer AJCC v7\|Stage IIIA Breast Cancer AJCC v7\|Stage IIIB Breast Cancer AJCC v7\|Stage IIIC Breast Cancer AJCC v7\|Triple-Negative Breast Carcinoma	NCT02593175
A Study of Atezolizumab in Combination With Carboplatin Plus (+) Paclitaxel With or Without Bevacizumab Compared With Carboplatin+Paclitaxel+Bevacizumab in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)	Active, not recruiting	Carcinoma, Non-Small-Cell Lung	NCT02366143
Study to Compare the Efficacy and Safety of Olaparib When Given in Combination With Carboplatin and Paclitaxel, Compared With Carboplatin and Paclitaxel in Patients With Advanced Ovarian Cancer	Active, not recruiting	Ovarian Cancer	NCT01081951
Bevacizumab Combined With Carboplatin Plus Paclitaxel Chemotherapy to Treat Metastatic Mucosal Melanoma	Unknown status	Melanoma	NCT02023710
Sorafenib, Carboplatin, and Paclitaxel in Treating Patients With Stage IV Melanoma of the Eye	Completed	Ciliary Body and Choroid Melanoma, Medium/Large Size\|Extraocular Extension Melanoma\|Iris Melanoma\|Metastatic Intraocular Melanoma\|Recurrent Intraocular Melanoma	NCT00329641
Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer	Active, not recruiting	Mixed Mesodermal (Mullerian) Tumor\|Ovarian Carcinosarcoma\|Recurrent Fallopian Tube Carcinoma\|Recurrent Ovarian Carcinoma\|Recurrent Primary Peritoneal Carcinoma\|Stage I Ovarian Cancer AJCC v6 and v7\|Stage IA Fallopian Tube Cancer AJCC v6 and v7\|Stage IA Ovarian Cancer AJCC v6 and v7\|Stage IA Uterine Sarcoma AJCC v7\|Stage IB Fallopian Tube Cancer AJCC v6 and v7\|Stage IB Ovarian Cancer AJCC v6 and v7\|Stage IB Uterine Sarcoma AJCC v7\|Stage IC Fallopian Tube Cancer AJCC v6 and v7\|Stage IC Ovarian Cancer AJCC v6 and v7\|Stage IC Uterine Sarcoma AJCC v7\|Stage II Ovarian Cancer AJCC v6 and v7\|Stage IIA Fallopian Tube Cancer AJCC v6 and v7\|Stage IIA Ovarian Cancer AJCC V6 and v7\|Stage IIA Uterine Sarcoma AJCC v7\|Stage IIB Fallopian Tube Cancer AJCC v6 and v7\|Stage IIB Ovarian Cancer AJCC v6 and v7\|Stage IIB Uterine Sarcoma AJCC v7\|Stage IIC Fallopian Tube Cancer AJCC v6 and v7\|Stage IIC Ovarian Cancer AJCC v6 and v7\|Stage IIIA Fallopian Tube Cancer AJCC v7\|Stage IIIA Ovarian Cancer AJCC v6 and v7\|Stage IIIA Primary Peritoneal Cancer AJCC v7\|Stage IIIA Uterine Sarcoma AJCC v7\|Stage IIIB Fallopian Tube Cancer AJCC v7\|Stage IIIB Ovarian Cancer AJCC v6 and v7\|Stage IIIB Primary Peritoneal Cancer AJCC v7\|Stage IIIB Uterine Sarcoma AJCC v7\|Stage IIIC Fallopian Tube Cancer AJCC v7\|Stage IIIC Ovarian Cancer AJCC v6 and v7\|Stage IIIC Primary Peritoneal Cancer AJCC v7\|Stage IIIC Uterine Sarcoma AJCC v7\|Stage IV Fallopian Tube Cancer AJCC v6 and v7\|Stage IV Ovarian Cancer AJCC v6 and v7\|Stage IV Primary Peritoneal Cancer AJCC v7\|Stage IVA Uterine Sarcoma AJCC v7\|Stage IVB Uterine Sarcoma AJCC v7\|Uterine Carcinosarcoma	NCT00954174
Pennsylvania	Bryn Mawr	United States\|Geisinger Medical Center	Bethlehem
Phase I Study of EOC202 Plus Paclitaxel in Chinese Patients With Metastatic Breast Cancer	Recruiting	Solid Tumor, Adult	NCT03600090
A Study of Gemcitabine and Demcizumab (OMP-21M18) With or Without AbraxaneÂ® as 1st-line Treatment in Subjects With Locally Advanced or Metastatic Pancreatic Cancer	Completed	Pancreatic Cancer	NCT01189929
A Study to Look at the Combination of Chemotherapy, Trastuzumab and RAD001 in HER2 Positive Breast Cancer	Withdrawn	Breast Cancer	NCT01163929
Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer	Completed	Carcinoma, Non-Small-Cell Lung	NCT00088556
Restenosis Following Paclitaxel Eluting Balloon Angioplasty of Hemodialysis Access Stenosis	Completed	Renal Failure	NCT01001676
Study of BMN-673 With Carboplatin and Paclitaxel in Patients With Advanced BRCA-mutated Solid Tumor or Triple Negative Metastatic Breast Cancer	Terminated	Triple Negative Metastatic Breast Cancer\|BRCA-mutated Solid Tumor	NCT02358200
A Study of MM-111 and Paclitaxel With Trastuzumab in Patients HER2 Positive Carcinomas of the Distal Esophagus, Gastroesophageal (GE) Junction and Stomach	Terminated	HER-2 Gene Amplification\|Esophagus Cancer\|Gastroesophageal Junction Cancer\|Stomach Cancer	NCT01774851
Ipatasertib and Carboplatin With or Without Paclitaxel in Treating Patients With Metastatic Triple Negative Breast Cancer	Recruiting	Anatomic Stage IV Breast Cancer AJCC v8\|Estrogen Receptor Negative\|HER2/Neu Negative\|Metastatic Triple-Negative Breast Carcinoma\|Progesterone Receptor Negative\|Prognostic Stage IV Breast Cancer AJCC v8	NCT03853707
Effect of All-trans Retinoic Acid With Chemotherapy Based on Paclitaxel and Cisplatin As First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer and Expression of RAR-alfa and RAR-beta as Response Biomarker	Unknown status	Non Small Cell Lung Cancer	NCT01041833
Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer	Recruiting	Endometrial Clear Cell Adenocarcinoma\|Endometrial Dedifferentiated Carcinoma\|Endometrial Endometrioid Adenocarcinoma\|Endometrial Mixed Cell Adenocarcinoma\|Endometrial Serous Adenocarcinoma\|Endometrial Undifferentiated Carcinoma\|Recurrent Endometrial Adenocarcinoma\|Recurrent Endometrial Carcinoma\|Recurrent Endometrial Clear Cell Adenocarcinoma\|Recurrent Endometrial Dedifferentiated Carcinoma\|Recurrent Endometrial Endometrioid Adenocarcinoma\|Recurrent Endometrial Mixed Cell Adenocarcinoma\|Recurrent Endometrial Serous Adenocarcinoma\|Recurrent Endometrial Undifferentiated Carcinoma\|Stage III Uterine Corpus Cancer AJCC v8\|Stage IIIA Uterine Corpus Cancer AJCC v8\|Stage IIIB Uterine Corpus Cancer AJCC v8\|Stage IIIC Uterine Corpus Cancer AJCC v8\|Stage IIIC1 Uterine Corpus Cancer AJCC v8\|Stage IIIC2 Uterine Corpus Cancer AJCC v8\|Stage IV Uterine Corpus Cancer AJCC v8\|Stage IVA Uterine Corpus Cancer AJCC v8\|Stage IVB Uterine Corpus Cancer AJCC v8	NCT03914612
Pazopanib (VOTRIENT) Plus Paclitaxel (TAXOL), Pazopanib Plus Paclitaxel (TAXOL) Plus Carboplatin (PARAPLATIN), and Pazopanib Plus Paclitaxel (TAXOL) Plus Lapatinib (TYKERB)	Completed	Neoplasms, Breast	NCT00388076
GANNET53: Ganetespib in Metastatic, p53-mutant, Platinum-resistant Ovarian Cancer	Terminated	Epithelial Ovarian Cancer\|Fallopian Tube Cancer\|Primary Peritoneal Cancer	NCT02012192
High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer	Withdrawn	Metastatic Pancreatic Cancer	NCT03797443
Paclitaxel Liposome for Squamous Non-Small-cell Lung Cancer Study(LIPUSU)	Active, not recruiting	Squamous Non-small-cell Lung Cancer	NCT02996214
A Randomized Phase II Trial of Gemcitabine and Nab-Paclitaxel vs Gemcitabine, Nab-Paclitaxel, Durvalumab and Tremelimumab as 1st Line Therapy in Metastatic Pancreatic Adenocarcinoma	Active, not recruiting	Pancreatic Adenocarcinoma	NCT02879318
Auranofin in Decreasing Pain in Patients With Paclitaxel-Induced Pain Syndrome	Completed	Pain	NCT02063698
Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastatic Breast Cancer	Completed	Estrogen Receptor-negative Breast Cancer\|HER2-negative Breast Cancer\|Progesterone Receptor-negative Breast Cancer\|Recurrent Breast Cancer\|Stage IV Breast Cancer\|Triple-negative Breast Cancer	NCT00733408
PD0332991/Paclitaxel in Advanced Breast Cancer	Active, not recruiting	Breast Cancer	NCT01320592
Study Of PF-03084014 In Combination With Gemcitabine And Nab-Paclitaxel In Patients With Metastatic Pancreatic Adenocarcinoma Not Previously Treated With Anticancer Therapies	Terminated	Metastatic Cancer Pancreas	NCT02109445
Paclitaxel Liposome and Cisplatin as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer	Withdrawn	Esophageal Cancer	NCT01998347
Trial of Paclitaxel/Bevacizumab +/- Everolimus for Patients With HER2-Negative Metastatic Breast Cancer	Completed	Metastatic Breast Cancer	NCT00915603
Paclitaxel-coated Balloons in Femoral Indication to Defeat Restenosis	Completed	Peripheral Artery Disease	NCT01083030
Efficacy and Safety Study of Trastuzumab, Paclitaxel and Carboplatin on HER2+ Preoperative Breast Cancer	Unknown status	Breast Cancer	NCT01170143
Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine in Treating Patients With Advanced Metastatic Solid Tumors	Completed	Unspecified Adult Solid Tumor, Protocol Specific	NCT00307255
Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary	Completed	Carcinoma of Unknown Primary Origin	NCT00936702
Phase II Clinical Trial of NIVO-IPI-TAXANE in Untreated Metastatic NSCLC	Recruiting	Non-small Cell Lung Cancer	NCT03573947
Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast Cancer	Completed	Breast Cancer	NCT00129922
Chemotherapy With Nab-paclitaxel/Germcitabine/Cisplatin +/- BGB324 With Pancreatic Cancer	Recruiting	Cancer of Pancreas	NCT03649321
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer	Active, not recruiting	Ovarian Cancer\|Fallopian Tube Cancer\|Peritoneal Neoplasms	NCT03038100
Trial of NanoPac Intratumoral Injection in Lung Cancer	Not yet recruiting	Lung Cancer, Nonsmall Cell\|Lung Cancer\|Lung Cancer, Small Cell\|Neoplasm of Lung	NCT04314895
A Randomized Phase 2 Study of Ixabepilone Plus Carboplatin and Paclitaxel Plus Carboplatin in Advanced Nonsmall-Cell Lung Cancer	Completed	Advanced/Metastatic Non-Small Cell Lung Cancer	NCT00723957
Gemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney Function	Completed	Distal Urethral Cancer\|Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter\|Proximal Urethral Cancer\|Recurrent Bladder Cancer\|Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter\|Recurrent Urethral Cancer\|Regional Transitional Cell Cancer of the Renal Pelvis and Ureter\|Stage III Bladder Cancer\|Stage IV Bladder Cancer\|Transitional Cell Carcinoma of the Bladder\|Urethral Cancer Associated With Invasive Bladder Cancer	NCT00478361
Mesothelin-Targeted Immunotoxin LMB-100 Alone or in Combination With Nab-Paclitaxel in People With Previously Treated Metastatic and/or Locally Advanced Pancreatic Ductal Adenocarcinoma and Mesothelin Expressing Solid Tumors	Active, not recruiting	Neoplasms\|Pancreatic Neoplasms	NCT02810418
Role of Intraperitoneal Intraoperative Chemotherapy With Paclitaxel in the Surgical Treatment of Peritoneal Carcinomatosis From Ovarian Cancer. Hyperthermia Versus Normothermia	Completed	Peritoneal Carcinomatosis	NCT02739698
A Safety and Efficacy of CCRT With Paclitaxel as Adjuvant Therapy to Post-Operative Advanced Endometrial Cancer Patients	Unknown status	Endometrial Cancer	NCT00373620
RIBS V (Restenosis Intra-stent of Bare Metal Stents: Paclitaxel-eluting Balloon vs Everolimus-eluting Stent)	Unknown status	In-Stent Restenosis	NCT01239953
Lower Dose Decitabine (DAC)-Primed TC (Carboplatin-Paclitaxel) Regimen in Ovary Cancer	Recruiting	Primary Malignant Neoplasm of Ovary\|FIGO Stages II to IV	NCT02159820
S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer	Completed	Adenocarcinoma of the Lung\|Adenosquamous Cell Lung Cancer\|Bronchoalveolar Cell Lung Cancer\|Large Cell Lung Cancer\|Recurrent Non-small Cell Lung Cancer\|Squamous Cell Lung Cancer\|Stage IIIB Non-small Cell Lung Cancer\|Stage IV Non-small Cell Lung Cancer	NCT00368992
RIBS IV (Restenosis Intra-stent of Drug-eluting Stents: Paclitaxel-eluting Balloon vs Everolimus-eluting Stent)	Unknown status	In-stent Restenosis	NCT01239940
HAI Abraxane With Gemcitabine and Bevacizumab	Completed	Advanced Cancers	NCT01057264
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer	Completed	Breast Cancer	NCT00662129
Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer	Active, not recruiting	Endometrial Adenocarcinoma\|Endometrial Clear Cell Adenocarcinoma\|Endometrial Serous Adenocarcinoma\|Endometrial Undifferentiated Carcinoma\|Recurrent Uterine Corpus Carcinoma\|Stage III Uterine Corpus Cancer AJCC v7\|Stage IIIA Uterine Corpus Cancer AJCC v7\|Stage IIIB Uterine Corpus Cancer AJCC v7\|Stage IIIC Uterine Corpus Cancer AJCC v7\|Stage IV Uterine Corpus Cancer AJCC v7\|Stage IVA Uterine Corpus Cancer AJCC v7\|Stage IVB Uterine Corpus Cancer AJCC v7	NCT02065687
Wisconsin	Wausau	United States\|Marshfield Clinic-Wausau Center	Waukesha
Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Uterine Cancer	Terminated	Stage IA Uterine Sarcoma\|Stage IB Uterine Sarcoma\|Stage IC Uterine Sarcoma\|Stage IIA Uterine Sarcoma\|Stage IIB Uterine Sarcoma\|Stage IIIA Uterine Sarcoma\|Stage IIIB Uterine Sarcoma\|Stage IIIC Uterine Sarcoma\|Stage IVA Uterine Sarcoma\|Stage IVB Uterine Sarcoma\|Uterine Carcinosarcoma	NCT01367301
Efficacy and Safety of Tislelizumab Combined With Bevacizumab and Albumin Paclitaxel in Lung Adenocarcinoma	Not yet recruiting	Lung Adenocarcinoma Stage IV	NCT04310943
A Study of Reolysin For Patients With Advanced/Metastatic Breast Cancer	Completed	Metastatic Breast Cancer	NCT01656538
Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors	Completed	Ovarian Sarcoma\|Ovarian Stromal Cancer\|Recurrent Endometrial Carcinoma\|Recurrent Ovarian Epithelial Cancer\|Recurrent Ovarian Germ Cell Tumor\|Stage III Endometrial Carcinoma\|Stage III Ovarian Epithelial Cancer\|Stage III Ovarian Germ Cell Tumor\|Stage IV Endometrial Carcinoma\|Stage IV Ovarian Epithelial Cancer\|Stage IV Ovarian Germ Cell Tumor\|Unspecified Adult Solid Tumor, Protocol Specific	NCT00408655
A Study of Fluzoparib Given in Combination With Apatinib and Paclitaxel in Gastric Cancer Patients	Unknown status	Recurrent and Metastatic Gastric Cancer	NCT03026881
FOLFOX-A in the Treatment of Metastatic or Advanced Unresectable Gastric, Gastro-Esophageal Junction Adenocarcinoma	Recruiting	Gastro-Esophageal Junction Adenocarcinoma\|Gastric Cancer	NCT03283761
Paclitaxel and Carboplatin Combination as 1st Line Treatment in Ovarian Carcinomas	Completed	Ovarian Cancer	NCT00750386
Study of Abraxane and Carboplatin to Treat Small Cell Lung Cancer	Terminated	Small Cell Lung Cancer	NCT00454324
A Trial of Oral BEZ235 and BKM120 in Combination With Paclitaxel With or Without Trastuzumab	Completed	Metastatic or Locally Advanced Solid Tumors	NCT01285466
Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery	Completed	Recurrent Melanoma\|Stage IV Melanoma	NCT00255762
Paclitaxel + Carboplatin With AVB-S6-500 in Women With Stage III or IV Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Receiving Neoadjuvant Chemotherapy	Not yet recruiting	Epithelial Ovarian Cancer\|Primary Peritoneal Carcinoma\|Fallopian Tube Cancer	NCT03607955
Balloon Elution and Late Loss Optimization (BELLO) Study	Unknown status	Coronary Artery Disease	NCT01086579
Hypofractionated Radiotherapy With Carboplatin and Paclitaxel in Non-Small Cell Lung Cancer	Recruiting	Non Small Cell Lung Cancer	NCT03699033
Weekly and Every 3 Week Administration of Paclitaxel Liposome Injection in Metastatic Breast Cancer	Unknown status	Breast Cancer	NCT02142790
CoStarâ„˘ Paclitaxel-Eluting Coronary Stent Catheter System Evaluation	Completed	Coronary Disease	NCT00422435
Prospective Study of VEGFR-2 /IL-8 Genetic Interaction in MBC Treated With Paclitaxel and Bevacizumab vs. Chemotherapy	Unknown status	Metastatic Breast Cancer	NCT02329639
Selective Inhibitor of Nuclear Export, Selinexor (KPT-330) in Combination With Paclitaxel and Carboplatin in Patients With Advanced Ovarian or Endometrial Cancers	Recruiting	Ovarian Cancer\|Endometrial Cancer	NCT02269293
Paclitaxel Plus Carboplatin With or Without Endostar in Patients With Advanced Non-small Cell Lung Cancer	Completed	Advanced Non-small Cell Lung Cancer	NCT00708812
Phase I Trial of Bevacizumab and Temsirolimus in Combination With 1) Carboplatin, 2) Paclitaxel, 3) Sorafenib for the Treatment of Advanced Cancer	Active, not recruiting	Advanced Cancer	NCT01187199
RCT of Paclitaxel DEB Compared to Standard PTA in Dialysis Fistula	Unknown status	Complication of Hemodialysis\|Vascular Access Complication	NCT02558153
Gemcitabine Hydrochloride, Cisplatin, and Nab-Paclitaxel in Treating Patients With Advanced or Metastatic Biliary Cancers	Active, not recruiting	Stage III Intrahepatic Cholangiocarcinoma AJCC v7\|Stage IIIA Gallbladder Cancer AJCC v7\|Stage IIIB Gallbladder Cancer AJCC v7\|Stage IVA Gallbladder Cancer AJCC v7\|Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7\|Stage IVB Gallbladder Cancer AJCC v7\|Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7\|Unresectable Extrahepatic Bile Duct Carcinoma\|Unresectable Gallbladder Carcinoma	NCT02392637
A Phase 1b Study of Paclitaxel And Ricolinostat For The Treatment Of Gynecological Cancer	Terminated	Ovarian Cancer\|Fallopian Tube Cancer\|Primary Peritoneal Carcinoma	NCT02661815
Trial of NanoPac Focal Therapy for Prostate Cancer	Not yet recruiting	Prostate Cancer\|Prostate Adenocarcinoma\|Prostate Cancer Adenocarcinoma\|Prostatic Neoplasm\|Urogenital Neoplasms\|Genital Neoplasms, Male\|Localized Cancer	NCT04221828
Comparison of the Rangerâ„˘ Paclitaxel-Coated PTA Balloon Catheter and Uncoated PTA Balloons in Femoropopliteal Arteries	Completed	Peripheral Artery Disease\|Claudication\|Atherosclerosis\|Arteriosclerosis	NCT02013193
Phase I Study in Patients With Solid Tumours	Completed	Neoplasms	NCT00496028
S1+ Paclitaxel (IV&IP) + Bevacizumab (IP) Versus S1+Oxaliplatin as First-line Treatment in Gastric Cancer With Malignant Ascites	Recruiting	Metastatic Gastric Adenocarcinoma	NCT03990103
Safety and Efficacy Study of Vintafolide and Vintafolide Plus Paclitaxel Compared to Paclitaxel Alone in Participants With Triple Negative Breast Cancer (TNBC) (MK-8109-004)	Withdrawn	Breast Neoplasms	NCT01953536
Breast Cancer Study: Paclitaxel Versus Paclitaxel Plus Sorafenib in Second- or Third-line Treatment	Completed	Metastatic Breast Cancer	NCT01320111
Phase I Trial of Paclitaxel With Perifosine	Completed	Neoplasms	NCT00399126
Paclitaxel Plus Radiation Therapy in Treating Women With Stage II or Stage III Breast Cancer	Active, not recruiting	Breast Cancer	NCT00006256
Lapatinib Ditosylate, Trastuzumab, Paclitaxel, and Surgery in Treating Patients With Breast Cancer	Completed	HER2-positive Breast Cancer\|Stage II Breast Cancer\|Stage IIIA Breast Cancer	NCT01688609
Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Unresectable, Metastatic Cancer of the Esophagus or Gastroesophageal Junction	Completed	Esophageal Cancer	NCT00107341
Phase I/II Study of Nab-paclitaxel and Gemcitabine Followed by AG-mFOLFOX in Patients With Metastatic Pancreatic Adenocarcinoma	Active, not recruiting	Metastatic Pancreatic Adenocarcinoma	NCT02504333
A Study of Cobimetinib Plus Paclitaxel, Cobimetinib Plus Atezolizumab Plus Paclitaxel, or Cobimetinib Plus Atezolizumab Plus Nab-Paclitaxel as Initial Treatment for Participants With Triple-Negative Breast Cancer That Has Spread	Active, not recruiting	Breast Cancer	NCT02322814
Ipilimumab With Carboplatin and Paclitaxel in Patients With Unresectable Stage III and Stage IV Melanoma	Active, not recruiting	Untreated Stage III Melanoma or Stage IV Melanoma	NCT01676649
Outcome of Cisplatin and Vinblastine Versus Paclitaxel and Carboplatin as Sequential Chemotherapy Followed by Radiotherapy in Locally Advanced Non-small Cell Lung Cancer	Completed	Carcinoma, Non-Small-Cell Lung	NCT03092986
A Phase III Study of Comparing Paclitaxel Plus 5-Fluorouracil Versus Cisplatin Plus 5-Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Carcinoma	Completed	Esophageal Squamous Cell Carcinoma	NCT01591135
Impact of Pegfilgrastim on Trastuzumab Anti-tumor Effect and ADCC in Operable HER2+ Breast Cancer Breast Cancer	Recruiting	HER2-positive Breast Cancer\|Operable Breast Cancer	NCT03571633
Cetuximab, Paclitaxel, Carboplatin & Radiation for Esoph, Gastroesoph & Gastric Cancer	Completed	Esophageal Cancer\|Gastric Cancer	NCT00439608
Paclitaxel Balloon Versus Standard Balloon in In-stent Restenoses of the Superficial Femoral Artery (PACUBA I Trial)	Unknown status	Peripheral Arterial Disease	NCT01247402
Phase II Trial of Standard Chemotherapy (Carboplatin & Paclitaxel) +Various Proton Beam Therapy (PBT) Doses	Recruiting	Non Small Cell Lung Cancer	NCT03132532
A Pharmacogenomics Study for Breast Cancer Patients Undergoing Adjuvant Chemotherapy With Doxorubicin (A)/Cyclophosphamide Â©) and/or Weekly Paclitaxel	Completed	Breast Cancer	NCT00131963
Vorinostat, Carboplatin, and Paclitaxel in Treating Patients With Advanced or Metastatic Non-Small Cell Lung Cancer	Completed	Recurrent Non-small Cell Lung Cancer\|Stage IIIB Non-small Cell Lung Cancer\|Stage IV Non-small Cell Lung Cancer	NCT00481078
Drug-Drug Interaction - 3 Arm - Carboplatin/Paclitaxel, Dacarbazine	Completed	Advanced Melanoma	NCT00796991
Neoadjuvant 5-fluorouracil, Epirubicin and Cyclophosphamide (FEC) Followed by Weekly Paclitaxel and Trastuzumab in Her2 Positive Breast Cancer	Active, not recruiting	HER-2 Positive Breast Cancer	NCT01340430
Adjuvant Chemotherapy for Elderly Non Frail Patients With an Increased Risk for Relapse of a Primary Carcinoma of the Breast	Completed	Breast Cancer	NCT01204437
Nab-Paclitaxel and Bevacizumab or Ipilimumab as First-Line Therapy in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery	Completed	Metastatic Melanoma\|Mucosal Melanoma\|Stage IV Cutaneous Melanoma AJCC v6 and v7\|Stage IV Uveal Melanoma AJCC v7\|Unresectable Melanoma	NCT02158520
High Dose Ascorbic Acid and Nanoparticle Paclitaxel Protein Bound and Cisplatin and Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer	Withdrawn	Metastatic Pancreatic Cancer\|Pancreatic Cancer\|Pancreas Cancer\|Pancreatic Adenocarcinoma Resectable\|Pancreatic Ductal Adenocarcinoma\|Pancreatic Metastasis	NCT03908333
Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung Cancer	Recruiting	Carcinoma, Non-Small-Cell Lung\|Squamous Cell Carcinoma	NCT03802058
First-line Everolimus +/- Paclitaxel for Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma	Terminated	Transitional Cell Carcinoma\|Bladder Carcinoma\|Urothelial Carcinoma	NCT01215136
A Safety and Efficacy Study of BCD-021 With Paclitaxel and Carboplatin Compared to Avastin With Paclitaxel and Carboplatin in Non-Small Cell Lung Cancer	Completed	Non-small Cell Lung Cancer	NCT01763645
Therapy With Abraxane and 5-Fluorouracil, Epirubicin, Cyclophosphamide (FEC) for Patients With Breast Cancer	Completed	Breast Neoplasms	NCT00110695
Evaluation of Cetuximab (ERBITUX) and Concurrent Carboplatin, Paclitaxel & Radiotherapy in the Management of Patients With Advanced Locoregional Squamous Cell Carcinomas of the Head and Neck (GCC 0442)	Completed	Cancer of Head and Neck	NCT00343083
Cetuximab, Carboplatin, and Paclitaxel Followed by Radiation Therapy, With or Without Cisplatin, in Treating Patients With Metastatic Head and Neck Cancer	Completed	Head and Neck Cancer	NCT00301028
Japanese Study of Ipilimumab Administered in Combination With Paclitaxel/Carboplatin in Patients With Nonsmall-cell Lung Cancer	Completed	Non-Small Cell Lung Cancer	NCT01165216
Comparison of the Conor Sirolimus-eluting Coronary Stent to the Taxus Liberte Paclitaxel-eluting Coronary Stent in the Treatment of Coronary Artery Lesions	Terminated	Coronary Atherosclerosis	NCT00606333
Durvalumab Plus Tremelimumab Combination Immunotherapy With or Without Weekly Paclitaxel in Patients With Advanced Biliary Tract Carcinoma (BTC) After Failure of Platinum-based Chemotherapy	Recruiting	Advanced Biliary Tract Carcinoma	NCT03704480
Paclitaxel-coated Peripheral Stents Used in the Treatment of Femoropopliteal Stenoses	Active, not recruiting	Peripheral Arterial Disease (PAD)	NCT02936622
Cetuximab in Combination With Paclitaxel Plus Cisplatin Versus Paclitaxel Plus Cisplatin Alone for the First-line Treatment of Metastatic Esophageal Squamous Cell Carcinoma	Recruiting	Esophageal Cancer, Squamous Cell\|Cetuximab Effect\|Chemotherapy Effect	NCT03126708
A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment	Recruiting	Metastatic Adenocarcinoma of the Pancreas	NCT04083235
Efficacy Study of REOLYSINÂ® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck Cancers	Completed	Carcinoma, Squamous Cell of the Head and Neck	NCT01166542
High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer	Withdrawn	Metastatic Pancreatic Cancer\|Pancreatic Cancer\|Pancreas Cancer\|Pancreatic Adenocarcinoma Resectable\|Pancreatic Ductal Adenocarcinoma\|Pancreatic Metastasis	NCT03697239
Paclitaxel Eluting Balloon and Conventional Balloon for In-Stent Restenosis of the Superficial Femoral Artery	Unknown status	Peripheral Vascular Disease	NCT01083394
Paclitaxel, Carboplatin and Gemcitabine in the Treatment of Patients With Advanced Transitional Cell Cancer of the Bladder	Completed	Bladder Cancer	NCT00136175
Efficacy and Safety of the Paclitaxel Eluting Covered Biliary Stent to the Common Covered Metallic Biliary Stent	Terminated	Biliary Stricture\|Malignant Neoplasms	NCT01413386
Taxoprexin Plus Carboplatin Treatment for Advanced Lung Cancer	Completed	Non-Small Cell Lung Cancer	NCT00243867
Neoadjuvant Chemotherapy of Nimotuzumab Plus Nab-Paclitaxel in Squamous Cell Carcinoma of Esophagus	Withdrawn	Squamous Cell Carcinoma of Esophagus	NCT02041819
Trial of Best Supportive Care and Either Cisplatin or Paclitaxel to Treat Patients With Primary Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer and Inoperable Malignant Bowel Obstruction	Terminated	Ovarian Cancer\|Peritoneal Cancer\|Fallopian Tube Cancer\|Bowel Obstruction	NCT01083537
Combination of Weekly Paclitaxel With Neratinib and Trastuzumab in Women With Metastatic HER2-positive Breast Cancer	Completed	Breast Cancer	NCT01423123
Nab-pacliatxel Plus Gemcitabine in Korean Patients With Metastatic Pancreatic Ductal Adenocarcinoma	Recruiting	Pancreatic Ductal Adenocarcinoma	NCT02426281
Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive Women	Not yet recruiting	Cervical Adenocarcinoma\|Cervical Adenosquamous Carcinoma\|Cervical Squamous Cell Carcinoma, Not Otherwise Specified\|FIGO Stage IIB Cervix Carcinoma\|FIGO Stage III Cervix Carcinoma\|FIGO Stage IVA Cervix Carcinoma\|HIV Infection	NCT03834571
Paclitaxel in Advanced Refractory Kaposi's Sarcoma (AIDS-KS): A Phase II Trial of Paclitaxel From Baker Norton Pharmaceuticals	Completed	Sarcoma, Kaposi\|HIV Infections	NCT00002189
Evaluation of Votrient in Angiosarcoma	Unknown status	Angiosarcoma	NCT02212015
A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse Treatment	Completed	Ovarian Cancer\|Epithelial Ovarian Cancer\|Fallopian Tube Cancer\|Bladder Cancer	NCT00421889
NUVOLA TRIAL Open-label Multicentre Study	Recruiting	High Grade Serous Ovarian Cancer	NCT04261465
MCS110 Combined With Neoadjuvant Doxorubicin, Cyclophosphamide, and Weekly Paclitaxel in Patients With Hormone-Receptor Positive and HER2- Breast Cancer	Withdrawn	Breast Cancer\|Cancer of Breast	NCT03285607
Split-course Thoracic Radiotherapy Combined With Nab-paclitaxel Plus Nedaplatin for Local Advanced NSCLC With Impaired Baseline Pulmonary Function	Recruiting	Non-small Cell Lung Cancer	NCT04212052
Vorinostat, Paclitaxel, and Carboplatin in Treating Patients With Advanced or Refractory Solid Tumors	Completed	Unspecified Adult Solid Tumor, Protocol Specific	NCT00287937
A Phase II Study of Paclitaxel and Carboplatin in Patients With an Elevated-Risk Cancer of the Uterus	Terminated	Uterine Cancer	NCT00584909
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas	Completed	Metastatic Pancreatic Cancer	NCT00844649
Weekly Paclitaxel Liposome Injection Plus Cisplatin in Preoperative Treatment of Breast Cancer	Unknown status	Breast Cancer	NCT02142010
Taxol Epirubicin Cyclophosphamide Herceptin Neoadjuvant (TECHNO)	Completed	Breast Cancer	NCT00795899
Identifying Genetic Markers That Predict Response to Paclitaxel in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer	Terminated	Ovarian Cancer\|Peritoneal Cavity Cancer	NCT00897806
Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast Cancer	Completed	Breast Cancer	NCT00680758
Phase II Study of Preoperative FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel in Patients With Resectable Pancreatic Cancer	Terminated	Resectable Pancreatic Cancer\|Pancreatic Ductal Carcinoma	NCT02243007
Study of REOLYSINÂ® in Combination With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma	Completed	Metastatic Melanoma	NCT00984464
Combination Chemotherapy With Sildenafil Plus Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer	Completed	Non-small Cell Lung Cancer	NCT00752115
Topotecan and Paclitaxel in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer	Completed	Lung Cancer	NCT00003281
Gemcitabine/Abraxane Chemotherapy and Dose Escalated Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer	Terminated	Pancreatic Cancer	NCT01693276
Study of Weekly Paclitaxel With Ramucirumab in Participants With Advanced Gastric Adenocarcinomas	Completed	Adenocarcinoma	NCT01253525
Evaluation of Plasma Alcohol Concentration in Patients Receiving Paclitaxel or Docetaxel	Completed	Tumors	NCT01448759
ENGOT-cx1/BGOG-cx1: 3 Weekly Carboplatin/Paclitaxel With or Without Nintedanib in Cervix Cancer	Active, not recruiting	Uterine Cervical Neoplasms	NCT02009579
Investigating Safety, Tolerability and Efficacy of AZD5363 When Combined With Paclitaxel in Breast Cancer Patients	Active, not recruiting	Advanced or Metastatic Breast Cancer\|ER+ve Advanced or Metastatic Breast Cancer	NCT01625286
CT-2103/Carboplatin vs Paclitaxel/Carboplatin for NSCLC in Women With Estradiol > 25 pg/mL	Unknown status	NSCLC	NCT00576225
A Study of Carboplatin-Paclitaxel/Nab-Paclitaxel Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With First Line Metastatic Squamous Non-small Cell Lung Cancer (MK-3475-407/KEYNOTE-407)-China Extension Study	Active, not recruiting	Non-small Cell Lung Cancer	NCT03875092
Treatment of in-Stent Restenosis by Paclitaxel Coated PTCA Balloons (PACCOCATH â€“ ISR II)	Completed	Coronary Restenosis	NCT00409981
A Study of KN046 in Subjects With Locally Advanced or Metastatic Triple-negative Breast Cancer	Recruiting	Triple-negative Breast Cancer	NCT03872791
Pharmacokinetic Study of Drug-coated Angioplasty Balloons in the Superficial Femoral or Popliteal Arteries:	Completed	Peripheral Artery Disease	NCT01912937
Real-world Evidence Prospective Study on the Effect of Nab-paclitaxel Treatment on the Clinical Outcomes and HRQoL in Patients With MBC in Greece	Completed	Metastatic Breast Cancer	NCT02626013
Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III-IV Clear Cell Ovarian Cancer	Completed	Ovarian Clear Cell Cystadenocarcinoma\|Stage III Ovarian Cancer\|Stage IV Ovarian Cancer	NCT01196429
Combination Of Lapatinib With Carboplatin, Paclitaxel, and With or Without Trastuzumab In Metastatic Breast Cancer.	Completed	Neoplasms, Breast	NCT00367471
A Study of REOLYSINÂ® in Combination With Paclitaxel and Carboplatin in Patients With Squamous Cell Carcinoma of the Lung	Completed	Metastatic or Recurrent Squamous Cell Carcinoma of the Lung	NCT00998192
A Phase III Study of NK105 in Patients With Breast Cancer	Completed	Breast Cancer Nos Metastatic Recurrent	NCT01644890
Study of CP-751,871 in Combination With Carboplatin and Paclitaxel in Advanced Lung Cancer	Completed	Carcinoma, Non-Small-Cell Lung	NCT00603538
A Safety and Efficacy of CCRT With Paclitaxel/Carboplatin as Adjuvant Therapy to Post-operative Cervical Cancer Patients	Completed	Cervical Cancer	NCT00340184
Effect of Pembrolizumab With or Without Carboplatin and Paclitaxel on Immune Response in Patients With Recurrent or Stage IIIB-IV Non-small Cell Lung Cancer	Active, not recruiting	Recurrent Non-Small Cell Lung Carcinoma\|Stage IIIB Non-Small Cell Lung Cancer\|Stage IV Non-Small Cell Lung Cancer	NCT02581943
Trial of Carboplatin/Paclitaxel/Cetuximab in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)	Completed	Non-small Cell Lung Cancer	NCT00097227
Paclitaxel Compared With Doxorubicin in Treating Patients With Advanced AIDS-Related Kaposi's Sarcoma	Completed	AIDS-related Kaposi Sarcoma	NCT00003350
Abraxane and Lapatinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer	Completed	Breast Cancer	NCT00331630
Bevacizumab, Paclitaxel, Carboplatin, and Radiation Therapy to the Chest in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer	Terminated	Adenocarcinoma of the Lung\|Bronchoalveolar Cell Lung Cancer\|Large Cell Lung Cancer\|Stage II Non-small Cell Lung Cancer\|Stage IIIA Non-small Cell Lung Cancer\|Stage IIIB Non-small Cell Lung Cancer	NCT00369551
Glutamine in Preventing Myalgia and/or Arthralgia in Patients Who Are Receiving Paclitaxel For Cancer	Terminated	Pain\|Unspecified Adult Solid Tumor, Protocol Specific	NCT00217724
Safety and Efficacy of Angiotech Vascular Wrap Paclitaxel-Eluting Mesh for Hemodialysis Vascular Access	Terminated	Kidney Diseases\|ESRD	NCT00448708
Clinical Trial of the Combination of Intravenous Alvespimycin (KOS-1022), Trastuzumab With or Without Paclitaxel in Patients With Advanced Solid Tumor Malignancies or Her2 Positive Metastatic Breast Cancer Who Have Previously Failed Trastuzumab Therapy	Completed	Solid Tumor\|Breast Cancer	NCT00803556
Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Investigator's Choice of Standard Chemotherapy in Subjects Receiving First Cytotoxic Chemotherapy for Metastatic or Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC) and Who Are Current or Former Smokers	Completed	Non-squamous Non-small Cell Lung Cancer	NCT02264990
Paclitaxel Coated PTA Balloons for Treatment of Dysfunctional AV Fistulae and Grafts	Withdrawn	Dysfunctional AV Graft\|Dysfunctional AV Fistula	NCT02183194
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma	Completed	Melanoma (Skin)	NCT00976573
A Trial of Paclitaxel and Bevacizumab vs. Gemcitabine, Paclitaxel, and Bevacizumab in Advanced Breast Cancer	Completed	Breast Cancer	NCT00320541
A Study to Evaluate Lumretuzumab in Combination With Pertuzumab and Paclitaxel in Participants With Metastatic Breast Cancer Expressing Human Epidermal Growth Factor Receptor (HER) 3 and HER2 Protein	Completed	Breast Cancer	NCT01918254
Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM)	Recruiting	Pancreatic Cancer\|Pancreas Cancer\|Pancreatic Adenocarcinoma Resectable\|Pancreatic Ductal Adenocarcinoma\|Pancreas Metastases	NCT03410030
Estramustine, Etoposide and Paclitaxel Treatment for Hormonally Responsive Adenocarcinoma of the Prostate	Completed	Prostate Cancer	NCT00151060
RAmucirumab Combined wIth Standard Nab-paclitaxel and Gemcitabine as First-line Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma	Recruiting	Pancreatic Adenocarcinoma	NCT03745430
A Phase IIclinical Trial of Carboplatin and Paclitaxel or Carboplatin and Gemcitabine in Platinum-sensitive, Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer	Unknown status	Fallopian Tube Cancer\|Ovarian Cancer\|Primary Peritoneal Cancer	NCT01570582
Gossypol, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery	Completed	Adult Grade III Lymphomatoid Granulomatosis\|Adult Nasal Type Extranodal NK/T-cell Lymphoma\|Contiguous Stage II Adult Burkitt Lymphoma\|Contiguous Stage II Adult Diffuse Large Cell Lymphoma\|Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma\|Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma\|Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma\|Contiguous Stage II Adult Lymphoblastic Lymphoma\|Contiguous Stage II Grade 1 Follicular Lymphoma\|Contiguous Stage II Grade 2 Follicular Lymphoma\|Contiguous Stage II Grade 3 Follicular Lymphoma\|Contiguous Stage II Mantle Cell Lymphoma\|Contiguous Stage II Marginal Zone Lymphoma\|Contiguous Stage II Small Lymphocytic Lymphoma\|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue\|Nodal Marginal Zone B-cell Lymphoma\|Noncontiguous Stage II Adult Burkitt Lymphoma\|Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma\|Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma\|Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma\|Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma\|Noncontiguous Stage II Adult Lymphoblastic Lymphoma\|Noncontiguous Stage II Grade 1 Follicular Lymphoma\|Noncontiguous Stage II Grade 2 Follicular Lymphoma\|Noncontiguous Stage II Grade 3 Follicular Lymphoma\|Noncontiguous Stage II Mantle Cell Lymphoma\|Noncontiguous Stage II Marginal Zone Lymphoma\|Noncontiguous Stage II Small Lymphocytic Lymphoma\|Peripheral T-cell Lymphoma\|Recurrent Adult Burkitt Lymphoma\|Recurrent Adult Diffuse Large Cell Lymphoma\|Recurrent Adult Diffuse Mixed Cell Lymphoma\|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma\|Recurrent Adult Grade III Lymphomatoid Granulomatosis\|Recurrent Adult Immunoblastic Large Cell Lymphoma\|Recurrent Adult Lymphoblastic Lymphoma\|Recurrent Grade 1 Follicular Lymphoma\|Recurrent Grade 2 Follicular Lymphoma\|Recurrent Grade 3 Follicular Lymphoma\|Recurrent Mantle Cell Lymphoma\|Recurrent Marginal Zone Lymphoma\|Recurrent Small Lymphocytic Lymphoma\|Splenic Marginal Zone Lymphoma\|Stage I Adult Burkitt Lymphoma\|Stage I Adult Diffuse Large Cell Lymphoma\|Stage I Adult Diffuse Mixed Cell Lymphoma\|Stage I Adult Diffuse Small Cleaved Cell Lymphoma\|Stage I Adult Immunoblastic Large Cell Lymphoma\|Stage I Adult Lymphoblastic Lymphoma\|Stage I Grade 1 Follicular Lymphoma\|Stage I Grade 2 Follicular Lymphoma\|Stage I Grade 3 Follicular Lymphoma\|Stage I Mantle Cell Lymphoma\|Stage I Marginal Zone Lymphoma\|Stage I Small Lymphocytic Lymphoma\|Stage III Adult Burkitt Lymphoma\|Stage III Adult Diffuse Large Cell Lymphoma\|Stage III Adult Diffuse Mixed Cell Lymphoma\|Stage III Adult Diffuse Small Cleaved Cell Lymphoma\|Stage III Adult Immunoblastic Large Cell Lymphoma\|Stage III Adult Lymphoblastic Lymphoma\|Stage III Grade 1 Follicular Lymphoma\|Stage III Grade 2 Follicular Lymphoma\|Stage III Grade 3 Follicular Lymphoma\|Stage III Mantle Cell Lymphoma\|Stage III Marginal Zone Lymphoma\|Stage III Small Lymphocytic Lymphoma\|Stage IV Adult Burkitt Lymphoma\|Stage IV Adult Diffuse Large Cell Lymphoma\|Stage IV Adult Diffuse Mixed Cell Lymphoma\|Stage IV Adult Diffuse Small Cleaved Cell Lymphoma\|Stage IV Adult Immunoblastic Large Cell Lymphoma\|Stage IV Adult Lymphoblastic Lymphoma\|Stage IV Grade 1 Follicular Lymphoma\|Stage IV Grade 2 Follicular Lymphoma\|Stage IV Grade 3 Follicular Lymphoma\|Stage IV Mantle Cell Lymphoma\|Stage IV Marginal Zone Lymphoma\|Stage IV Small Lymphocytic Lymphoma\|Unspecified Adult Solid Tumor, Protocol Specific\|WaldenstrĂ¶m Macroglobulinemia	NCT00891072
Paclitaxel, Carboplatin and Radiotherapy as Induction Therapy in Locally Advanced Head and Neck Cancer	Completed	Squamous Cell Carcinoma	NCT00176254
A Dose-escalation Study of Ombrabulin in Combination With Paclitaxel and Carboplatin in Patients With Advanced Solid Tumors	Completed	Advanced Solid Tumors	NCT01293630
Pregabalin in Preventing Acute Pain Syndrome in Patients Receiving Paclitaxel	Completed	Pain\|Peripheral Neuropathy	NCT01637077
Pharmacokinetic, Safety and Efficacy Study of Nanoparticle Paclitaxel in Patients With Peritoneal Cancers	Completed	Peritoneal Neoplasms	NCT00666991
Cisplatin and Paclitaxel With or Without Everolimus in Treating Patients With Stage II or Stage III Breast Cancer	Completed	Breast Cancer	NCT00930930
Abraxane in Patients With Visceral Metastases Dominant Metastatic Breast Cancer	Recruiting	Metastatic Breast Cancer	NCT02687490
Zotarolimus-Eluting Stent Versus Sirolimus-Eluting Stent and PacliTaxel-Eluting Stent for Coronary Lesions	Completed	Coronary Artery Disease	NCT00418067
A Study of MEHD7945A in Combination With Cisplatin and 5-Fluorouracil (5-FU) or Paclitaxel and Carboplatin in Participants With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN)	Completed	Head and Neck Cancer	NCT01911598
Treatment of in-Stent Restenosis by Paclitaxel Coated PTCA Balloons (PACCOCATH â€“ ISR I)	Completed	Coronary Restenosis	NCT00106587
Trial of AZD5363 Plus Paclitaxel /AZD2014 Plus Paclitaxel in Biomarker Negative (PIK3CA/MEK/RAS/TP53/MET) Gastric Adenocarcinoma Patients as Second-line Chemotherapy	Terminated	Advanced Gastric Adenocarcinoma	NCT02449655
Study Evaluating Safety And Tolerability, Solid Tumor	Completed	Advanced Malignant Solid Tumors	NCT00768469
Study of CB-839 in Combination w/ Paclitaxel in Patients of African Ancestry and Non-African Ancestry With Advanced TNBC	Completed	Triple Negative Breast Cancer\|TNBC - Triple-Negative Breast Cancer	NCT03057600
A Phase II Study of Abraxane Gemcitabine Combination in Patients With Metastatic Breast Cancer	Completed	Metastatic Breast Cancer	NCT01550848
Study of SBP-101 Combined With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer	Recruiting	Pancreatic Cancer Metastatic\|Pancreatic Cancer Stage IV\|Stage IV Pancreatic Cancer	NCT03412799
Combination Study Of CP-751,871 With Paclitaxel And Carboplatin In Advanced Lung Cancer	Completed	Carcinoma, Non-Small-Cell Lung	NCT00147537
PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic Cancer	Completed	Metastatic Pancreatic Cancer	NCT01839487
A Study of Mycobacterium w in Combination With Paclitaxel Plus Cisplatin in Advanced Non Small Cell Lung Cancer	Completed	Non Small Cell Lung Cancer	NCT00680940
Neoadjuvant Paclitaxel Poliglumex, Cisplatin and Radiation for Esophageal Cancer: A Phase II Trial (CTI#X64001)	Completed	Esophageal Cancer	NCT00522795
Topotecan, Paclitaxel, and Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer	Completed	Lung Cancer	NCT00004055
Phase I and Pharmacokinetic Trial of Paclitaxel (Taxol) Given as a 3-Hour Infusion in Pediatric Patients With Refractory Malignancy	Completed	Neoplasms	NCT00001387
Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer	Completed	Breast Cancer	NCT00041119
United States\|Providence Cancer Center at Providence Portland Medical Center	Oregon	Portland	Oregon
Comparison of Neoadjuvant Chemotherapy With Weekly Paclitaxel or Eribulin Followed by A/C in Women With Locally Advanced HER2-Negative Breast Cancer	Completed	Breast Cancer\|HER2-negative Breast Cancer	NCT01705691
Phase II NCT (Neoadjuvant Chemotherapy) w/ Weekly Abraxane in Combination With Carboplatin & Bevacizumab in Breast Cancer	Completed	Breast Cancer	NCT00675259
Paclitaxel and Bavituximab in Treating Patients With HER2-Negative Metastatic Breast Cancer	Completed	Human Epidermal Growth Factor 2 Negative Carcinoma of Breast\|Male Breast Cancer\|Recurrent Breast Cancer\|Stage IIIC Breast Cancer\|Stage IV Breast Cancer	NCT01288261
P E P C A D II, The Paclitaxel-Eluting PTCA-Balloon Catheter in Coronary Artery Disease to Treat In-Stent Restenoses	Completed	In-Stent Restenosis	NCT00393315
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers	Not yet recruiting	Metastatic Small Intestinal Adenocarcinoma\|Stage III Small Intestinal Adenocarcinoma AJCC v8\|Stage IIIA Small Intestinal Adenocarcinoma AJCC v8\|Stage IIIB Small Intestinal Adenocarcinoma AJCC v8\|Stage IV Small Intestinal Adenocarcinoma AJCC v8	NCT04205968
Panitumumab, Paclitaxel, Carboplatin and 5FU in the Treatment of Potentially Resectable Gastroesophageal Adenocarcinoma	Terminated	Gastroesophageal Adenocarcinoma\|Adenocarcinoma of the Distal Esophagus\|Adenocarcinomas of the Gastroesophageal Junction\|Adenocarcinoma of the Proximal Stomach	NCT01182610
Stromal TARgeting for PAncreatic Cancer (STAR_PAC)	Completed	Pancreatic Adenocarcinoma	NCT03307148
Paclitaxel + Carboplatin + Durvalumab With or Without Oleclumab for Previously Untreated Locally Recurrent Inoperable or Metastatic TNBC	Recruiting	Triple Negative Breast Cancer	NCT03616886
Paclitaxel (Albumin Bound),Bleomycin And Cisplatin Or Carboplatin for Recurrent Or Metastatic Squamous Cell Carcinoma Of The Head And Neck	Recruiting	Squamous Cell Carcinoma Of The Head And Neck	NCT03830385
A Study of Avastin (Bevacizumab) in Combination With Taxane-based Chemotherapy as First Line Treatment in Patients With HER-2 Negative Breast Cancer	Completed	Breast Cancer	NCT00846027
Acute Pain Caused by Paclitaxel in Patients With Cancer	Completed	Chemotherapeutic Agent Toxicity\|Neurotoxicity\|Pain\|Unspecified Adult Solid Tumor, Protocol Specific	NCT00860041
Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2	Active, not recruiting	Breast Cancer	NCT01593020
Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer	Active, not recruiting	Fallopian Tube Clear Cell Adenocarcinoma\|Fallopian Tube Endometrioid Adenocarcinoma\|Fallopian Tube Mucinous Adenocarcinoma\|Fallopian Tube Serous Adenocarcinoma\|Fallopian Tube Transitional Cell Carcinoma\|Fallopian Tube Undifferentiated Carcinoma\|Ovarian Brenner Tumor\|Ovarian Clear Cell Adenocarcinoma\|Ovarian Endometrioid Adenocarcinoma\|Ovarian Mucinous Adenocarcinoma\|Ovarian Seromucinous Carcinoma\|Ovarian Serous Adenocarcinoma\|Ovarian Transitional Cell Carcinoma\|Ovarian Undifferentiated Carcinoma\|Primary Peritoneal Serous Adenocarcinoma\|Stage IIIA Fallopian Tube Cancer AJCC v7\|Stage IIIA Ovarian Cancer AJCC v6 and v7\|Stage IIIA Primary Peritoneal Cancer AJCC v7\|Stage IIIB Fallopian Tube Cancer AJCC v7\|Stage IIIB Ovarian Cancer AJCC v6 and v7\|Stage IIIB Primary Peritoneal Cancer AJCC v7\|Stage IIIC Fallopian Tube Cancer AJCC v7\|Stage IIIC Ovarian Cancer AJCC v6 and v7\|Stage IIIC Primary Peritoneal Cancer AJCC v7\|Stage IV Fallopian Tube Cancer AJCC v6 and v7\|Stage IV Ovarian Cancer AJCC v6 and v7\|Stage IV Primary Peritoneal Cancer AJCC v7	NCT00108745
Paclitaxel and CBT-1(Registered Trademark) to Treat Solid Tumors	Completed	Cervical\|Ovarian\|Lung\|Breast\|Renal	NCT00972205
Study of Ibrutinib vs Placebo, in Combination With Nab-paclitaxel and Gemcitabine, in the First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma (RESOLVE)	Completed	Metastatic Pancreatic Adenocarcinoma	NCT02436668
Calcium and Magnesium Infusion for the Prevention of Taxane Induced Neuropathy	Completed	Paclitaxel-induced Neuropathy	NCT01682499
ErbB2 Over-expressing Metastatic Breast Cancer Study Using Paclitaxel, Trastuzumab, and Lapatinib	Completed	Neoplasms, Breast	NCT00272987
A Study of Carboplatin-Paclitaxel/Nab-Paclitaxel Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With First Line Metastatic Squamous Non-small Cell Lung Cancer (MK-3475-407/KEYNOTE-407)	Active, not recruiting	Non-small Cell Lung Cancer	NCT02775435
Abraxane/Bevacizumab	Terminated	Ovarian Cancer\|Peritoneal Cancer	NCT01821859
Pembrolizumab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-IIIB Non-Small Cell Lung Cancer	Active, not recruiting	Stage II Non-Small Cell Lung Cancer\|Stage IIIA Non-Small Cell Lung Cancer\|Stage IIIB Non-Small Cell Lung Cancer	NCT02621398
A Trial of Everolimus-eluting Stents and Paclitaxel-eluting Stents for Coronary Revascularization in Daily Practice: The COMPARE Trial	Completed	Stable Angina\|Unstable Angina\|Acute Coronary Syndrome	NCT01016041
Papillary Serous Carcinoma of the Endometrium	Completed	Endometrial Cancer	NCT00515073
A Study to Determine Whether EGFR Status by FISH Can Predict Results in Non Small Cell Lung Cancer (NSCLC) Patients Treated With Cetuximab, Carboplatin and Paclitaxel	Withdrawn	Lung Neoplasms\|Carcinoma, Non-Small-Cell Lung	NCT00768131
Efficacy Study of Paclitaxel-eluting Balloon, -Stent vs. Plain Angioplasty for Drug-eluting Stent Restenosis	Completed	Heart Disease\|Ischemia\|Restenosis	NCT00987324
Weekly Paclitaxel/Carboplatin With Neupogen in Gynaecological Cancers	Completed	Ovarian Cancer\|Endometrial Cancer\|Uterine Cervical Cancer	NCT01523678
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer	Active, not recruiting	Endometrial Clear Cell Adenocarcinoma\|Endometrial Serous Adenocarcinoma\|Stage IA Uterine Corpus Cancer AJCC v7\|Stage IB Uterine Corpus Cancer AJCC v7\|Stage II Uterine Corpus Cancer AJCC v7\|Stage IIIA Uterine Corpus Cancer AJCC v7\|Stage IIIB Uterine Corpus Cancer AJCC v7\|Stage IIIC Uterine Corpus Cancer AJCC v7\|Stage IVA Uterine Corpus Cancer AJCC v7	NCT00942357
Stony Brook	United States\|State University of New York Upstate Medical University	New York	United States\|Stony Brook University Medical Center
A Phase I/II Clinical Trial of Vidaza With Abraxane in Patients With Advanced/Metastatic Solid Tumors and Breast Cancer	Completed	Advanced or Metastatic Solid Tumors\|Advanced or Metastatic Breast Cancer	NCT00748553
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer	Completed	Recurrent Non-small Cell Lung Cancer\|Stage IIIA Non-small Cell Lung Cancer\|Stage IIIB Non-small Cell Lung Cancer	NCT00093756
Vinorelbine Plus Paclitaxel in Treating Patients With Metastatic Prostate Cancer That Is Refractory to Hormone Therapy	Withdrawn	Prostate Cancer	NCT00003622
A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer	Recruiting	Adenocarcinoma\|Pancreatic Neoplasms\|Neoplasm, Glandular\|Neoplasms\|Neoplasms Pancreatic\|Digestive System Neoplasm\|Endocrine Gland Neoplasms\|Digestive System Disease\|Pancreatic Diseases\|Endocrine System Diseases	NCT03535727
Paclitaxol Every 2 Week Versus Paclitaxol Every 1 Week in the Adjuvant Treatment of Breast Cancer	Not yet recruiting	Breast Cancer\|Paclitaxel\|Epirubicin\|Cyclophosphamide	NCT01848197
Paclitaxel Followed by FEC Versus Paclitaxel and RAD001 Followed by FEC In Women With Breast Cancer	Unknown status	Breast Cancer	NCT00499603
A Study of Paclitaxel With or Without Ramucirumab (LY3009806) in Participants With Gastric or Gastroesophageal Cancer	Recruiting	Gastroesophageal Junction Adenocarcinoma\|Gastric Adenocarcinoma	NCT02898077
Clinical Trial of Atezolizumab With Paclitaxel, Trastuzumab, and Pertuzumab in Patients With Metastatic HER-2 Positive Breast Cancer	Recruiting	HER2-positive Breast Cancer	NCT03125928
[18F]FLT PET/CT in Rb+ Metastatic Breast Cancer	Recruiting	Breast Neoplasm\|Metastatic Breast Cancer\|Rb+ Breast Cancer	NCT02608216
Weekly vs. Every 2 Week vs. Every 3 Week Administration of ABI-007 (Abraxane)/Bevacizumab Combination in Metastatic Breast Cancer	Terminated	Breast Neoplasms\|Neoplasm Metastasis	NCT00281528
Gemcitabine, Nab-Paclitaxel, Cisplatin and Anakinra Treatment on Patients With Pancreatic Cancer	Active, not recruiting	Pancreatic Adenocarcinoma	NCT02550327
Phase1b to Evaluate Safety of AMG706 in Combination With Paclitaxel or Docetaxel for Breast Cancer	Completed	Locally Recurrent and Metastatic Breast Cancer	NCT00322400
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)	Completed	Ovarian Cancer\|Solid Tumors	NCT00889382
Paclitaxel Plus Topotecan in Treating Patients With Solid Tumors	Completed	Unspecified Adult Solid Tumor, Protocol Specific	NCT00002587
Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Metastatic Solid Tumors	Completed	Unspecified Adult Solid Tumor, Protocol Specific	NCT00520000
Sequential HIPEC of Oxaliplatin and Paclitaxel for Gastric Cancer Patients With Peritoneum Metastasis	Unknown status	Gastric Cancer\|Metastases to Perineum	NCT01471132
Nab-PCE vs PC for MM After Failure of Anti-PD-1	Recruiting	Advanced Melanoma	NCT03917069
Chidamide in Combination With Carboplatin and Paclitaxel in Advanced Non-small Cell Lung Cancer	Completed	Non-small-cell Lung Cancer	NCT01836679
POF Versus FOLFOX Plus IP Paclitaxel in AGC	Not yet recruiting	Gastric Cancer	NCT04155671
Study of SHR-1210 in Combination With Chemotherapy in Advanced Esophageal Cancer	Recruiting	Advanced Esophageal Cancer	NCT03691090
Carboplatin With Either Paclitaxel Poliglumex or Paclitaxel in Treating Women With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer	Unknown status	Lung Cancer	NCT00551733
Carboplatin/Taxol/Ridaforolimus in Endometrial, Ovarian and Solids	Completed	Endometrial Cancer\|Ovarian Cancer	NCT01256268
Efficacy and Safety of Pegylated Recombinant Human Granulocyte Stimulating Factor in Secondary Prevention of Albumin Paclitaxel Combined With S-1 in the First-line Treatment of Advanced Pancreatic Cancer	Recruiting	Advanced Pancreatic Cancer	NCT04239001
Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization	Completed	Coronary Heart Disease	NCT00297661
Trial of Tri-weekly TJ Versus Weekly TJ for Stage II-IV Mullerian Carcinoma	Completed	Epithelial Ovarian Cancer\|Primary Peritoneal Cancer\|Fallopian Tube Cancer	NCT00226915
Hypofractionated Proton Beam Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Stage II-III Non-Small Cell Lung Cancer	Completed	Carcinoma, Non-Small-Cell Lung	NCT02172846
A Phase I Study of BMS-690514 in Combination With Paclitaxel and Carboplatin	Completed	Cancer (Solid Tumors)	NCT00420186
Predicting Response and Toxicity in Patients Receiving Paclitaxel and Avastin for Breast Cancer	Terminated	Breast Cancer	NCT00537173
Phase II Study of Neoadjuvant Weekly Paclitaxel and Carboplatin Followed by Dose Dense Epirubicin and Cyclophosphamide in Stage II and III Triple Negative Breast Cancer	Completed	Breast Cancer	NCT04224922
Per-cutaneous Intervention Based Paclitaxel and Sirolimus-Eluting Versus Bare Stents for the Treatment of de Novo Coronary Lesions (PAINT)	Completed	Coronary Restenosis	NCT00752362
Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma	Completed	Testicular Cancer\|Germ Cell Neoplasm	NCT00183820
Carboplatin and Nab-Paclitaxel With or Without Vorinostat in Treating Women With Newly Diagnosed Operable Breast Cancer	Active, not recruiting	Breast Cancer	NCT00616967
Small Coronary Artery Treated by TAXUS LibertĂ© Registry in Japan	Unknown status	Stable Angina Pectoris\|Unstable Angina Pectoris	NCT00955214
Carboplatin and Paclitaxel With or Without Sorafenib Tosylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery	Completed	Mucosal Melanoma\|Recurrent Melanoma\|Stage IIIA Skin Melanoma\|Stage IIIB Skin Melanoma\|Stage IIIC Skin Melanoma\|Stage IV Skin Melanoma	NCT00110019
The Study of Gemcitabine Plus Nab-Paclitaxel in Combination With Pegvorhyaluronidase Alfa (PVHA	N/A	N/A	NCT04045730
Cisplatin-Pemetrexed Compared With Carboplatin-Paclitaxel-Bevacizumab in KRAS Mutated Non-small Cell Lung Cancer	Recruiting	Carcinoma, Non-Small Cell Lung	NCT02743923
The Safety and Efficacy of DIOR Balloon in Coronary Bifurcation Lesions	Not yet recruiting	Percutaneous Coronary Intervention	NCT03820622
Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer	Recruiting	Recurrent Salivary Gland Cancer\|Recurrent Squamous Cell Carcinoma of the Hypopharynx\|Recurrent Squamous Cell Carcinoma of the Larynx\|Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity\|Recurrent Squamous Cell Carcinoma of the Nasopharynx\|Recurrent Squamous Cell Carcinoma of the Oropharynx\|Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity\|Recurrent Verrucous Carcinoma of the Larynx\|Recurrent Verrucous Carcinoma of the Oral Cavity\|Salivary Gland Squamous Cell Carcinoma\|Tongue Cancer	NCT01847326
The Pharmacokinetics and Safety of Olaparib Alone and With Paclitaxel in Chinese Patients With Advanced Solid Tumour.	Completed	Advanced Solid Tumours	NCT02430311
PReoperative Chemoradiation (Paclitaxel-carboplatin or FOLFOX) for Resectable Esophageal and Junctional Cancer	Recruiting	Esophageal Neoplasms	NCT02359968
Real-World Effectiveness of PLD in Platinum- Sensitive Recurrent Ovarian Cancer	Completed	Ovarian Carcinoma	NCT03562533
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)	Active, not recruiting	Breast Cancer	NCT01853748
Suramin, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer	Completed	Recurrent Non-small Cell Lung Cancer\|Stage IIIB Non-small Cell Lung Cancer\|Stage IV Non-small Cell Lung Cancer	NCT00006929
Carboplatin, Abraxane, and Bevacizumab in Previously Untreated Patients With Advanced Non-Small Cell Lung Cancer	Completed	Non-small Cell Lung Cancer	NCT00642759
Study To Evaluate the Efficacy and Safety Of Bevacizumab, and Associated Biomarkers, In Combination With Paclitaxel Compared With Paclitaxel Plus Placebo as First-line Treatment Of Patients With Her2-Negative Metastatic Breast Cancer	Completed	Metastatic Breast Cancer	NCT01663727
A Study of Nab-Paclitaxel and Gemcitabine With or Without Olaratumab (LY3012207) in Participants With Metastatic Pancreatic Cancer	Recruiting	Metastatic Pancreatic Cancer	NCT03086369
Gemcitabine, Doxorubicin and Paclitaxel (GAT) as Neoadjuvant Treatment of Breast Cancer Patients	Completed	Breast Cancer	NCT00128856
Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer	Active, not recruiting	Fallopian Tube Endometrioid Adenocarcinoma\|Fallopian Tube Mucinous Adenocarcinoma\|Fallopian Tube Transitional Cell Carcinoma\|Ovarian Brenner Tumor\|Ovarian Clear Cell Adenocarcinofibroma\|Ovarian Endometrioid Adenocarcinoma\|Ovarian Mucinous Adenocarcinoma\|Ovarian Seromucinous Carcinoma\|Ovarian Serous Adenocarcinoma\|Ovarian Transitional Cell Carcinoma\|Ovarian Undifferentiated Carcinoma\|Primary Peritoneal Serous Adenocarcinoma\|Stage IIA Fallopian Tube Cancer AJCC v6 and v7\|Stage IIA Ovarian Cancer AJCC V6 and v7\|Stage IIB Fallopian Tube Cancer AJCC v6 and v7\|Stage IIB Ovarian Cancer AJCC v6 and v7\|Stage IIC Fallopian Tube Cancer AJCC v6 and v7\|Stage IIC Ovarian Cancer AJCC v6 and v7\|Stage IIIA Fallopian Tube Cancer AJCC v7\|Stage IIIA Ovarian Cancer AJCC v6 and v7\|Stage IIIA Primary Peritoneal Cancer AJCC v7\|Stage IIIB Fallopian Tube Cancer AJCC v7\|Stage IIIB Ovarian Cancer AJCC v6 and v7\|Stage IIIB Primary Peritoneal Cancer AJCC v7\|Stage IIIC Fallopian Tube Cancer AJCC v7\|Stage IIIC Ovarian Cancer AJCC v6 and v7\|Stage IIIC Primary Peritoneal Cancer AJCC v7\|Stage IV Fallopian Tube Cancer AJCC v6 and v7\|Stage IV Ovarian Cancer AJCC v6 and v7\|Stage IV Primary Peritoneal Cancer AJCC v7	NCT01167712
Oregon	Portland	United States\|Abington Memorial Hospital	Portland
Paclitaxel and ABI-007 in Treating Patients With Locally Advanced or Metastatic Solid Tumors	Completed	Unspecified Adult Solid Tumor, Protocol Specific	NCT00095914
ABT-888, Carboplatin, and Paclitaxel for Cancer With Liver or Kidney Problems	Withdrawn	Neoplasms	NCT01419548
Study of Dose-dense Adriamycin Plus Cytoxan (AC) Followed by Either ABI-007 (Abraxane) or Taxol With Bevacizumab as Adjuvant Therapy for Patients With Breast Cancer	Completed	Breast Cancer	NCT00394251
Comparison of Paclitaxel-Eluting Coroflex Please Stent Versus Paclitaxel-Eluting Stent	Completed	Coronary Artery Disease	NCT00995423
A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLC	Completed	Non-Small Cell Lung Cancer	NCT00343291
A Comparative Study Of PF-06439535 Plus Paclitaxel-Carboplatin And Bevacizumab Plus Paclitaxel-Carboplatin Patients With Advanced Non-Squamous NSCLC	Completed	Non-Small Cell Lung Cancer	NCT02364999
Albumin-Bound Paclitaxel Combined With Carboplatin as Neoadjuvant Chemotherapy in Luminal B/HER-2 Negative Breast Cancer	Recruiting	HER-2 Negative Breast Cancer	NCT03799692
Paclitaxel + Trastuzumab + Pertuzumab as Pre-Op for Inflammatory BrCa	Active, not recruiting	Breast Cancer	NCT01796197
Therapy Management With Nab-Paclitaxel in Daily Routine	Active, not recruiting	Metastatic Breast Cancer	NCT02642406
Carboplatin/Paclitaxel +/-Gemcitabine in Treating Patients With Ovarian Epithelial or Fallopian Tube Cancer	Completed	Fallopian Tube Cancer\|Ovarian Cancer	NCT00052468
Erlotinib Hydrochloride With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III-IV Non-small Cell Lung Cancer	Completed	Lung Adenocarcinoma\|Lung Adenosquamous Carcinoma\|Malignant Pericardial Effusion\|Malignant Pleural Effusion\|Minimally Invasive Lung Adenocarcinoma\|Stage IIIB Lung Non-Small Cell Cancer AJCC v7\|Stage IV Lung Non-Small Cell Cancer AJCC v7	NCT00126581
TRIal evalUating the Menstrual and Ovarian Function of Young Breast Cancer Patients Treated With a cycloPHosphamide-free Regimen	Withdrawn	Breast Cancer	NCT02053597
Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery	Completed	HER2/Neu Positive\|Stage IA Breast Cancer\|Stage IB Breast Cancer\|Stage II Breast Cancer\|Stage IIIA Breast Cancer	NCT00513292
Feasibility Study of Biomarkers of Response to Neoadjuvant Paclitaxel in Locally Advanced Breast Cancer	Completed	Breast Cancer	NCT01263613
Debio 1143 in Combination With Carboplatin and Paclitaxel in Patient With Advanced Solid Malignancies	Terminated	Solid Tumors	NCT01930292
Paclitaxel and Carboplatin in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy	Completed	Prostate Cancer	NCT00049257
Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) in Patients With Advanced Cancer	Completed	Neoplasm	NCT00080418
Gefitinib With or Without Carboplatin and Paclitaxel in Treating Older Patients With Unresectable or Metastatic Non-Small Cell Lung Cancer	Completed	Lung Cancer	NCT00062062
Trial Exploring Afatinib (BIBW 2992) + Paclitaxel (Part A), Afatinib + Paclitaxel + Bevacizumab (Part B), Afatinib + Carboplatin (Part C) and Afatinib+ Paclitaxel +Carboplatin(Part D) in Patients With Advanced Solid Tumours	Completed	Neoplasms	NCT00809133
Paclitaxel and Bryostatin 1 in Treating Patients With Metastatic Prostate Cancer	Completed	Prostate Cancer	NCT00005028
A Randomized Controlled Trial of Neoadjuvant Weekly Paclitaxel Versus Weekly Paclitaxel Plus Weekly Carboplatin In Women With Large Operable or Locally Advanced, Triple Negative Breast Cancer	Active, not recruiting	Triple Negative Breast Cancer	NCT03168880
A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer	Unknown status	Invasive Breast Cancer	NCT00486668
PacLitaxel Eluting Balloon Application In Sfa In Stent Restenosis	Completed	Peripheral Arterial Disease	NCT01587482
A Safety and Efficacy Study of Carboplatin, Paclitaxel, Bevacizumab and CA4P in Non-Small Cell Lung Cancer	Completed	Tumors	NCT00653939
Paclitaxel and Oxaliplatin in Treating Patients With Recurrent or Advanced Non-small Cell Lung Cancer	Completed	Lung Cancer	NCT00004126
Paclitaxel Coated Balloon Catheter for Prevention of Restenosis in Femoropopliteal Arteries	Completed	Peripheral Arterial Disease	NCT00472472
LUX-Lung 5: Afatinib Plus Weekly Paclitaxel Versus Investigator's Choice of Single Agent Chemotherapy Following Afatinib Monotherapy in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib	Completed	Carcinoma, Non-Small-Cell Lung	NCT01085136
Efficacy Comparison Study of Combination Regimens to Treat Advanced Esophageal Squamous Cell Carcinoma	Unknown status	First Line Chemotherapy\|Capecitabine Plus Cisplatin Versus Capecitabine Plus Paclitaxel\|Advanced or Recurrent Esophageal Squamous Cell Carcinoma	NCT00816634
Efficacy and Safety of Paclitaxel-eluting Balloon for Treatment of Lesions in Native Small Coronary Arteries	Unknown status	Coronary Artery Disease	NCT01903902
Phase 2 Trial of Pertuzumab and Trastuzumab With Weekly Paclitaxel and Chemotherapy for HER2 Positive Breast Cancer	Unknown status	Her2-Positive Breast Cancer	NCT01855828
Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis	Completed	Bladder Cancer\|Cervical Cancer\|Endometrial Cancer\|Vaginal Cancer	NCT00002949
TReAtmeNt of Small Coronary Vessels: MagicTouch Sirolimus Coated Balloon	Not yet recruiting	Coronary Artery Disease	NCT03913832
Phase 2 Trial of Neoadjuvant Weekly Carboplatin Plus Paclitaxel in Triple Negative Breast Cancer	Recruiting	Triple Negative Breast Cancer	NCT04083963
Bryostatin 1 Plus Paclitaxel in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer	Completed	Lung Cancer	NCT00005849
Phase II Trial of Sequential Consolidation With Pembrolizumab Followed by Nab-paclitaxel	Active, not recruiting	Non Small Cell Lung Cancer	NCT02684461
Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread	Not yet recruiting	Metastatic Pancreatic Adenocarcinoma\|Stage IV Pancreatic Cancer AJCC v8	NCT04233866
STA-4783 and Paclitaxel for Treatment of Solid Tumors	Completed	Neoplasms	NCT00088114
Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal Cancer	Completed	Cervical Cancer\|Vaginal Cancer	NCT00002562
Study Of Lapatinib In Combination With Paclitaxel In The Treatment Of Newly Diagnosed Inflammatory Breast Cancer	Completed	Neoplasms, Breast	NCT00111787
A Phase I/II Study of Paclitaxel, Carboplatin and YM155 (Survivin Suppressor) in Subjects With Solid Tumors (Phase I) and Advanced Non-Small Cell Lung Carcinoma (Phase II)	Completed	NSCLC\|Solid Tumors	NCT01100931
Paclitaxel in Treating Patients With Advanced Head and Neck Cancer	Completed	Head and Neck Cancer	NCT00002922
Treatment of Coronary De-novo Stenosis by a Sirolimus Coated Balloon or a Paclitaxel Coated Balloon Catheter Malaysia	Recruiting	Coronary Artery Disease	NCT04017364
Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Adjuvant Chemotherapy in the Treatment of the Lymph Node Positive Thoracic Esophageal Squamous Cell Carcinoma	Recruiting	Esophageal Cancer	NCT02461043
Pancreatic Resectability in Cancers With Known Limited Extension (PRICKLE)	Terminated	Pancreatic Adenocarcinoma	NCT02124369
Intra-Individual Comparison of Sirolimus and Paclitaxel Coated Stent (FRE-RACE Study)	Completed	Coronary Artery Disease	NCT00130546
Radiation Therapy, Paclitaxel, and Cisplatin in Treating Patients With Cancer of the Cervix	Completed	Cervical Cancer	NCT00003377
Study of Neo-adjuvant RO7009789 Alone or Neo-adjuvant RO7009789 Plus Nab-Paclitaxel and Gemcitabine Followed by Adjuvant RO7009789 Plus Nab-Paclitaxel and Gemcitabine for Patients With Newly Diagnosed Resectable Pancreatic Carcinoma	Completed	Pancreatic Cancer	NCT02588443
Paclitaxel in Treating Patients With Early-Stage Bladder Cancer	Completed	Bladder Cancer	NCT00002917
Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer	Terminated	Large Cell Lung Carcinoma\|Lung Adenocarcinoma\|Recurrent Non-Small Cell Lung Carcinoma\|Stage IV Non-Small Cell Lung Cancer\|Bronchioloalveolar Lung Carcinoma	NCT00955305
Paclitaxel in Treating Patients With Recurrent or Refractory Non-small Cell Lung Cancer	Unknown status	Lung Cancer	NCT00004265
First Line TIP in Poor Prognosis TGCTs.	Recruiting	Germ Cell Tumor	NCT02414685
A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-small Cell Lung Cancer	Completed	Non Small Cell Lung Cancer	NCT00583830
Phase 2 Study of ABT-869 in Combination With Paclitaxel Versus Paclitaxel Alone to Treat Metastatic Breast Cancer	Completed	Metastatic Breast Cancer	NCT00645177
A Clinical Trial to Study the Effects of Nanoparticle Based Paclitaxel Drug, Which Does Not Contain the Solvent Cremophor, in Advanced Breast Cancer	Unknown status	Advanced Breast Cancer	NCT00915369
Paclitaxel and Radiation Therapy in Treating Patients Undergoing Surgery for Stage II or Stage III Breast Cancer	Completed	Breast Cancer	NCT00647218
Paclitaxel in Treating Patients With Recurrent or Progressive Advanced Ovarian Cancer	Completed	Ovarian Cancer	NCT00002928
Paclitaxel in Treating Patients With Recurrent or Persistent Cancer of the Uterus	Terminated	Sarcoma	NCT00003054
Neoadjuvant ABI-007, Carboplatin and Gemcitabine in Locally Advanced Bladder Cancer	Completed	Bladder Cancer	NCT00585689
Efficacy Study of Stenting, Paclitaxel Eluting Balloon or Atherectomy to Treat Peripheral Artery Disease	Unknown status	Peripheral Vascular Diseases	NCT00986752
Paclitaxel Poliglumex and Estradiol in Treating Patients With Stage IV Prostate Cancer	Terminated	Prostate Cancer	NCT00459810
Pre-Operative Trial (PGHA vs. PGH) for Resectable Pancreatic Cancer	Suspended	Pancreatic Cancer Resectable	NCT03344172
A Phase I Trial of SS1 (dsFv) PE38 With Paclitaxel, Carboplatin, and Bevacizumab in Subjects With Unresectable Non-Small Cell Lung Adenocarcinoma	Completed	Non-Small Cell Lung Cancer\|Adenocarcinoma	NCT01051934
A Randomized, Double-blind, Placebo Controlled Phase III Study to Investigate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy (Carboplatin-Nanoparticle Albumin Bound (Nab) Paclitaxel) in Patients With Stage IIIB/IIIC or IV NSCLC	Recruiting	Squamous Non Small Cell Lung Cancer	NCT04033354
A Study of AMG 706 or Bevacizumab, in Combination With Paclitaxel Chemotherapy, as Treatment for Breast Cancer	Terminated	Breast Neoplasms\|Breast Tumors\|Breast Cancer\|Locally Recurrent and Metastatic Breast Cancer	NCT00356681
Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors	Active, not recruiting	Germ Cell Tumors	NCT01873326
A Study of Onartuzumab (MetMAb) Versus Placebo in Combination With Paclitaxel Plus Platinum in Patients With Squamous Non-Small Cell Lung Cancer	Completed	Non-Squamous Non-Small Cell Lung Cancer	NCT01519804
Efficacy and Safety of QL1101 and AvastinÂ® Respectively Combined With Paclitaxel and Carboplatin in the First-line Treatment of Non-squamous Non-small Cell Lung Cancer	Completed	Non-squamous Non-small Cell Lung Cancer	NCT03169335
A BRIDGING STUDY OF PF-06439535 (CN) PLUS PACLITAXEL-CARBOPLATIN VERSUS BEVACIZUMAB PLUS PACLITAXEL-CARBOPLATIN IN NSCLC	Not yet recruiting	Advanced Non-squamous NSCLC	NCT04325698
International Multicentre Study in Advanced Anal Cancer Comparing Cisplatin Plus 5 FU vs Carboplatin Plus Weekly Paclitaxel	Unknown status	Squamous Cell Carcinoma of the Anus	NCT02051868
Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor	Recruiting	Gestational Trophoblastic Neoplasms	NCT02639650
Paclitaxel in Treating Patients With Recurrent or Refractory Head and Neck Cancer	Unknown status	Head and Neck Cancer	NCT00003327
Paclitaxel in Treating Patients With Metastatic, Recurrent, or Unresectable Cancer of the Esophagus	Unknown status	Esophageal Cancer	NCT00003326
Paclitaxel in Treating Patients With Refractory or Recurrent Endometrial Cancer	Completed	Endometrial Cancer	NCT00022620
Talimogene Laherparepvec With Paclitaxel or Endocrine Therapy in Treating Participants With Metastatic, Unresectable, or Recurrent HER2- Negative Breast Cancer	Recruiting	Anatomic Stage III Breast Cancer AJCC v8\|Anatomic Stage IIIA Breast Cancer AJCC v8\|Anatomic Stage IIIB Breast Cancer AJCC v8\|Anatomic Stage IIIC Breast Cancer AJCC v8\|Anatomic Stage IV Breast Cancer AJCC v8\|Estrogen Receptor Positive\|HER2/Neu Negative\|Invasive Breast Carcinoma\|Prognostic Stage III Breast Cancer AJCC v8\|Prognostic Stage IIIA Breast Cancer AJCC v8\|Prognostic Stage IIIB Breast Cancer AJCC v8\|Prognostic Stage IIIC Breast Cancer AJCC v8\|Prognostic Stage IV Breast Cancer AJCC v8\|Recurrent Breast Carcinoma	NCT03554044
Dose Escalation, Multi-arm Study of MLN4924 Plus Docetaxel, Gemcitabine, or Combination of Carboplatin and Paclitaxel in Patients With Solid Tumors	Completed	Solid Tumors	NCT01862328
A Trial of Ribocilcib (LEE011) and Weekly Paclitaxel in Patients With Rb+ Advanced Breast Cancer	Recruiting	Advanced Breast Cancer	NCT02599363
Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer	Completed	Endometrial Adenocarcinoma\|Endometrial Adenosquamous Carcinoma\|Endometrial Clear Cell Adenocarcinoma\|Endometrial Serous Adenocarcinoma\|Stage IA Uterine Corpus Cancer AJCC v7\|Stage IB Uterine Corpus Cancer AJCC v7\|Stage II Uterine Corpus Cancer AJCC v7\|Stage IIIA Uterine Corpus Cancer AJCC v7\|Stage IIIB Uterine Corpus Cancer AJCC v7\|Stage IIIC Uterine Corpus Cancer AJCC v7\|Stage IVA Uterine Corpus Cancer AJCC v7\|Stage IVB Uterine Corpus Cancer AJCC v7	NCT01005329
Cisplatin and Fluorouracil Compared With Carboplatin and Paclitaxel in Treating Patients With Inoperable Locally Recurrent or Metastatic Anal Cancer	Active, not recruiting	Anal Basaloid Carcinoma\|Anal Canal Cloacogenic Carcinoma\|Anal Squamous Cell Carcinoma\|Metastatic Anal Canal Carcinoma\|Recurrent Anal Canal Carcinoma\|Stage IIIB Anal Canal Cancer\|Stage IV Anal Canal Cancer	NCT02560298
A Randomized, Double-blind Study to Assess Paclitaxel-eluting Stents in Treatment of Longer Lesions	Completed	Coronary Artery Disease	NCT00297804
Observational Study on Quality of Life of Patients Receiving Nab-paclitaxel/Gemcitabine First Line Therapy, Including a Translational Program	Active, not recruiting	Metastatic Pancreatic Cancer	NCT02691052
Cyclophosphamide and Paclitaxel With or Without Trastuzumab in Stage I-II Breast Cancer Who Have Undergone Surgery	Completed	Stage IA Breast Cancer\|Stage IB Breast Cancer\|Stage IIA Breast Cancer\|Stage IIB Breast Cancer	NCT01106898
A Multicentre Phase I-II Study to Investigate the Combination of Bendamustine With Weekly Paclitaxel as First or Second Line Therapy in Patients With Metastatic Breast Cancer	Completed	Metastatic Breast Cancer	NCT00661739
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer	Terminated	Fallopian Tube Cancer\|Ovarian Cancer\|Peritoneal Cancer	NCT01493505
Metformin for Reduction of Paclitaxel-Related Neuropathy in Patients With Breast Cancer	Terminated	Breast Cancer	NCT02360059
A Clinical Trial of Paclitaxel Loaded Polymeric Micelle in Patients With Taxane-Pretreated Recurrent Breast Cancer	Unknown status	Recurrent Breast Cancer	NCT00912639
Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors & Lymphomas	Terminated	Neoplasm\|Lymphomas\|Neoplasm Metastasis	NCT00023166
Local Paclitaxel Delivery to Prevent Restenosis in Peripheral Arterial Disease	Withdrawn	Peripheral Arterial Disease\|Restenosis	NCT03858764
Bcl-2 Antisense Oligodeoxynucleotide G3139 and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer	Completed	Lung Cancer	NCT00005032
Triciribine Phosphate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide in Treating Patients With Stage IIB-IV Breast Cancer	Active, not recruiting	Breast Adenocarcinoma\|Estrogen Receptor Positive\|HER2/Neu Negative\|Recurrent Breast Carcinoma\|Stage IIB Breast Cancer\|Stage IIIA Breast Cancer\|Stage IIIB Breast Cancer\|Stage IIIC Breast Cancer\|Stage IV Breast Cancer	NCT01697293
Trial of Cisplatin Plus Radiation Followed by Carbo and Taxol Vs. Sandwich Therapy of Carbo and Taxol Followed Radiation Then Further Carbo and Taxol	Recruiting	Endometrial Clear Cell Adenocarcinoma\|Endometrial Serous Adenocarcinoma\|Stage IIIA Uterine Corpus Cancer\|Stage IIIB Uterine Corpus Cancer\|Stage IIIC Uterine Corpus Cancer\|Stage IVA Uterine Corpus Cancer	NCT02501954
A Study of SHR-1210 in Combination With Carboplatin + Paclitaxel in Subjects With Squamous NSCLC	Not yet recruiting	Lung Cancer Squamous Cell\|Lung Cancer Stage IV\|PD-1 Antibody\|Chemotherapy Effect	NCT03668496
Micellar Paclitaxel to Treat Severe Psoriasis	Completed	Psoriasis	NCT00006276
Albumin-Bound Paclitaxel Followed by Epirubicin in Combination With Cyclophosphamide in Triple Negative Breast Cancer	Recruiting	Triple Negative Breast Cancer	NCT03799679
Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery or Gynecological Cancers	Recruiting	Cervical Adenosarcoma\|Cervical Adenosquamous Carcinoma\|Cervical Carcinosarcoma\|Cervical Squamous Cell Carcinoma, Not Otherwise Specified\|Endometrial Clear Cell Adenocarcinoma\|Endometrial Endometrioid Adenocarcinoma\|Endometrial Mixed Adenocarcinoma\|Endometrial Mucinous Adenocarcinoma\|Endometrial Squamous Cell Carcinoma\|Endometrial Transitional Cell Carcinoma\|Endometrial Undifferentiated Carcinoma\|Fallopian Tube Adenocarcinoma\|Fallopian Tube Clear Cell Adenocarcinoma\|Fallopian Tube Mucinous Adenocarcinoma\|Fallopian Tube Serous Adenocarcinoma\|Fallopian Tube Transitional Cell Carcinoma\|Malignant Ovarian Epithelial Tumor\|Malignant Peritoneal Neoplasm\|Ovarian Carcinosarcoma\|Ovarian Clear Cell Adenocarcinoma\|Ovarian Endometrioid Adenocarcinoma\|Ovarian Mucinous Adenocarcinoma\|Ovarian Serous Adenocarcinoma\|Ovarian Transitional Cell Carcinoma\|Primary Peritoneal Serous Adenocarcinoma\|Recurrent Fallopian Tube Carcinoma\|Recurrent Melanoma\|Recurrent Ovarian Carcinoma\|Recurrent Primary Peritoneal Carcinoma\|Stage IV Skin Melanoma\|Undifferentiated Fallopian Tube Carcinoma\|Undifferentiated Ovarian Carcinoma\|Uterine Corpus Carcinosarcoma	NCT02020707
Safety and Effectiveness of Combretastatin A-4 Phosphate Combined With Chemotherapy in Advanced Solid Tumors	Completed	Cancer\|Tumor	NCT00113438
An Open Label Study in Patients With Advanced NSCLC With ABI-007(Abraxane) in Combination With Carboplatin	Completed	Non-Small Cell Lung Cancer (NSCLC)	NCT00274443
Platinum Chemotherapy Plus Paclitaxel With Bevacizumab and Atezolizumab in Metastatic Carcinoma of the Cervix	Recruiting	Carcinoma of the Cervix, Stage IVB	NCT03556839
Trastuzumab (Herceptin), Paclitaxel, Carboplatin and Gemcitabine in Advanced Urothelial Cancer	Completed	Urologic Neoplasms	NCT00151034
Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Combination With Paclitaxel and Carboplatin in Patients With Advanced or Metastatic Solid Tumors	Completed	Advanced Solid Tumors\|Metastatic Solid Tumors	NCT00793897
Paclitaxel Eluting Stent or Exercise for Thigh Atherosclerosis	Unknown status	Peripheral Arterial Disease	NCT02033135
A Feasibility Study for Convernsion Therapy Using S1/Paclitaxel Chemotherapy Plus Apatinib in ELM Gastric Cancer	Enrolling by invitation	Gastric Cancer	NCT03258034
Paclitaxel in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer	Terminated	Ovarian Cancer\|Primary Peritoneal Cavity Cancer	NCT00023907
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC	Recruiting	Locally Advanced Pancreatic Cancer	NCT03257033
Intravenous Estramustine With Taxol in Hormone Refractory Prostate Adenocarcinoma	Completed	Prostate Cancer	NCT00038168
A Study to Assess the Efficacy and Safety of ABTL0812	Recruiting	Endometrial Cancer\|Squamous Non-Small Cell Lung Cancer	NCT03366480
Paclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-2/Neu Breast Cancer That is Inoperable, Recurrent, or Metastatic	Completed	HER2-negative Breast Cancer\|HER2-positive Breast Cancer\|Recurrent Breast Cancer\|Stage IIIC Breast Cancer\|Stage IV Breast Cancer	NCT00003440
Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors	Completed	Male Breast Cancer\|Recurrent Breast Cancer\|Recurrent Endometrial Carcinoma\|Recurrent Gastric Cancer\|Recurrent Non-small Cell Lung Cancer\|Recurrent Ovarian Epithelial Cancer\|Recurrent Small Cell Lung Cancer	NCT00028535
Sirolimus- and Paclitaxel-Eluting Stents for Small Vessels (ISAR-SMART-3)	Completed	Coronary Disease	NCT00146575
Ultrasound to Enhance Paclitaxel Uptake in Critical Limb Ischemia: the PACUS Trial	Completed	Peripheral Arterial Disease, Angioplasty	NCT02625740
Nab-Pac+Cis+Gem in Pts w Previously Untreated Metastatic PDA	Completed	Stage IV Pancreatic Cancer	NCT01893801
A Study of RO6927005 Either As Monotherapy (Part A) or in Combination With Gemcitabine and Nab-Paclitaxel (Part B) to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Clinical Activity in Patients With Mesothelin-positive Metastatic and/or Locally Advanced Malignant Solid Tumors	Terminated	Cancer	NCT02317419
Combination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach Cancer	Completed	Esophageal Cancer\|Gastric Cancer	NCT00006081
Study of Carboplatin/Paclitaxel With or Without Investigational Drug (CS-7017) in Subjects With Metastatic Non-small Cell Lung Cancer	Completed	Metastatic Non-small Cell Lung Cancer	NCT00806286
Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stents to Treat De Novo Coronary Lesions	Completed	Coronary Stenosis	NCT00301522
A Real-world Study of Albumin-bound Paclitaxel in the Treatment of Pancreatic Cancer	Not yet recruiting	Pancreatic Cancer	NCT03768687
Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology	Terminated	Carcinoma, Squamous Cell\|Carcinoma, Adenosquamous\|Carcinoma, Large Cell\|Carcinoma, Non-Small-Cell Lung	NCT00596830
A Study Of Ipatasertib in Combination With Atezolizumab and Paclitaxel as a Treatment for Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer.	Recruiting	Triple-Negative Breast Cancer	NCT04177108
Efficacy/Safety of Imprime PGG With Cetuximab & Paclitaxel/Carboplatin Therapy in Pts With Untreated Advanced Non-Small Cell Lung Cancer	Completed	NSCLC	NCT00874848
ABI-007 in Taxol Resistant Patients With Metastatic Breast Cancer	Completed	Breast Neoplasms\|Metastases, Neoplasm	NCT00046514
Doxorubicin HCL Liposome Injection (DOXIL) in Combination With Abraxane in Patients With Metastatic Breast Cancer	Completed	Metastatic Breast Cancer	NCT00442260
A Pilot Study of Paclitaxel With Radiation Therapy for Locally Advanced Head and Neck Cancer	Completed	Head and Neck Neoplasm\|Squamous Cell Carcinoma	NCT00001442
Concomitant Limb Cryocompression and Scalp Cooling to Reduce Paclitaxel-induced Neuropathy and Alopecia	Recruiting	Chemotherapy-induced Peripheral Neuropathy (CIPN)	NCT03248193
Carboplatin and ABI-007 in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery	Completed	Melanoma (Skin)	NCT00404235
A Phase II Study of Radiation Therapy, Paclitaxel Poliglumex, and Carboplatin in Stage III Non-Small Cell Lung Cancer	Terminated	Carcinoma, Non-Small-Cell Lung	NCT00352690
Weekly Infusions of Paclitaxel in Treating Women With Stage III or Stage IV Ovarian Cancer Refractory to Paclitaxel and Platinum	Unknown status	Fallopian Tube Cancer\|Ovarian Cancer\|Primary Peritoneal Cavity Cancer	NCT00003160
Minocycline Hydrochloride in Reducing Chemotherapy-Induced Peripheral Neuropathy and Acute Pain in Patients With Breast Cancer Undergoing Treatment With Paclitaxel	Completed	Acute Pain\|Breast Carcinoma\|Peripheral Neuropathy	NCT02297412
Xeloda Plus Paclitaxel in Gastric Cancer With Liver Metastasis	Unknown status	Gastric Cancer	NCT01167049
Taxol Carboplatin and Erythropoetin	Completed	Ovarian Cancer	NCT00158379
Study of Neoadjuvant Chemotherapy With Nanoparticle Albumin Bound Paclitaxel, Doxorubicin and Cyclophosphamide (NAC) in Patients With Stages II-III Breast Cancer	Terminated	Stages II-III Breast Cancer	NCT01090128
Neoadjuvant Chemotherapy Versus Surgery Alone for Esophageal Squamous Cell Carcinoma	Active, not recruiting	Esophageal Neoplasm	NCT02395705
A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors	Completed	Urinary Bladder Neoplasms\|Carcinoma, Transitional Cell\|Ovarian Neoplasms\|Fallopian Tube Neoplasms\|Peritoneal Neoplasms\|Carcinoma, Non-Small-Cell Lung\|Carcinoma, Pancreatic Ductal\|Tumor Virus Infections	NCT01478685
Trastuzumab Beyond Progression in HER2 Positive Metastatic Gastric Cancer	Withdrawn	Gastric Cancer	NCT03766607
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer	Active, not recruiting	Clear Cell Adenocarcinoma\|Fallopian Tube Clear Cell Adenocarcinoma\|Fallopian Tube Endometrioid Adenocarcinoma\|Fallopian Tube Mucinous Adenocarcinoma\|Fallopian Tube Serous Adenocarcinoma\|Fallopian Tube Undifferentiated Carcinoma\|Mucinous Adenocarcinoma\|Ovarian Brenner Tumor\|Ovarian Clear Cell Adenocarcinofibroma\|Ovarian Endometrioid Adenocarcinoma\|Ovarian Seromucinous Carcinoma\|Ovarian Serous Adenocarcinoma\|Ovarian Undifferentiated Carcinoma\|Primary Peritoneal Serous Adenocarcinoma\|Recurrent Fallopian Tube Carcinoma\|Recurrent Ovarian Carcinoma\|Recurrent Primary Peritoneal Carcinoma\|Undifferentiated Carcinoma	NCT00565851
New York	Rochester	United States\|Stony Brook University Medical Center	New York
First Line IRESSAâ„˘ Versus Carboplatin/Paclitaxel in Asia	Completed	Non-Small Cell Lung Cancer	NCT00322452
Comparing Paclitaxel/Cisplatin and Cisplatin/5-fluorouracil in Neo-CRT for ESCC	Recruiting	Esophageal Squamous Cell Carcinoma\|Chemoradiation	NCT03623737
Paclitaxel and Radiation Therapy Plus Chemoprotection With Amifostine in Treating Patients With Stage III or Stage IV Head and Neck Cancer	Completed	Head and Neck Cancer\|Oral Complications	NCT00003193
TOCOSOL(TM) Paclitaxel in Metastatic or Locally Advanced Unresectable Transitional Cell Carcinoma of the Urothelium	Completed	Bladder Neoplasms\|Ureteral Neoplasms\|Urethral Neoplasms\|Carcinoma, Transitional Cell	NCT00077688
Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Sunitinib as First-Line Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer	Withdrawn	Lung Cancer	NCT00748163
Trial of Vascular Endothelial Growth Factor (VEGF), Bevacizumab, in Combination With Cytotoxic Chemotherapy for Endometrial Cancer	Completed	Endometrial Carcinoma	NCT00879359
A Study of PI3-Kinase Inhibitor GDC-0941 in Combination With Paclitaxel, With and Without Bevacizumab or Trastuzumab, and With Letrozole, in Participants With Locally Recurrent or Metastatic Breast Cancer	Completed	Breast Cancer	NCT00960960
Study to Evaluate Motesanib With or Without Carboplatin/Paclitaxel or Panitumumab in the Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)	Completed	Lung Cancer\|Non-Small Cell Lung Cancer	NCT00094835
S9714: Paclitaxel in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer	Completed	Lung Cancer	NCT00002969
DHA-Paclitaxel in Treating Patients With Metastatic Pancreatic Cancer	Unknown status	Pancreatic Cancer	NCT00024375
Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy	Completed	Brenner Tumor\|Fallopian Tube Cancer\|Ovarian Clear Cell Cystadenocarcinoma\|Ovarian Endometrioid Adenocarcinoma\|Ovarian Mixed Epithelial Carcinoma\|Ovarian Mucinous Cystadenocarcinoma\|Ovarian Serous Cystadenocarcinoma\|Ovarian Undifferentiated Adenocarcinoma\|Peritoneal Cavity Cancer\|Recurrent Ovarian Epithelial Cancer\|Stage III Ovarian Epithelial Cancer\|Stage IV Ovarian Epithelial Cancer	NCT00466960
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery	Active, not recruiting	Pancreatic Adenocarcinoma\|Resectable Pancreatic Carcinoma	NCT02562716
Missouri	Kansas City	United States\|The University of Kansas Cancer Center-Lee's Summit	Kansas City
Dose-Escalation Study of Intraperitoneal (IP) Cisplatin, IV/IP Paclitaxel, IV Bevacizumab, and Oral Olaparib for Newly Diagnosed Ovarian, Primary Peritoneal, and Fallopian Tube Cancer	Active, not recruiting	Ovarian Cancer\|Primary Peritoneal Cancer\|Fallopian Tube Cancer	NCT02121990
DHA-Paclitaxel in Treating Patients With Metastatic Prostate Cancer	Unknown status	Prostate Cancer	NCT00024414
Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer	Active, not recruiting	Estrogen Receptor Negative\|Estrogen Receptor Positive\|HER2/Neu Negative\|HER2/Neu Positive\|Progesterone Receptor Negative\|Progesterone Receptor Positive\|Recurrent Breast Carcinoma\|Stage IIIC Breast Cancer AJCC v6\|Stage IV Breast Cancer AJCC v6 and v7	NCT00785291
North Carolina	Chapel Hill	United States\|Novant Health Presbyterian Medical Center	Burlington
Safety and Clinical Pharmacology of GDC-0068 in Combination With Docetaxel, Fluoropyrimidine Plus Oxaliplatin, Paclitaxel, or Enzalutamide in Participants With Advanced Solid Tumors	Active, not recruiting	Neoplasms	NCT01362374
Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer	Completed	Lung Cancer	NCT00729612
Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients of Different Ages With Metastatic Breast Cancer	Active, not recruiting	Breast Cancer	NCT00609791
Neoadjuvant Nab-PTX and Trastuzumab for ER Negative and HER2 Positive Breast Cancer	Terminated	Breast Cancer\|Estrogen Receptor Negative Neoplasm\|HER-2 Positive Breast Cancer	NCT02598310
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer	Active, not recruiting	Endometrial Clear Cell Adenocarcinoma\|Endometrial Serous Adenocarcinoma\|Fatigue\|Neurotoxicity Syndrome\|Obesity\|Stage I Uterine Corpus Cancer AJCC v7\|Stage II Uterine Corpus Cancer AJCC v7	NCT00807768
United States\|Greenville Health System Cancer Institute-Eastside	South Carolina	Greer	South Carolina
Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction	Completed	Esophageal Cancer\|Gastric Cancer	NCT00022139
Cetuximab, Chemotherapy, and Radiation Therapy for Operable Stage III or IV Head and Neck Cancer	Completed	Head and Neck Cancer	NCT00089297
A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833	Completed	Breast Cancer\|Cancer\|Carcinoma, Renal Cell\|Lymphoma\|Ovarian Cancer	NCT00001383
A Trial Comparing a Paclitaxel Eluting Stent With Biodegradable Polymer Versus a Bare Metal Stent	Completed	Coronary Artery Disease	NCT00825279
Nab-paclitaxel/Rituximab-coated Nanoparticle AR160 in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma	Recruiting	Aggressive Non-Hodgkin Lymphoma\|CD20 Positive\|Recurrent B-Cell Non-Hodgkin Lymphoma\|Recurrent Small Lymphocytic Lymphoma\|Refractory B-Cell Non-Hodgkin Lymphoma\|Refractory Small Lymphocytic Lymphoma	NCT03003546
A Randomized, Multi-Center Study of the Pimecrolimus-Eluting and Pimecrolimus/Paclitaxel-Eluting Coronary Stent Systems (GENESIS)	Completed	Coronary Disease	NCT00322569
Phase 2 Study of REOLYSINÂ® in Combination With Paclitaxel and Carboplatin for Non-Small Cell Lung Cancer With KRAS or EGFR Activation	Completed	Carcinoma, Non-small Cell Lung	NCT00861627
A Study of Gemcitabine, Epirubicin, and Paclitaxel Combination Chemotherapy Given Before Surgery to Patients With Locally Advanced Breast Cancer	Completed	Stage IIB Breast Cancer\|Stage IIIA Breast Cancer\|Stage IIIB Breast Cancer\|Stage IV Breast Cancer\|Breast Cancer\|Locally Advanced	NCT00378313
Paclitaxel and Capecitabine in Patients With Metastatic/Recurrence Esophageal Cancer	Unknown status	Esophageal Cancer	NCT00453323
A Two-arm (Phase 2) Exploratory Study of Nivolumab Monotherapy or in Combination With Nab-paclitaxel and Carboplatin in Early Stage NSCLC in China	Recruiting	Non Small Cell Lung Cancer	NCT04015778
Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Cancer	Completed	Adult Solid Neoplasm\|BRCA1 Mutation Carrier\|BRCA2 Mutation Carrier\|Hereditary Breast and Ovarian Cancer Syndrome	NCT00535119
Combination Chemotherapy of Gemcitabine and Paclitaxel for Metastatic Breast Cancer	Completed	Metastatic Breast Cancer	NCT00334802
ABI-007 in Treating Patients With Chemotherapy-NaĂŻve Stage IV Non-Small Cell Lung Cancer	Completed	Lung Cancer	NCT00077246
Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer	Active, not recruiting	Fallopian Tube Carcinosarcoma\|Fallopian Tube Clear Cell Adenocarcinoma\|Fallopian Tube Endometrioid Adenocarcinoma\|Fallopian Tube Mucinous Adenocarcinoma\|Fallopian Tube Serous Neoplasm\|Fallopian Tube Transitional Cell Carcinoma\|Fallopian Tube Undifferentiated Carcinoma\|Ovarian Brenner Tumor\|Ovarian Carcinosarcoma\|Ovarian Clear Cell Adenocarcinoma\|Ovarian Endometrioid Adenocarcinoma\|Ovarian Mucinous Adenocarcinoma\|Ovarian Seromucinous Tumor\|Ovarian Serous Adenocarcinoma\|Ovarian Transitional Cell Carcinoma\|Ovarian Undifferentiated Carcinoma\|Primary Peritoneal Serous Adenocarcinoma\|Stage IIA Fallopian Tube Cancer AJCC v6 and v7\|Stage IIA Ovarian Cancer AJCC V6 and v7\|Stage IIB Fallopian Tube Cancer AJCC v6 and v7\|Stage IIB Ovarian Cancer AJCC v6 and v7\|Stage IIC Fallopian Tube Cancer AJCC v6 and v7\|Stage IIC Ovarian Cancer AJCC v6 and v7\|Stage IIIA Fallopian Tube Cancer AJCC v7\|Stage IIIA Ovarian Cancer AJCC v6 and v7\|Stage IIIA Primary Peritoneal Cancer AJCC v7\|Stage IIIB Fallopian Tube Cancer AJCC v7\|Stage IIIB Ovarian Cancer AJCC v6 and v7\|Stage IIIB Primary Peritoneal Cancer AJCC v7\|Stage IIIC Fallopian Tube Cancer AJCC v7\|Stage IIIC Ovarian Cancer AJCC v6 and v7\|Stage IIIC Primary Peritoneal Cancer AJCC v7\|Stage IV Fallopian Tube Cancer AJCC v6 and v7\|Stage IV Ovarian Cancer AJCC v6 and v7\|Stage IV Primary Peritoneal Cancer AJCC v7	NCT00989651
Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast Cancer	Active, not recruiting	Breast Cancer	NCT01036087
Combination Chemotherapy Plus Oblimersen in Treating Patients With Advanced Solid Tumors	Completed	Unspecified Adult Solid Tumor, Protocol Specific	NCT00054548
Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx Cancer	Completed	Human Papilloma Virus Infection\|Stage III Squamous Cell Carcinoma of the Hypopharynx\|Stage III Squamous Cell Carcinoma of the Larynx\|Stage III Squamous Cell Carcinoma of the Oropharynx\|Stage III Verrucous Carcinoma of the Larynx\|Stage IV Squamous Cell Carcinoma of the Hypopharynx\|Stage IV Verrucous Carcinoma of the Larynx\|Stage IVA Squamous Cell Carcinoma of the Larynx\|Stage IVA Squamous Cell Carcinoma of the Oropharynx\|Stage IVA Verrucous Carcinoma of the Larynx\|Stage IVB Squamous Cell Carcinoma of the Larynx\|Stage IVB Squamous Cell Carcinoma of the Oropharynx\|Stage IVB Verrucous Carcinoma of the Larynx\|Stage IVC Squamous Cell Carcinoma of the Larynx\|Stage IVC Squamous Cell Carcinoma of the Oropharynx\|Stage IVC Verrucous Carcinoma of the Larynx	NCT02048020
Feasibility Study of Metronomic Chemotherapy for Locally Advanced HER2-Negative Breast Cancer	Terminated	Locally Advanced HER2-negative Breast Cancer	NCT01329627
Efficacy and Safety of TC+AVASTIN Versus TC in Patients With Metastatic Nasopharyngeal Carcinoma	Unknown status	Nasopharyngeal Neoplasms	NCT02250599
The Trial Comparing Dose-dense AC-T With PC as Adjuvant Therapy for TNBC	Unknown status	Breast Cancer	NCT01378533
Paclitaxel and Cisplatin as First-Line Treatment for Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer	Unknown status	Ovarian Cancer	NCT00964626
Treatment of Advanced Gastrointestinal Tumors With Albumin Taxol	Not yet recruiting	Advanced Gastrointestinal Tumors	NCT03977077
Clinical Study of Neoadjuvant Therapy With Apatinib and Paclitaxel in Local Advanced Triple-negative Breast Cancer	Unknown status	Triple Negative Breast Cancer	NCT03348098
Zotarolimus-Versus Sirolimus-Versus PacliTaxel-Eluting Stent for Acute Myocardial Infarction Patients	Terminated	Myocardial Infarction	NCT00422565
CCRT With Twice Weekly Paclitaxel and Cisplatin Followed by Surgery for Locally Advanced Esophageal Cancer	Completed	Esophageal Cancer	NCT00154804
Study of Abraxane Plus Hormonal Therapy as Initial Treatment of Unresectable or Metastatic Prostate Cancer	Terminated	Prostatic Neoplasms	NCT00521781
Neratinib and Paclitaxel With or Without Pertuzumab and Trastuzumab Before Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Breast Cancer	Recruiting	ERBB2 Gene Amplification\|Estrogen Receptor Positive\|Inflammatory Breast Carcinoma\|Metastatic Breast Carcinoma\|Progesterone Receptor Positive\|Stage III Breast Cancer AJCC v7\|Stage IIIA Breast Cancer AJCC v7\|Stage IIIB Breast Cancer AJCC v7\|Stage IIIC Breast Cancer AJCC v7\|Stage IV Breast Cancer AJCC v6 and v7	NCT03101748
Clinical Trial on Peripheral Arteries Treated With SeQuentÂ® Please P Paclitaxel Coated Balloon Catheter	Active, not recruiting	Stenosis\|Restenosis	NCT01970579
Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck	Terminated	Squamous Cell Carcinoma of the Head and Neck\|Basaloid Squamous Cell Carcinoma\|Undifferentiated Carcinoma\|Adenosquamous Cell Carcinoma	NCT00570674
Abraxane With Anti-PD1/PDL1 in Patients With Advanced Urothelial Cancer	Suspended	Urothelial Carcinoma	NCT03240016
Trial of TP Versus TC Regimens for Stage IVb, Persistent, or Recurrent Cervical Cancer (JCOG0505, CC-TPTC-P3)	Completed	Uterine Cervical Neoplasms	NCT00295789
Two Different Schedules of Carboplatin, Paclitaxel, Gemcitabine, and Surgery in Treating Patients With Newly Diagnosed Stage IIIC or Stage IV Primary Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer	Unknown status	Fallopian Tube Cancer\|Ovarian Cancer\|Primary Peritoneal Cavity Cancer	NCT00838656
Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer	Active, not recruiting	Recurrent Uterine Corpus Carcinoma\|Stage IIIA Uterine Corpus Cancer AJCC v7\|Stage IIIB Uterine Corpus Cancer AJCC v7\|Stage IIIC Uterine Corpus Cancer AJCC v7\|Stage IVA Uterine Corpus Cancer AJCC v7\|Stage IVB Uterine Corpus Cancer AJCC v7	NCT00063999
Ohio	Cleveland	United States\|MetroHealth Medical Center	Cincinnati
A Study Of PF-05280014 [Trastuzumab-Pfizer] Or HerceptinÂ® [Trastuzumab-EU] Plus Paclitaxel In HER2 Positive First Line Metastatic Breast Cancer Treatment (REFLECTIONS B327-02)	Active, not recruiting	Metastatic Breast Cancer	NCT01989676
Singapore INfra-Genicular Angioplasty With PAclitaxel-eluting Balloon for Critical Limb Ischaemia (SINGA-PACLI) Trial	Completed	Peripheral Arterial Disease	NCT02129634
LUME-Ovar 1: Nintedanib (BIBF 1120) or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer	Completed	Ovarian Neoplasms\|Peritoneal Neoplasms	NCT01015118
Paclitaxel Plus Capecitabine With Capecitabine Maintenance Treatment in Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction	Unknown status	Advanced Gastric Cancer	NCT01015339
A Study Of SU011248 Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel In Patients With Advanced Breast Cancer	Completed	Breast Neoplasms	NCT00373256
High or Standard Intensity Radiation Therapy After Gemcitabine Hydrochloride and Nab-paclitaxel in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery	Terminated	Pancreatic Adenocarcinoma\|Stage III Pancreatic Cancer	NCT01921751
Ph 1B Trial With ADI-PEG 20 Plus Nab-Paclitaxel and Gemcitabine in Subjects With Pancreatic Cancer	Terminated	Advanced Pancreatic Cancer	NCT02101580
Abraxane and RT for Non-Small Cell Lung Cancer (NSCLC)	Withdrawn	Non-small Cell Lung Cancer, Stage III	NCT00903942
Primary Patency in Post-angioplasty Dysfunctional Arteriovenous Fistula in Renal Dialysis: Paclitaxel-releasing PTA Balloon Catheter vs PTA Balloon	Completed	Arteriovenous Fistula Renal Dialysis Devices Obstruction	NCT02565953
Phase II Study of ABI-007 for Gastric Cancer	Completed	Gastric Cancer	NCT00661167
Paclitaxel, Carboplatin, and Panitumumab in Treating Patients With Metastatic Breast Cancer	Terminated	Breast Cancer\|Recurrent Breast Cancer\|Stage IV Breast Cancer	NCT01009983
Lapatinib/Carboplatin/Paclitaxel in Previously Treated Ovarian or Breast Cancer Patients	Completed	Ovarian Epithelial Cancer Stage III\|Stage IV Ovarian Cancer\|Stage IV Breast Cancer	NCT00316407
Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer	Active, not recruiting	Endometrial Adenocarcinoma\|Endometrial Adenosquamous Carcinoma\|Endometrial Clear Cell Adenocarcinoma\|Endometrial Serous Adenocarcinoma\|Recurrent Uterine Corpus Carcinoma\|Stage IIIA Uterine Corpus Cancer AJCC v7\|Stage IIIB Uterine Corpus Cancer AJCC v7\|Stage IIIC Uterine Corpus Cancer AJCC v7\|Stage IVA Uterine Corpus Cancer AJCC v7\|Stage IVB Uterine Corpus Cancer AJCC v7	NCT00977574
BP1001-A in Patients With Advanced or Recurrent Solid Tumors	Not yet recruiting	Solid Tumor, Adult\|Carcinoma, Ovarian Epithelial\|Fallopian Tube Neoplasms\|Endometrial Cancer\|Peritoneal Cancer\|Solid Tumor	NCT04196257
Neoadjuvant Carbo/Paclitaxel Followed by Doxorubicin/Cyclophosphamide in Breast Cancer	Suspended	Breast Cancer\|Triple Negative Breast Cancer	NCT03301350
Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast Cancer	Completed	Breast Cancer	NCT01031446
Neoadjuvant FOLFIRINOX or Nab-paclitaxel With Gemcitabine for Borderline Resectable Pancreatic Cancer	Enrolling by invitation	Borderline Resectable Pancreatic Cancer	NCT02717091
Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I - II Trial	Terminated	Breast Cancer	NCT00041470
Chemotherapy Plus Bevacizumab in Elderly Non-small Cell Lung Cancer Patients	Unknown status	Non-small Cell Lung Cancer (NSCLC)	NCT01980472
Rituxan and Abraxane for the Treatment of Patients With Inoperable Stage III and IV Malignant Melanoma	Unknown status	Malignant Melanoma of Skin Stage III\|Metastatic Melanoma	NCT02142335
Paclitaxel Poliglumex and Capecitabine in Treating Patients With Metastatic Breast Cancer	Completed	Breast Cancer	NCT00265733
Paclitaxel and GM-CSF in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery	Suspended	Melanoma (Skin)	NCT00278122
Optical Coherence Tomography Following Paclitaxel Eluting Stent Implantation in Multivessel Coronary Artery Disease	Completed	Coronary Artery Disease	NCT00704145
Mesothelin-Targeted Immunotoxin LMB-100 in People With Malignant Mesothelioma	Active, not recruiting	Mesothelioma	NCT02798536
A Phase I/II Study of ABI-007 (AbraxaneÂ®, NabÂ®-Paclitaxel)and Vinorelbine in Patients With Stage IV (Metastatic) Breast Cancer	Terminated	Stage IV (Metastatic) Breast Cancer	NCT00140140
Safety and Efficacy of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy	Completed	Ovarian Cancer	NCT02948075
CCRT for Esophageal Cancer.	Completed	Esophageal Cancer\|Concurrent Chemoradiotherapy\|Oxaliplatin\|Paclitaxel	NCT02607982
Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC)	Completed	Carcinoma, Non-Small-Cell Lung	NCT00087802
STA-4783/Paclitaxel or Paclitaxel Alone in Melanoma	Completed	Melanoma	NCT00084214
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors	Recruiting	Ovarian Granulosa Cell Tumor\|Ovarian Gynandroblastoma\|Ovarian Sertoli-Leydig Cell Tumor\|Ovarian Sex Cord Tumor With Annular Tubules\|Ovarian Sex Cord-Stromal Tumor\|Ovarian Sex Cord-Stromal Tumor of Mixed or Unclassified Cell Types\|Ovarian Steroid Cell Tumor	NCT01042522
Dose Escalating Study With BAY43-9006 With Carboplatin, Paclitaxel and Bevacizumab in Untreated Stage IIIb Non-small Cell Lung Cancer (NSCLC)	Completed	Carcinoma, Non-Small-Cell Lung\|Lung Cancer	NCT01069328
A Study of The Safety Profile of First-line Avastin (Bevacizumab) in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Her2-negative Breast Cancer (AVATAX)	Withdrawn	Breast Cancer	NCT01156961
Prospective, Multi-Center, Random. Study of CoStar Paclitaxel-Eluting Coronary Stent(Direct Stenting vs. Pre-Dilatation)	Terminated	Coronary Artery Disease	NCT00440674
Study of Paclitaxel, Estramustine Phosphate and Thalidomide for Patients With Metastatic Androgen-Independent Prostate Carcinoma	Completed	Prostate Cancer	NCT00038246
Study to Evaluate GSK3052230 in Combination With Paclitaxel and Carboplatin, or Docetaxel or as Single Agent in Subjects With Solid Malignancies and Deregulated Fibroblast Growth Factor (FGF) Pathway Signaling	Completed	Neoplasms	NCT01868022
RESOLUTE China RCT	Completed	Ischemic Heart Disease\|Stenotic Coronary Lesion\|Cardiovascular Diseases\|Arteriosclerosis\|Coronary Artery Disease	NCT01334268
European Study of POBA Versus Cotavance(R) Paclitaxel Coated Balloon for the Treatment of Infrapopliteal Lesions in Critical Limb Ischemia (EURO CANAL)	Terminated	PAD	NCT01260870
A Study MLN2480 in Combination With MLN0128 or Alisertib, or Paclitaxel, or Cetuximab, or Irinotecan in Adult Participants With Advanced Nonhematologic Malignancies	Completed	Advanced Nonhematologic Malignancies	NCT02327169
Study of ABI-007 and Taxol in Patients With Metastatic Breast Cancer	Completed	Breast Neoplasms\|Metastases, Neoplasm	NCT00046527
Study of Ombrabulin in Patients With Platinum-Sensitive Recurrent Ovarian Cancer Treated With Carboplatin/Paclitaxel	Completed	Ovarian Cancer Recurrent	NCT01332656
2-arm Trial of Paclitaxel Plus Bevacizumab vs. Capecitabine Plus Bevacizumab	Completed	Metastatic Breast Cancer	NCT00600340
Sorafenib With or Without Paclitaxel and Carboplatin in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer	Completed	Recurrent Fallopian Tube Carcinoma\|Recurrent Ovarian Carcinoma\|Recurrent Primary Peritoneal Carcinoma	NCT00096200
Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer	Active, not recruiting	Esophageal Cancer	NCT00655876
An Efficacy and Safety Study of MORAb-003 in Platinum-Resistant or Refractory Relapsed Ovarian Cancer	Terminated	Ovarian Cancer	NCT00738699
Paclitaxel in Treating Patients With Lung Cancer	Completed	Lung Cancer	NCT00002972
Erlotinib, Trastuzumab, and Paclitaxel in Treating Patients With Advanced Solid Tumors	Completed	Unspecified Adult Solid Tumor, Protocol Specific	NCT00042809
Neoadjuvant Study of Two Platinum Regimens in Triple Negative Breast Cancer	Completed	Triple-negative Breast Cancer	NCT02413320
A Study of Bevacizumab With Carboplatin and Paclitaxel Chemotherapy for the First-Line Treatment of Patients With Metastatic Melanoma	Completed	Melanoma	NCT00434252
Paclitaxel Eluting Stent in Long SFA Obstruction: A Prospective, Randomized Comparison With Bypass Surgery	Recruiting	Chronic Lower Limb Ischemia\|Peripheral Athero Obstructive Disease\|Critical Ischemia\|Claudication	NCT01450722
Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy	Recruiting	Recurrent Cervical Carcinoma\|Persistent Advanced Cervical Carcinoma\|Chemotherapy\|Anti-PD-1 Antibody\|Immunotherapy	NCT04188860
Cediranib, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer	Completed	Lung Cancer	NCT00795340
Paclitaxel in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer	Completed	Head and Neck Cancer	NCT00002632
Induction Chemotherapy Using Paclitaxel, Carboplatin, CPT-11 With Pegfilgrastim	Completed	Non Small Cell Lung Cancer	NCT00280787
Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer	Completed	Fallopian Tube Clear Cell Adenocarcinoma\|Fallopian Tube Endometrioid Adenocarcinoma\|Fallopian Tube Mucinous Adenocarcinoma\|Fallopian Tube Serous Adenocarcinoma\|Fallopian Tube Transitional Cell Carcinoma\|Malignant Ovarian Mixed Epithelial Tumor\|Ovarian Brenner Tumor\|Ovarian Clear Cell Adenocarcinoma\|Ovarian Endometrioid Adenocarcinoma\|Ovarian Mucinous Adenocarcinoma\|Ovarian Serous Adenocarcinoma\|Ovarian Transitional Cell Carcinoma\|Primary Peritoneal Serous Adenocarcinoma\|Stage IIIA Fallopian Tube Cancer\|Stage IIIA Ovarian Cancer\|Stage IIIA Primary Peritoneal Cancer\|Stage IIIB Fallopian Tube Cancer\|Stage IIIB Ovarian Cancer\|Stage IIIB Primary Peritoneal Cancer\|Stage IIIC Fallopian Tube Cancer\|Stage IIIC Ovarian Cancer\|Stage IIIC Primary Peritoneal Cancer\|Stage IV Fallopian Tube Cancer\|Stage IV Ovarian Cancer\|Stage IV Primary Peritoneal Cancer\|Undifferentiated Fallopian Tube Carcinoma\|Undifferentiated Ovarian Carcinoma	NCT00262847
Winston-Salem	United States\|Southeast Cancer Consortium-Upstate NCORP	North Carolina	United States\|Novant Health Oncology Specialists
Treatment of In-Stent Restenosis 2 Study	Recruiting	Coronary Restenosis	NCT03667313
A Study of Carboplatin/Paclitaxel With Pegfilgrastim Supported by Haematopoietic Progenitor Cell Re-Infusion in Whole Blood	Completed	Breast Cancer\|Lung Cancer\|Ovarian Cancer	NCT00117442
Trial of ABI-007 Administered Weekly in Chemotherapy Naive Patients With Advanced Non-Small Cell Lung Cancer	Completed	Non-Small Cell Lung Cancer	NCT00073723
Abraxane and Temodar Plus Genasense in Advanced Melanoma	Unknown status	Melanoma	NCT00409383
Study of Neoadjuvant MyocetÂ®, Paclitaxel, Pertuzumab, and Trastuzumab in HER2-positive Breast Cancer	Completed	Breast Cancer	NCT01669239
Bevacizumab Study With Carboplatin & Paclitaxel in Ovarian, Fallopian Tube or Primary Peritoneal Cancer	Terminated	Ovarian Cancer\|Peritoneal Cancer\|Fallopian Tube Cancer\|Stage 3 Cancer\|Stage 4 Cancer	NCT00408070
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer	Recruiting	Breast Adenocarcinoma\|Estrogen Receptor Negative\|HER2/Neu Negative\|Progesterone Receptor Negative\|Stage IB Breast Cancer\|Stage IIA Breast Cancer\|Stage IIB Breast Cancer\|Stage IIIA Breast Cancer\|Stage IIIC Breast Cancer\|Triple-Negative Breast Carcinoma	NCT02488967
Louisiana	Shreveport	United States\|Harold Alfond Center for Cancer Care	Shreveport
Ohio	Maumee	United States\|Toledo Radiation Oncology at Northwest Ohio Onocolgy Center	Marion
Phenoxodiol Combined With Either Cisplatin or Paclitaxel in Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer	Completed	Fallopian Tube Cancer\|Ovarian Cancer\|Primary Peritoneal Cavity Cancer	NCT00091377
Paclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by Surgery	Active, not recruiting	Male Breast Carcinoma\|Stage IIA Breast Cancer AJCC v6 and v7\|Stage IIB Breast Cancer AJCC v6 and v7\|Stage IIIA Breast Cancer AJCC v7\|Stage IIIB Breast Cancer AJCC v7\|Stage IIIC Breast Cancer AJCC v7	NCT00770809
Metformin in Combined With Cisplatin Plus Paclitaxel With Advanced Esophageal Squamous Cell Carcinoma (ECMTPneo)	Not yet recruiting	Esophageal Squamous Cell Carcinoma	NCT03833466
A Study of ABTL0812 in Pancreatic Cancer	Not yet recruiting	Pancreatic Cancer	NCT03417921
Paclitaxel With or Without Carboplatin in Treating Patients With Advanced Non-small Cell Lung Cancer	Completed	Lung Cancer	NCT00003117
Treatment of Coronary In-Stent Restenosis	Unknown status	Restenosis	NCT01735825
Retrospective Study of Ramucirumab and Paclitaxel in Gastric or Gastroesophageal Junction Adenocarcinoma	Not yet recruiting	Gastric or Gastroesophageal Junction Adenocarcinoma	NCT04192734
Study on Neutropenia Induced by Adjuvant Paclitaxel/Carboplatin Chemotherapy in Patients With Epithelial Ovarian Cancer	Unknown status	Epithelial Ovarian Cancer	NCT01680575
Study of NOV-002 in Combination With Chemotherapy to Treat Lung Cancer	Completed	Non Small Cell Lung Cancer	NCT00347412
Study of Atezolizumab Combination Carboplatin + Paclitaxel + Bevacizumab in EGRF Mutation or ALK Translocation NSCLC	Not yet recruiting	Non-small Cell Lung Cancer	NCT03991403
Neoadjuvant MEDI4736 Concomitant With Weekly Nab-paclitaxel and Dose-dense AC for Stage I-III Triple Negative Breast Cancer	Recruiting	Breast Neoplasms	NCT02489448
Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung Cancer	Unknown status	Carcinoma, Non-Small-Cell Lung\|Carcinoma, Squamous Cell	NCT01494415
Paclitaxel and Carboplatin in Treating Patients With Locally Advanced or Metastatic Renal Cell Cancer	Completed	Kidney Cancer	NCT00077129
Paclitaxel in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia	Completed	Leukemia	NCT00003230
TEW-7197 With Paclitaxel for the Treatment of Metastatic Gastric Cancer	Recruiting	Metastatic Gastric Cancer	NCT03698825
PERVIDEO I Registry, The Lutonix Paclitaxel-Coated Balloon Catheter for the Treatment of Coronary In-Stent Restenosis	Completed	In-Stent Restenosis	NCT00916279
Neoadjuvant Carboplatin, Weekly Abraxane and Trastuzumab in HER2+ Breast Cancer	Completed	Breast Cancer	NCT00617942
Paclitaxel or Docetaxel in Treating Women With Advanced Breast Cancer	Completed	Breast Cancer	NCT00002662
Phase â…ˇ Clinical Study of R435 (Bevacizumab) in Combination With Paclitaxel in Patients With Inoperable Metastatic Breast Cancer	Completed	Metastatic Breast Cancer	NCT00467012
Global Study of a Drug-coated Balloon to Treat Obstructive SFA and/or Popliteal Lesions	Active, not recruiting	Peripheral Arterial Disease	NCT01927068
BAY 43-9006 in Previously Untreated Patients With Non-Small Cell Lung Cancer (NSCLC)	Completed	Lung Cancer	NCT00533585
Efficacy Study of Gemcitabine-Paclitaxel to Treat Metastatic Breast Cancer	Completed	Metastatic Breast Cancer	NCT00316199
Paclitaxel and Celecoxib in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer	Terminated	Ovarian Cancer\|Primary Peritoneal Cavity Cancer	NCT00084448
Cisplatin Plus Etoposide With or Without Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer	Completed	Lung Cancer	NCT00003299
A Study of Trastuzumab Emtansine, Paclitaxel, and Pertuzumab in Patients With HER2-Positive, Locally Advanced or Metastatic Breast Cancer	Completed	Metastatic Breast Cancer	NCT00951665
Celecoxib, Paclitaxel, and Carboplatin in Treating Patients With Cancer of the Esophagus	Completed	Esophageal Cancer	NCT00066716
Safety Study of the Vascular Wrap Paclitaxel-Eluting Mesh for Hemodialysis Vascular Access	Terminated	End Stage Renal Failure on Dialysis\|Hyperplasia	NCT01033357
Abraxane, Avastin, and Gemcitabine as First-Line Therapy for Patients With Metastatic Breast Cancer	Completed	Breast Cancer	NCT00503906
Paclitaxel With or Without Gemcitabine in Treating Women With Advanced Breast Cancer	Completed	Breast Cancer	NCT00006459
Study Comparing Paclitaxel Plus Carboplatin Versus Anthracyclines Followed by Docetaxel as Adjuvant Chemotherapy for Triple Negative Breast Cancer (PATTERN)	Completed	Breast Cancer	NCT04031703
Concomitant Chemoradiotherapy With Weekly Paclitaxel and Vinorelbine and Granulocyte Colony Stimulating Factor (GCSF) Support in Patients With Advanced Breast Cancer	Completed	Breast Cancer	NCT00724386
Safety and Tolerability of Oral LCL161 in Japanese Adult Patients With Advanced Solid Tumors	Completed	Neoplasms	NCT01968915
A Study of Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel, or Vinflunine for Participants With Advanced Urothelial Cancer (MK-3475-045/KEYNOTE-045)	Active, not recruiting	Urothelial Cancer	NCT02256436
Radiation Therapy, Bevacizumab, Paclitaxel, and Carboplatin in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer at High Risk for Hemoptysis Caused by Bevacizumab	Completed	Adenosquamous Cell Lung Cancer\|Drug/Agent Toxicity by Tissue/Organ\|Hemoptysis\|Squamous Cell Lung Cancer\|Stage IIIB Non-small Cell Lung Cancer\|Stage IV Non-small Cell Lung Cancer	NCT00387374
Paclitaxel With or Without PSC 833 in Treating Patients With Metastatic Breast Cancer	Completed	Breast Cancer	NCT00002937
Calcitriol Plus Paclitaxel in Treating Patients With Advanced Solid Tumors	Completed	Unspecified Adult Solid Tumor, Protocol Specific	NCT00009802
A Phase 1-2 XIAP Antisense AEG35156 With Carboplatin and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer	Terminated	Carcinoma, Non-Small-Cell Lung	NCT00558922
Effect of Chemotherapy With Paclitaxel/Cisplatin on Development Dysgeusia in Non Small Cell Lung Cancer	Completed	Non-Small Cell Lung Cancer\|Dysgeusia\|Taste Disorders\|Lung Neoplasms\|Small Cell Lung Carcinoma	NCT01540045
An Open-Label Study of Ruxolitinib Given With Chemotherapy in Patients With Advanced Solid Tumors	Terminated	Solid Tumors\|Pancreatic Cancer	NCT01822756
Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery	Active, not recruiting	Estrogen Receptor Negative\|HER2/Neu Negative\|Male Breast Carcinoma\|Progesterone Receptor Negative\|Stage IIA Breast Cancer AJCC v6 and v7\|Stage IIB Breast Cancer AJCC v6 and v7\|Stage IIIA Breast Cancer AJCC v7\|Triple-Negative Breast Carcinoma	NCT00861705
Wisconsin	Racine	United States\|HSHS Saint Nicholas Hospital	Oconto Falls
Phase II Study in Patients With Epidermal Growth Factor Receptor (EGFR) + Advanced Stage Ovarian, Primary Peritoneal and Fallopian Tube Cancer	Completed	Ovarian Cancer\|Peritoneal Neoplasms\|Fallopian Tube Neoplasms	NCT00063401
Gemcitabine, Carboplatin or Paclitaxel Plus Radiation Therapy in Treating Patients With Stage IIIA or IIIB Non-Small Cell Lung Cancer	Completed	Lung Cancer	NCT00016315
Caelyx Plus Carboplatin Versus Paclitaxel Plus Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse	Completed	Ovarian Cancer\|Fallopian Tube Cancer	NCT00189553
Phase 2 AMG 386 in Comb. Paclitaxel for Subjects With Advanced Recurrent Epithelial Ovarian or Primary Peritoneal Cancer	Completed	Ovarian Cancer\|Fallopian Tube Cancer\|Primary Peritoneal Cancer	NCT00479817
Gemcitabine and Nab-paclitaxel Combined With Momelotinib in Participants With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma	Terminated	Metastatic Pancreatic Ductal Adenocarcinoma	NCT02101021
Capecitabine Associated With Weekly Paclitaxel in Metastatic Breast Cancer.	Completed	Breast Cancer\|Neoplasm Metastasis	NCT00270491
ROCKIF Trial: Re-sensitization of Carboplatin-resistant Ovarian Cancer With Kinase Inhibition of FAK	Recruiting	Ovarian Cancer	NCT03287271
Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer	Completed	Cervical Adenocarcinoma\|Cervical Adenosquamous Carcinoma\|Cervical Squamous Cell Carcinoma\|Recurrent Cervical Carcinoma\|Stage IVB Cervical Cancer	NCT00803062
South Dakota	Sioux Falls	United States\|Medical X-Ray Center	Sioux Falls
Nab-Paclitaxel, Capecitabine, and Radiation Therapy Following Induction Chemotherapy in Treating Patients With Locally Advanced Pancreatic Cancer	Active, not recruiting	Borderline Resectable Pancreatic Adenocarcinoma\|Locally Advanced Pancreatic Adenocarcinoma\|Pancreatic Adenocarcinoma\|Stage II Pancreatic Cancer AJCC v6 and v7\|Stage IIA Pancreatic Cancer AJCC v6 and v7\|Stage IIB Pancreatic Cancer AJCC v6 and v7\|Stage III Pancreatic Cancer AJCC v6 and v7	NCT02394535
Neo-adjuvant Gemcitabine, Epirubicin, ABI-007 (GEA) in Locally Advanced or Inflammatory Breast Cancer	Completed	Breast Cancer	NCT00193206
Phase1 of Neratinib+Trastuzumab, Pertuzumab, Paclitaxel in Patients With Advanced Solid Tumors/HER2+	Terminated	Solid Tumor	NCT02593708
Broncho-Adventitial Delivery of Paclitaxel to Extend Airway Patency in Malignant Airway Obstruction Patients	Completed	Malignant Airway Obstruction Secondary to Non-small Cell Lung Cancer	NCT02066103
A Randomized, Double-Blind, Controlled Study of the Safety and Performance of the NIRxâ„˘ Paclitaxel-Coated Conformer Coronary Stent	Completed	Coronary Artery Disease	NCT00299026
Paclitaxel With or Without Carboplatin in Treating Women With Metastatic Breast Cancer	Unknown status	Breast Cancer	NCT00025688
Study of Carboplatin/Paclitaxel in Combination With ABT-869 in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)	Completed	Advanced or Metastatic Non-Small Cell Lung Cancer	NCT00716534
Gemcitabine With Abraxane and Other Investigational Therapies in Neoadjuvant Treatment of Pancreatic Adenocarcinoma	Completed	Pancreatic Cancer	NCT01470417
FREERIDE STUDY, Freeway Paclitaxel Coated Balloon Catheter to Treat Peripheral Artery Disease	Unknown status	Peripheral Artery Disease	NCT01960647
Paclitaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Vulva	Completed	Vulvar Cancer	NCT00014599
Bevacizumab With Abraxane in Patients With Recurrent Ovarian/ Peritoneal Cancer	Completed	Epithelial Ovarian Cancer\|Primary Peritoneal Carcinoma	NCT00407563
Methotrexate Compared With Paclitaxel in Treating Patients With Advanced Head and Neck Cancer	Completed	Head and Neck Cancer	NCT00003592
Prevention of Restenosis Following Revascularization	Terminated	Vascular Disease, Peripheral	NCT00518284
A Trial Evaluating the Efficacy and Safety of EndoTAGÂ®-1 in Combination With Paclitaxel and Gemcitabine Compared With Paclitaxel and Gemcitabine as First-line Therapy in Patients With Visceral Metastatic Triple-negative Breast Cancer	Recruiting	Triple-Negative Breast Cancer	NCT03002103
Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)	Recruiting	Ovarian Cancer\|Ovarian Neoplasms\|Ovarian Carcinosarcoma\|Ovarian Serous Adenocarcinoma\|Ovarian Endometrioid Adenocarcinoma\|Ovarian Clear Cell Adenocarcinoma\|Fallopian Tube Cancer\|Fallopian Tube Neoplasms\|Primary Peritoneal Carcinoma\|Primary Peritoneal Serous Adenocarcinoma	NCT03648489
Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer	Completed	Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma\|Recurrent Metastatic Squamous Neck Cancer With Occult Primary\|Recurrent Salivary Gland Cancer\|Recurrent Squamous Cell Carcinoma of the Hypopharynx\|Recurrent Squamous Cell Carcinoma of the Larynx\|Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity\|Recurrent Squamous Cell Carcinoma of the Nasopharynx\|Recurrent Squamous Cell Carcinoma of the Oropharynx\|Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity\|Recurrent Verrucous Carcinoma of the Larynx\|Recurrent Verrucous Carcinoma of the Oral Cavity\|Salivary Gland Squamous Cell Carcinoma\|Stage IV Salivary Gland Cancer\|Stage IV Squamous Cell Carcinoma of the Hypopharynx\|Stage IV Squamous Cell Carcinoma of the Larynx\|Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity\|Stage IV Squamous Cell Carcinoma of the Nasopharynx\|Stage IV Squamous Cell Carcinoma of the Oropharynx\|Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity\|Stage IV Verrucous Carcinoma of the Larynx\|Stage IV Verrucous Carcinoma of the Oral Cavity\|Tongue Cancer\|Untreated Metastatic Squamous Neck Cancer With Occult Primary	NCT01316757
A Study of the Safety and Pharmacology Of PI3-Kinase Inhibitor GDC-0941 In Combination With Either Paclitaxel And Carboplatin (With or Without Bevacizumab) or Pemetrexed, Cisplatin, And Bevacizumab in Patients With Advanced Non-Small Cell Lung Cancer	Completed	Non-Squamous Non-Small Cell Lung Cancer	NCT00974584
MITO-2: A Study Comparing 2 Chemotherapy Regimens (Carboplatin/Liposomal Doxorubicin vs Carboplatin/Paclitaxel) in Patients With Ovarian Cancer	Unknown status	Ovarian Cancer	NCT00326456
Paclitaxel Plus L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphomas	Completed	Lymphoma\|Unspecified Adult Solid Tumor, Protocol Specific	NCT00004057
To Evaluate the Efficacy and Safety of SCT510 in the Treatment of Non-small Cell Lung Cancer	Not yet recruiting	Non-squamous Cell Non-small Cell Lung Cancer	NCT03792074
Paclitaxel With or Without Trastuzumab Following Peripheral Stem Cell Transplantation in Treating Patients With Refractory Stage IV Breast Cancer	Completed	Breast Cancer	NCT00004013
An "All-Comers" Study of the AgentTM MONORAILTM Paclitaxel-Coated PTCA Balloon Catheter Used in Real-World Clinical Practice in Chinese Patients	Recruiting	Chinese Patients Treated With Agent DCB	NCT04085445
Endoscopic Ultrasound (EUS)-Guided Ablation of Pancreatic Cysts	Recruiting	Pancreatic Cyst\|Pancreatic Intraductal Papillary-Mucinous Neoplasm\|Cystadenoma, Mucinous\|Papillary Mucinous Cystadenoma, Borderline Malignancy	NCT01643460
Study of Metformin Plus Paclitaxel/Carboplatin/Bevacizumab in Patients With Adenocarcinoma.	Terminated	Carcinoma, Non-Small-Cell Lung\|Lung Adenocarcinoma	NCT01578551
Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer	Completed	Ovarian Cancer\|Primary Peritoneal Cavity Cancer	NCT00005046
Phase II Trial of a 96-Hour Continuous Infusion of Paclitaxel Followed by Cisplatin for Patients With Stage III/IV and Relapsed NSCLC	Completed	Carcinoma, Non-Small-Cell Lung\|Lung Neoplasms	NCT00001450
Taxol(Paclitaxel),UFT and Leucovorin in Patients With Advanced Gastric Cancer	Completed	Gastric Cancer	NCT00154778
Study In Women And Men With Metastatic Breast Cancer That Have Overexpression Of ErbB2	Active, not recruiting	Neoplasms, Breast	NCT00281658
A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer	Completed	Breast Cancer	NCT00789581
TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer	Completed	Malignant Ovarian Mixed Epithelial Tumor\|Ovarian Brenner Tumor\|Ovarian Clear Cell Cystadenocarcinoma\|Ovarian Endometrioid Adenocarcinoma\|Ovarian Mucinous Cystadenocarcinoma\|Ovarian Serous Cystadenocarcinoma\|Recurrent Fallopian Tube Carcinoma\|Recurrent Ovarian Carcinoma\|Recurrent Primary Peritoneal Carcinoma\|Undifferentiated Ovarian Carcinoma	NCT01294293
Paclitaxel, Carboplatin And Low Dose Radiation As Induction Therapy In Locally Advanced Head And Neck Cancer	Completed	Squamous Cell Carcinoma	NCT00176267
High-Dose or Low-Dose Vorinostat in Combination With Carboplatin or Paclitaxel in Treating Patients With Advanced Solid Tumors	Active, not recruiting	Adult Solid Neoplasm	NCT01281176
The SOS (Stenting Of Saphenous Vein Grafts) Trial	Completed	Coronary Artery Bypass\|Arteriosclerosis	NCT00247208
Phase 2 Study of Gemzar, Taxol & Avastin Combination as 1st Line Treatment for Metastatic Breast Cancer	Completed	Breast Cancer\|Metastatic Breast Cancer	NCT00403130
A Study of Intraperitoneal Paclitaxel in Combination With SOX Compared With SOX Alone in Gastric Cancer With Malignant Ascites	Recruiting	Gastric Cancer\|Stomach Neoplasms	NCT03475615
Azacitidine With Carboplatin and Paclitaxel for Newly Diagnosed Ovarian Cancer	Withdrawn	Ovarian Cancer	NCT00842582
Evaluate the Efficacy and Safety of IBI305 in Patients With Advanced or Recurrent Non-squamous NSCLC	Active, not recruiting	NSCLC	NCT02954172
A Trial of 2 Schedules of Ixabepilone Plus Bevacizumab and Paclitaxel Plus Bevacizumab for Breast Cancer	Completed	Metastatic Breast Cancer	NCT00370552
Paclitaxel and Carboplatin With or Without Cediranib Maleate in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer	Completed	Lung Cancer	NCT00245154
A Trial of ABI-010 & ABI-007 in Patients With Advanced Non-Hematologic Malignancies	Withdrawn	Solid Tumor	NCT00820768
A Study To Evaluate the Efficacy and Safety Of Atezolizumab or Placebo in Combination With Neoadjuvant Doxorubicin + Cyclophosphamide Followed By Paclitaxel + Trastuzumab + Pertuzumab In Early Her2-Positive Breast Cancer	Recruiting	Breast Cancer	NCT03726879
Paclitaxel Plus Gemcitabine in Treating Patients With Refractory Metastatic Germ Cell Tumors	Completed	Ovarian Cancer\|Testicular Germ Cell Tumor	NCT00003518
Efficacy/Safety of Imprime PGGÂ® Injection With Bevacizumab and Paclitaxel/Carboplatin in Patients With Untreated Advanced Non-Small Cell Lung Cancer (NSCLC)	Completed	Non-Small Cell Lung Cancer	NCT00874107
Bevacizumab Plus Paclitaxel Optimization Study With Interventional Aintenance Endocrine Therapy in Breast Cancer